company_name,website_timestamp,preclinical_stage,drug_molecule,target,therapeutic_area,target_type,development_stage,small_molecules,small_molecules_keyword,small_molecules_source_url,peptides,peptides_keyword,peptides_source_url,proteins,proteins_keyword,proteins_source_url,antibodies,antibodies_keyword,antibodies_source_url,antibody_conjugates,antibody_conjugates_keyword,antibody_conjugates_source_url,fusion_proteins,fusion_proteins_keyword,fusion_proteins_source_url,nucleic_acid_therapeutics,nucleic_acid_therapeutics_keyword,nucleic_acid_therapeutics_source_url,gene_cell_therapies,gene_cell_therapies_keyword,gene_cell_therapies_source_url,vaccines,vaccines_keyword,vaccines_source_url,protein_degraders,protein_degraders_keyword,protein_degraders_source_url,other_modalities,other_modalities_keyword,other_modalities_source_url
equillium inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.e,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,Yes,First-in-class structured-domain peptides that inhibit multiple disease driving cytokines,https://www.equilliumbio.com/home/default.aspx,No,,,Yes,"Our lead product candidate, itolizumab, is a first-in-class monoclonal antibody",https://www.linkedin.com/company/equillium,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pyxis oncology inc,2025-10-13 20:08:07,Yes,micvotabart pelidotin,Not specified,oncology,other,Phase 1,No,,,No,,,No,,,Yes,investigational fully human IgG1 Siglec-15-targeting antibody,https://stockanalysis.com/stocks/pyxs/company/,Yes,antibody-drug conjugates (ADCs),https://www.linkedin.com/company/pyxis-oncology,No,,,No,,,No,,,No,,,No,,,No,,
xilio therapeutics inc,2025-10-06 14:09:32,Yes,Vilastobart; Efarindodekin Alfa; XTX501; PSMA; CLDN18.2; STEAP1,"CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4; PD-L1, Programmed Death-Ligand 1; IL-12, Interleukin-12; PD-1, Programmed Cell Death Protein 1; IL-2, Interleukin-2; PSMA, Prostate-Specific Membrane Antigen; CLDN18.2, Claudin 18.2; STEAP1, Six Transmembrane Epithelial Antigen of Prostate 1",oncology,immune checkpoint; cytokine; other,Phase 1,No,,,No,,,Yes,tumor-activated cytokines,https://www.prnewswire.com/news-releases/abbvie-and-xilio-therapeutics-announce-collaboration-and-option-agreement-to-develop-novel-tumor-activated-immunotherapies-302371535.html,Yes,tumor-activated antibodies,https://www.prnewswire.com/news-releases/abbvie-and-xilio-therapeutics-announce-collaboration-and-option-agreement-to-develop-novel-tumor-activated-immunotherapies-302371535.html,No,,,No,,,No,,,No,,,No,,,No,,,Yes,masked T-cell engagers,https://www.prnewswire.com/news-releases/abbvie-and-xilio-therapeutics-announce-collaboration-and-option-agreement-to-develop-novel-tumor-activated-immunotherapies-302371535.html
spur therapeutics ltd,No timestamp found,Yes,SBT101,Not specified,rare diseases,Not specified,Preclinical,No,,,No,,,Yes,"GCase85, a version of the GCase enzyme that was rationally engineered by our scientists for improved stability",https://www.linkedin.com/company/spurtherapeutics,No,,,No,,,No,,,No,,,Yes,AAV gene therapy candidate for Gaucher disease and GBA1 Parkinson's disease,https://www.linkedin.com/company/spurtherapeutics,No,,,No,,,No,,
medalliance llc,2021-04-17 00:00:00,No,SELUTION SLR,Not specified,cardiovascular; peripheral vascular,Not specified,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kadmon holdings inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Rezurock; belumosudil,"ROCK2, Rho-associated coiled-coil kinase 2",immunology; fibrotic diseases,kinases,Approved,Yes,"Rezurock™ (belumosudil), an FDA-approved, first-in-class treatment",https://www.sanofi.com/en/media-room/press-releases/2021/2021-09-08-05-00-00-2293017,No,,,No,,,No,,,No,,,Yes,"KD033, an anti-PD-L1/IL-15 fusion protein",https://www.linkedin.com/company/kadmon-corporation-llc,No,,,No,,,No,,,No,,,No,,
spruce biosciences inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"tildacerfont, a non-steroidal therapy",https://www.marketbeat.com/instant-alerts/spruce-biosciences-sprb-sell-d-rating-reaffirmed-at-weiss-ratings-2025-10-14/,No,,,Yes,tralesinidase alfa enzyme replacement therapy (TA-ERT),https://www.linkedin.com/company/spruce-biosciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kelonia therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,KLN-1010,"BCMA, B-Cell Maturation Antigen",oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo,https://www.linkedin.com/company/kelonia-therapeutics,No,,,No,,,No,,
forward therapeutics inc,2023-11-08 07:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,small molecule biotech focused on creating transformative immunology drugs,https://www.linkedin.com/company/forward-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
guangzhou yinming biomedical technology co ltd,2021-09-09 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
858 therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,ETX-19477; QPCT/L; METTL3; ADAR1,"PARG, Poly(ADP-ribose) glycohydrolase; QPCT/L; METTL3; ADAR1",oncology; immunology,enzyme; other; other; other,Phase 1; Preclinical; Preclinical; Preclinical,Yes,Discovering innovative small molecule therapeutics for the treatment of cancer,https://www.linkedin.com/company/858-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ashvattha therapeutics llc,2025-10-14 13:00:29,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,link known small molecule drugs to HDs for selective delivery,https://www.linkedin.com/company/ashvattha-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developing a nanomedicine therapeutic that traverses the blood-retinal barrier,https://www.globenewswire.com/news-release/2025/10/14/3166111/0/en/Ashvattha-Therapeutics-Appoints-Ophthalmology-Veteran-Robert-J-Dempsey-as-Interim-CEO-Following-Positive-Phase-2-Results-and-FDA-Alignment-on-Pivotal-Program.html
lykos therapeutics,2025-06-30 00:00:00,Yes,MDMA,"PTSD, Post-Traumatic Stress Disorder",CNS; mental health,other,Not specified,Yes,MDMA capsules to treat PTSD,https://www.statnews.com/2024/08/15/lykos-therapeutics-cuts-75-of-staff-after-fda-rejects-mdma-assisted-therapy/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"psychedelics, MDMA-assisted therapy",https://www.npr.org/sections/shots-health-news/2024/08/09/nx-s1-5068634/mdma-therapy-fda-decision-ptsd-psychedelic-treatment
rycarma therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='endpts.com', port=443): ",No,ARM210; Rycals,"RyR, Ryanodine Receptor",cardiovascular; rare diseases; skeletal muscle diseases,ion channels,Phase 2,Yes,first-in-class small molecule therapeutics,https://www.linkedin.com/company/rycarma,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
beijing kanova biopharmaceutical co ltd,"Error: Connection failed - HTTPConnectionPool(host='en.kanovabiopharma.com', ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,recombinant humanized monoclonal antibody against IL-25,https://pubmed.ncbi.nlm.nih.gov/39815604/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
suzhou xinkanghe biomedical technology co ltd,"Error: Connection failed - HTTPConnectionPool(host='en.kanovabiopharma.com', ",Yes,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,Yes,Homo sapiens Interleukin-25 Proteins,https://patents.google.com/patent/CN112638940A/en,Yes,anti-IL-25 antibodies,https://patents.google.com/patent/CN112638940A/en,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ausper biopharma co ltd,2025-05-28 12:20:06,No,AHB-137,"Disease Name, Chronic Hepatitis B",infectious diseases,other,Phase 3,No,,,No,,,No,,,Yes,therapeutic antibodies,https://www.ventureradar.com/organisation/Ausper%20Biopharma/5c31ed06-c14d-4d4a-960b-bba3c4bd2416,No,,,No,,,Yes,antisense oligonucleotide (ASO),https://www.prnewswire.com/news-releases/ausperbio-raises-50-million-in-series-b-to-advance-functional-cure-for-chronic-hepatitis-b-302467345.html,No,,,Yes,mRNA vaccines,https://www.ventureradar.com/organisation/Ausper%20Biopharma/5c31ed06-c14d-4d4a-960b-bba3c4bd2416,No,,,No,,
neonc technologies inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,NEO100; NEO212,Disease Name,oncology; central nervous system cancers,other,Phase 2,Yes,"NEO212 is NeOnc’s first oral chemical conjugated chemotherapy drug, uniquely combining Temozolomide (TMZ).",https://lnkd.in/gD6MUkyE,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
suzhou medilink therapeutics ltd,2024-01-02 09:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,highly specific c-Met antibody,https://www.prnewswire.com/news-releases/medilink-therapeutics-announces-worldwide-collaboration-and-license-agreement-with-roche-to-develop-next-generation-antibody-drug-conjugate-in-oncology-302024162.html,Yes,Antibody Drug Conjugates,https://www.linkedin.com/company/mltx,No,,,No,,,No,,,No,,,No,,,No,,
bioaegis therapeutics inc,Error: Connection failed - HTTPSConnectionPool(host='www.bioaegistherapeutics,No,rhu-pGSN,"NLRP3, NLR Family Pyrin Domain Containing 3",inflammatory diseases,cytokine,Phase 2,No,,,No,,,Yes,recombinant human plasma gelsolin (rhu-pGSN),https://www.linkedin.com/company/bioaegis-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
biosimilar solutions llc,Error: Connection failed - HTTPSConnectionPool(host='biosimilarsolutions.com',Yes,ADL-018,"IgE, Immunoglobulin E",immunology,other,Phase 3,No,,,No,,,Yes,recombinant proteins,https://ocyonbio.com/ocyonbio-announces-biosimilar-solutions-to-begin-gmp-manufacturing-in-puerto-rico/,Yes,"monoclonal antibodies (mammalian, microbial cell culture)",https://ocyonbio.com/ocyonbio-announces-biosimilar-solutions-to-begin-gmp-manufacturing-in-puerto-rico/,No,,,No,,,No,,,Yes,"gene therapy, biological products",https://ocyonbio.com/ocyonbio-announces-biosimilar-solutions-to-begin-gmp-manufacturing-in-puerto-rico/,Yes,Covid-19 vaccine,https://ocyonbio.com/ocyonbio-announces-biosimilar-solutions-to-begin-gmp-manufacturing-in-puerto-rico/,No,,,No,,
aeovian pharmaceuticals inc,2024-03-28 09:00:00,No,AV078,"mTORC1, Mechanistic Target of Rapamycin Complex 1",CNS; rare diseases,kinases,Phase 1,Yes,developing targeted and highly selective small molecules,https://www.aeovian.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
liquidia corp,2025-10-07 12:17:08,Yes,YUTREPIA; L606; Treprostinil Injection,"Disease Name, Pulmonary Arterial Hypertension; Disease Name, Pulmonary Hypertension Associated with Interstitial Lung Disease",cardiopulmonary diseases; rare diseases,other,Phase 3; Approved; Marketed,Yes,Treprostinil Injection,"https://www.linkedin.com/company/liquidia-corporation#:~:text=Liquidia%20Corporation%20is%20a%20biopharmaceutical,of%20its%20PRINT%C2%AE%20Technology.",No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
liquidia technologies inc,2025-10-07 12:17:08,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Liquidia has developed YUTREPIA™ (treprostinil) inhalation powder,https://www.linkedin.com/company/liquidia-corporation,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Liquidia is also developing L606, an investigational liposomal formulation of treprostinil",https://www.linkedin.com/company/liquidia-corporation
transcend therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,TSND-201,Monoamine Transporters,CNS,other,Phase 3,Yes,"TSND-201, a rapid-acting neuroplastogen, is a proprietary formulation of methylone",https://www.prnewswire.com/news-releases/transcend-therapeutics-receives-breakthrough-therapy-designation-for-tsnd-201-methylone-for-the-treatment-of-ptsd-302501928.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ariceum therapeutics gmbh,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers,https://www.prnewswire.com/news-releases/ariceum-therapeutics-and-eckert--ziegler-sign-global-supply-agreement-for-the-development-of-next-generation-radiotherapeutics-for-precision-cancer-treatments-302322822.html
ym biosciences inc. (inactive),Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,CYT387; idelalisib; simtuzumab,"JAK1, Janus Kinase 1; JAK2, Janus Kinase 2; LOXL2, Lysyl Oxidase-Like 2; PI3K delta, Phosphoinositide-3 Kinase Delta Isoform",oncology; hematology; inflammation; fibrotic diseases,kinases; enzyme; other,Phase 3; Phase 2,Yes,"CYT 387, a JAK 1/2 small molecule inhibitor",https://www.newswire.ca/news-releases/ym-biosciences-closes-us175-million-financing-539559901.html,No,,,No,,,Yes,"nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM)",https://www.newswire.ca/news-releases/ym-biosciences-closes-us175-million-financing-539559901.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
elicera therapeutics ab,"Error: Connection failed - HTTPSConnectionPool(host='se.linkedin.com', port=4",Yes,ELC-301; ELC-100; ELC-201; ELC-401,B-cell lymphoma; Neuroendocrine tumors,oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"CAR T-cell therapy, Oncolytic viruses, iTANK platform",https://www.elicera.com/,No,,,No,,,Yes,Oncolytic viruses,https://www.elicera.com/
aceragen inc,"Error: Connection failed - HTTPSConnectionPool(host='news.biobuzz.io', port=4",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
protego biopharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,Not specified,Transthyretin Amyloidosis,rare diseases; degenerative diseases; cardiomyopathy; myopathy,enzyme,Preclinical,Yes,small molecule therapeutics,https://www.globenewswire.com/news-release/2021/11/17/2336493/0/en/Protego-Biopharma-Raises-51-Million-Series-A-Financing-to-Advance-the-Treatment-of-Protein-Misfolding-Diseases.html,No,,,Yes,protein misfolding diseases,https://www.globenewswire.com/news-release/2021/11/17/2336493/0/en/Protego-Biopharma-Raises-51-Million-Series-A-Financing-to-Advance-the-Treatment-of-Protein-Misfolding-Diseases.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
walden biosciences inc,2025-09-04 20:28:02,Yes,WAL0921,"suPAR, Soluble Urokinase-Type Plasminogen Activator Receptor",rare diseases; nephrology,cytokine,Phase 2,Yes,IND-ready small molecule that is designed to stabilize and restore the function of dynamin,https://www.globenewswire.com/news-release/2025/01/10/3007547/0/en/Walden-Biosciences-Highlights-2024-Accomplishments-and-2025-Priorities.html,No,,,No,,,Yes,humanized monoclonal antibody that inhibits suPAR,https://www.globenewswire.com/news-release/2025/01/10/3007547/0/en/Walden-Biosciences-Highlights-2024-Accomplishments-and-2025-Priorities.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
noveome biotherapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cbs42.com', port=443",No,ST266,Not specified,ophthalmology; CNS; pulmonary; gastrointestinal; dermatology,cytokine,Phase 2,No,,,No,,,Yes,multi-targeted secretome containing hundreds of biologically active proteins,https://noveome.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"multi-targeted secretome containing hundreds of biologically active proteins and other factors crucial to neuroprotection, the modulation of inflammation, cell recovery and healing",https://noveome.com/
anrs research center,"Error: Connection failed - HTTPSConnectionPool(host='www.glopid-r.org', port=",No,Not specified,Not specified,neurology,Not specified,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tenaya therapeutics inc,2025-10-14 18:00:25,Yes,TN-201; TN-401; DWORF; TN-301,"MYBPC3, Myosin Binding Protein C3; PKP2, Plakophilin-2; SERCA2a, Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase 2a; HDAC6, Histone Deacetylase 6",cardiovascular; rare diseases,other; other; enzyme; enzyme,Phase 1; IND-enabling; candidate selection; Phase 1,Yes,"TN-301, a small molecule for heart failure with preserved ejection fraction",https://www.marketbeat.com/instant-alerts/tenaya-therapeutics-inc-nasdaqtnya-given-average-recommendation-of-buy-by-analysts-2025-09-20/,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Gene Therapy for Cardiomyopathies,https://www.tenayatherapeutics.com/,No,,,No,,,No,,
windtree therapeutics inc,2025-09-02 13:00:00,Yes,Istaroxime; KL4 Surfactant; aPKCi Inhibitors,"SERCA2a, Sarcoplasmic/Endoplasmic Reticulum Calcium-ATPase 2a; Na+/K+-ATPase; Disease Name",cardiovascular; respiratory; oncology,enzyme; other; Not specified,Phase 2; Preclinical,Yes,"SERCA2a activators which activate SERCA2a. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds.",https://windtreetx.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
artery therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.nia.nih.gov', port=4",No,CS6253,"ABCA1, ATP Binding Cassette A1",neurology; Alzheimer's disease,other,Phase 1,No,,,Yes,novel peptide library is derived from ApoE,https://www.arterytx.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
arnatar therapeutics inc,2025-08-25 15:41:05,Yes,ART4; ART104; ART1,"JAG1, Jagged-1; AGT, Angiotensinogen",rare diseases; cardiovascular; liver; CNS; kidney,other; enzyme,Phase 1,No,,,No,,,Yes,upregulate protein expression,https://globalgenes.org/raredaily/arnatar-therapeutics-emerges-from-stealth-with-52-million-and-an-rpdd-for-alagille-syndrome-therapy/,No,,,No,,,No,,,Yes,antisense oligonucleotides (ASOs) and small interfering RNA (siRNA),https://www.linkedin.com/company/arnatar-therapeutics,No,,,No,,,No,,,No,,
alpheus medical inc,"Error: Connection failed - HTTPSConnectionPool(host='tcbmag.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,oral 5-aminolevulinic acid (5-ALA),https://www.prnewswire.com/news-releases/alpheus-medical-raises-52m-in-series-b-round-to-advance-groundbreaking-glioblastoma-therapy-302455795.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,sonodynamic therapy (SDT),https://www.prnewswire.com/news-releases/alpheus-medical-raises-52m-in-series-b-round-to-advance-groundbreaking-glioblastoma-therapy-302455795.html
narrows institute for biomedical research inc,"Error: Connection failed - HTTPSConnectionPool(host='taggs.hhs.gov', port=443",No,Not specified,Not specified,infectious diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
35pharma inc,2024-11-26 00:00:00,Yes,HS235; HS370,"Activin x GDF, Growth Differentiation Factor",cardiometabolic diseases; pulmonary hypertension; obesity; heart failure,cytokine,Phase 1/II,No,,,No,,,Yes,protein engineering,https://www.globenewswire.com/news-release/2024/11/26/2987436/0/en/35Pharma-Closes-Series-C-Financing-to-Advance-Clinical-Pipeline-of-Activin-Inhibitors-for-Pulmonary-Hypertension-Cardiometabolic-Disease-and-Obesity.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,ligand traps,https://www.35pharma.com/
gt medical technologies inc,"Error: Connection failed - HTTPSConnectionPool(host='www.prnewswire.com', por",No,GammaTile,"Disease Name, Brain Tumors",oncology,other,Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds",https://www.linkedin.com/company/gt-medical-technologies-inc
ixaka ltd,2021-02-19 00:00:00,No,REX-001,Chronic Limb-Threatening Ischemia,cardiovascular; diabetes,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell and gene therapy company,https://uk.linkedin.com/company/ixaka-limited,No,,,No,,,Yes,nanoparticle therapeutics,https://uk.linkedin.com/company/ixaka-limited
ixaka ltd (inactive),2021-02-19 00:00:00,Yes,REX-001,"Disease Name, Chronic Limb-Threatening Ischemia",cardiovascular; diabetes-related conditions,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell and gene therapy company,https://uk.linkedin.com/company/ixaka-limited,No,,,No,,,Yes,targeted nano-particles,https://uk.linkedin.com/company/ixaka-limited
vanda pharmaceuticals inc,2014-11-29 00:00:00,No,VGT-1849B,"JAK2, Janus Kinase 2",hematologic malignancies,kinases,Preclinical,Yes,"Fanapt®, HETLIOZ®, PONVORY®",https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-reports-second-quarter-2025-financial-results-302518338.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
grace science llc,"Error: Connection failed - HTTPSConnectionPool(host='timmermanreport.com', po",Yes,GTx-104,Not specified,rare diseases; CNS,ion channels,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy,https://www.linkedin.com/company/grace-science-llc,No,,,No,,,No,,
minervax aps,"Error: Connection failed - HTTPSConnectionPool(host='www.wacker.com', port=44",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,adjuvanted proteins antigens covering close to 100% of clinical GBS isolates,https://www.linkedin.com/company/minervax-aps/,Yes,generate antibodies (IgG) capable of crossing the placenta,https://pubmed.ncbi.nlm.nih.gov/37010372/,No,,,No,,,No,,,No,,,Yes,Developing a maternal vaccine for Group B Streptococcus,https://www.linkedin.com/company/minervax-aps/,No,,,No,,
inspirna inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"ompenaclid (RGX-202), is an orally-administered small molecule",https://www.linkedin.com/company/inspirna,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aveo pharmaceuticals inc,2025-10-07 12:34:00,No,Tivozanib,"VEGFR, Vascular Endothelial Growth Factor Receptor",oncology,kinases,Approved,Yes,FOTIVDA® (tivozanib),https://www.linkedin.com/company/aveo-oncology,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
jupiter neurosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,resveratrol platform product,https://www.cnbc.com/quotes/JUNS,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bicycle therapeutics plc,2025-10-10 14:41:47,Yes,BT5528; zelenectide pevedotin; BT1718; BT7401,"EphA2, Ephrin type-A receptor 2; Nectin-4, Cell adhesion molecule; MT1-MMP, Membrane Type 1 Matrix Metalloproteinase; CD137, Cluster of Differentiation 137",oncology,kinases; other; enzyme; immune checkpoint,Phase 1; Phase 2; Phase 2a,Yes,small molecule scaffolds,https://www.linkedin.com/company/bicycle-therapeutics,Yes,bicyclic peptides,https://www.linkedin.com/company/bicycle-therapeutics,No,,,No,,,Yes,Bicycle® Toxin Conjugate (BTC®),https://www.linkedin.com/company/bicycle-therapeutics,No,,,No,,,No,,,No,,,No,,,Yes,Bicycle® Radio Conjugates (BRC™),https://www.linkedin.com/company/bicycle-therapeutics
tango therapeutics inc,2025-10-14 15:46:54,Yes,TNG462; daraxonrasib; zoldonrasib,"PRMT5, Protein Arginine Methyltransferase 5; RAS, Rat Sarcoma Viral Oncogene Homolog",oncology,enzyme; other,Phase 1/2,Yes,The Company's novel small molecules are designed to be selectively active in cancer cells with specific genetic alterations,https://www.cnbc.com/quotes/TNGX,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,utilize synthetic lethality - the interaction between two genes that causes cell death when both are inactivated,https://www.linkedin.com/company/tango-therapeutics
basking biosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='oied.osu.edu', port=443)",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,Yes,BB-031 is an RNA aptamer optimized for rapid onset of action and short duration of effect.,https://www.linkedin.com/company/basking-biosciences-inc,No,,,No,,,No,,,No,,
red queen therapeutics inc,2024-08-06 07:00:00,Yes,RQ-01,Not specified,infectious diseases,other,Phase 1,No,,,Yes,stapled lipopeptide technology,https://www.linkedin.com/company/red-queen-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
replimune ltd,2023-02-11 20:57:05,No,RP1; RP2,"PD-1, Programmed Death-1; CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,oncolytic immunotherapies,https://www.foresitecapital.com/portfolio/replimune-group/
nodthera inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://pitch,No,NT-0796; NT-0249; NT-0150,"NLRP3, NLRP3 Inflammasome",obesity; cardiovascular diseases; neurodegenerative diseases; Parkinson's disease,other,Phase 2,Yes,"small molecule, brain-penetrant NLRP3 inflammasome inhibitor",https://www.linkedin.com/company/nodthera,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
jounce therapeutics inc,2021-04-10 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"vopratelimab, a monoclonal antibody that binds to and activates ICOS",https://www.linkedin.com/company/jounce-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,
naurex inc,2018-06-28 18:02:19,Yes,GLYX-13; NRX-1074,"NMDA, N-methyl-D-aspartate receptor",CNS; mental health,ion channels,Phase 3; Phase 1,Yes,small molecule NMDA receptor modulators,https://www.prnewswire.com/news-releases/allergan-to-acquire-naurex-300118764.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
asociacion europea y latinoamericana selnet para la investigacion en sarcomas,"Error: Connection failed - HTTPSConnectionPool(host='cordis.europa.eu', port=",Yes,Not specified,Disease Name,oncology; rare diseases,Not specified,Preclinical,Yes,fármacos en subtipos de sarcomas raros,http://eulacfoundation.org/es/selnet,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mycenax biotech inc,2025-10-09 06:15:27,Yes,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,Yes,fusion proteins,https://www.linkedin.com/company/mycenax,Yes,"mAb, bi-specific (BsAb), multi-specific antibodies",https://www.linkedin.com/company/mycenax,Yes,"Antibody-Drug-Conjugates, ADCs/PDCs",https://www.linkedin.com/company/mycenax,Yes,fusion proteins,https://www.linkedin.com/company/mycenax,Yes,plasmid DNA,https://www.linkedin.com/company/mycenax,Yes,cell therapy products,https://www.linkedin.com/company/mycenax,Yes,vaccines,https://www.linkedin.com/company/mycenax,No,,,No,,
attralus inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,124I-evuzamitide,Disease Name,rare diseases; cardiovascular,Not specified,Phase 3,No,,,Yes,pan-amyloid binding peptide,https://www.globenewswire.com/news-release/2025/04/01/3053148/0/en/Attralus-Presents-New-Data-on-Its-Pan-Amyloid-Diagnostic-Candidates-at-the-2025-American-College-of-Cardiology-ACC-Annual-Scientific-Session.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
imbria pharmaceuticals inc,2025-04-10 00:00:00,No,ninerafaxstat,Not specified,cardiovascular; cardiometabolic disorders,enzyme,Phase 2,Yes,Ninerafaxstat is a simple orally administered compound,https://www.imbria.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
allay therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,No,ATX101,Intracellular Sodium Ion Channel,pain management; orthopedics,ion channels,Phase 2,Yes,bupivacaine,https://www.linkedin.com/company/allaytx,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,implantable #NonOpioid solution,https://www.linkedin.com/company/allaytx
medytox inc,2021-05-12 00:00:00,No,LIV001,"Disease Name, Inflammatory Bowel Disease",gastroenterology,other,Preclinical,No,,,No,,,Yes,botulinum toxin products,https://www.doctormedica.co/blog/meditoxin-manufacturer,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
fkd therapies oy,"Error: Connection failed - HTTPSConnectionPool(host='ferringusa.com', port=44",No,Nadofaragene Firadenovec,"IFN-α2b, Interferon Alpha-2b",oncology,cytokine,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,adenovirus vector-based gene therapy,https://www.biopharmadive.com/news/ferring-fda-approval-bladder-cancer-gene-therapy/639078/,No,,,No,,,No,,
dice therapeutics inc,2023-08-09 13:02:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,small molecule antagonist targeting IL-17,https://www.stocktitan.net/news/DICE/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nuvalent inc,2025-10-15 13:00:21,Yes,NVL-520; NVL-655; NVL-330,"ROS1, ROS Proto-Oncogene 1; ALK, Anaplastic Lymphoma Kinase; HER2, Human Epidermal Growth Factor Receptor 2",oncology,kinases,Phase 2; Phase 3; Phase 1,Yes,innovative small molecules that precisely inhibit clinically proven kinase targets,https://nuvalent.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
editas medicine inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,EDIT-401,"LDLR, Low-Density Lipoprotein Receptor",cardiovascular,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CRISPR/Cas9 and CRISPR/Cas12a genome editing systems,https://www.linkedin.com/company/editas-medicine,No,,,No,,,No,,
claris biotherapeutics inc,2024-01-04 00:00:00,Yes,CSB-001,Disease Name,rare diseases; ophthalmology,Not specified,Phase 3,No,,,No,,,Yes,"recombinant human variant hepatocyte growth factor, dHGF",https://www.globenewswire.com/news-release/2024/01/04/2803976/0/en/Claris-Bio-Emerges-From-Stealth-With-a-New-Investor-and-Prepares-for-Next-Development-Stage-With-Late-Stage-Data-Expected-in-1H24.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
rivus pharmaceuticals inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,HU6,"ANT-channel, Adenine Nucleotide Translocator Channel",metabolic diseases; cardiovascular; liver diseases,other,Phase 2,Yes,oral small molecules,https://www.prnewswire.com/news-releases/rivus-pharmaceuticals-expands-leadership-team-and-establishes-new-san-francisco-bay-area-office-ahead-of-phase-2-read-out-in-mash-302425581.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
leap therapeutics inc,2025-10-06 09:00:00,Yes,Sirexatamab; FL-501,"DKK1, Dickkopf-1; GDF-15, Growth and Differentiation Factor 15",oncology,cytokine; cytokine,Phase 2; Preclinical,No,,,No,,,No,,,Yes,"humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein and FL-501, a humanized monoclonal antibody targeting the growth and differentiation factor 15 (GDF-15) protein",https://www.prnewswire.com/news-releases/leap-therapeutics-announces-58-88-million-private-placement-in-cash-commitments-led-by-winklevoss-capital-to-initiate-a-digital-asset-treasury-strategy-302575729.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
azora therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,AT193; AT177,"AHR, Aryl Hydrocarbon Receptor",inflammatory diseases; autoimmune diseases,nuclear receptors,Phase 1,Yes,novel small molecule new chemical entities,https://www.azoratherapeutics.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
arialys therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"ART5803, a monoclonal antibody",https://www.linkedin.com/company/arialys-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,
fortis therapeutics inc,2025-05-08 00:00:00,Yes,FOR46,Not specified,oncology,other,Phase 1,No,,,No,,,No,,,Yes,monoclonal antibodies,https://www.cbinsights.com/company/fortis-therapeutics,Yes,antibody-drug conjugate (ADC),https://investor.fibrogen.com/news-releases/news-release-details/fibrogen-enters-exclusive-license-for46-fortis-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,
actym therapeutics inc,2023-10-18 09:00:00,Yes,ACTM-838,"IL-15, Interleukin-15; STING, Stimulator of Interferon Genes",oncology,cytokine; other,Phase 1,No,,,Yes,therapeutic peptides,https://www.prnewswire.com/news-releases/actym-therapeutics-expands-management-team-with-key-appointments-to-build-product-pipeline-and-advance-clinical-development-strategies-302181468.html,Yes,therapeutic proteins,https://www.prnewswire.com/news-releases/actym-therapeutics-expands-management-team-with-key-appointments-to-build-product-pipeline-and-advance-clinical-development-strategies-302181468.html,No,,,No,,,No,,,Yes,RNA and gene editing effectors,https://www.prnewswire.com/news-releases/actym-therapeutics-expands-management-team-with-key-appointments-to-build-product-pipeline-and-advance-clinical-development-strategies-302181468.html,No,,,No,,,No,,,Yes,genetically modified bacterial vehicle,https://www.actymthera.com/
immutep ltd,"Error: Connection failed - HTTPSConnectionPool(host='au.linkedin.com', port=4",No,IMP321; IMP701; CVac; Eftilagimod Alfa,"LAG-3, Lymphocyte Activation Gene-3",oncology; autoimmune diseases,immune checkpoint,Phase 3,No,,,No,,,Yes,"eftilagimod alfa, a proprietary soluble LAG-3 protein",https://au.linkedin.com/company/immutep-ltd,Yes,IMP761 is the world's first LAG-3 agonist antibody,https://au.linkedin.com/company/immutep-ltd,No,,,No,,,No,,,No,,,No,,,No,,,No,,
edgewise therapeutics inc,2025-08-07 08:00:00,Yes,Sevasemten; EDG-7500; EDG-15400,Fast Skeletal Myosin; Cardiac Sarcomere; Not specified,rare diseases; cardiovascular,enzyme; other; Not specified,Phase 3; Phase 2; Phase 1,Yes,Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor,https://www.prnewswire.com/news-releases/edgewise-therapeutics-reports-second-quarter-2025-financial-results-and-recent-business-highlights-302523640.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
institut pasteur de tunis,No timestamp found,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ab-biotics sa,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zymeworks inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,ZW191; ZD06519; Zanidatamab; ZW251,"FRα, Folate Receptor-⍺; HER2, Human Epidermal Growth Factor Receptor 2",oncology; inflammation; autoimmune disease,enzyme; immune checkpoint,Phase 1; Approved,No,,,No,,,No,,,Yes,bispecific antibodies,https://ca.linkedin.com/company/zymeworks,Yes,antibody-drug conjugates (ADCs),https://ca.linkedin.com/company/zymeworks,No,,,No,,,No,,,No,,,No,,,Yes,T cell engagers,https://ca.linkedin.com/company/zymeworks
alzamend neuro inc,"Error: Connection failed - HTTPSConnectionPool(host='alzamend.com', port=443)",Yes,Aducanumab; AGB101; AR1001; AVP-786; AXS-05; Blarcamesine; BPDO-1603; Brexpiprazole; Caffeine; Donanemab; Donepezil; E2814; Escitalopram; Fosgonimeton; Gantenerumab; Guanfacine; Hydralazine hydrochloride; Icosapent ethyl,"Aβ, Amyloid beta; SV2A, Synaptic Vesicle Glycoprotein 2A; Neurotransmitter receptors; Tau, Tau protein; Synaptic plasticity/neuroprotection; Oxidative stress; Hepatocyte growth factor (HGF); Alpha-2 adrenergic receptor",CNS; Alzheimer's disease,other; other; other; other; other; other; other; other,Phase 3,Yes,Our lead therapeutic is a lithium-based small molecule designed to treat Alzheimer's Disease and other psychiatric disorders.,https://www.linkedin.com/company/alzamend-neuro,Yes,ALZN002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine,https://www.linkedin.com/company/alzamend-neuro,No,,,No,,,No,,,No,,,No,,,No,,,Yes,ALZN002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine,https://www.linkedin.com/company/alzamend-neuro,No,,,No,,
gamamabs pharma sa,"Error: Connection failed - HTTPSConnectionPool(host='www.eurobiomed.org', por",No,murlentamab,"AMHR2, Anti-Müllerian Hormone Receptor 2",oncology,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
gie medical inc,2025-04-29 21:41:49,No,ProTractX3,Benign Stricture Disease,gastroenterology,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tallac therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,antibody against CD22,https://www.linkedin.com/company/tallac-therapeutics,Yes,Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform,https://www.linkedin.com/company/tallac-therapeutics,No,,,No,,,No,,,No,,,No,,,Yes,Toll-like receptor (TLR9) agonist (T-CpG),https://www.linkedin.com/company/tallac-therapeutics
kamau therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,nula-cel; nulabeglogene autogedtemcel,"HBB, Beta-Globin Gene",hematology; genetic diseases,other,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene therapy, HDR-editing technology, targeted gene integration, curative cell therapies",https://www.linkedin.com/company/kamau-therapeutics,No,,,No,,,No,,
ethris gmbh,Error: Connection failed - HTTPSConnectionPool(host='european-biotechnology.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
smart immune sas,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"ProTcell, a thymus-empowered T-cell progenitor platform to rapidly re-arm the immune system against cancer and infection",https://www.linkedin.com/company/smartimmune,No,,,No,,,No,,
allvascular pty ltd.,"Error: Connection failed - HTTPSConnectionPool(host='www.afr.com', port=443):",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Infusions of oxaliplatin,https://pmc.ncbi.nlm.nih.gov/articles/PMC11075399/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
gri bio inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,GRI-0621,"iNKT, Invariant Natural Killer T cells",fibrotic diseases; inflammatory diseases; autoimmune diseases,other,Phase 2,Yes,"GRI-0621, is a small molecule RAR-beta and gamma dual agonist",https://www.home.saxo/markets/stocks/gri-xnas,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pieris pharmaceuticals inc,2024-12-13 20:40:33,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,"Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules.","https://www.redchip.com/stocks/PIRS/filings/4#:~:text=Pieris%20Pharmaceuticals%20Inc%20is%20a,a%20wide%20spectrum%20of%20molecules.",Yes,"The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators.","https://www.redchip.com/stocks/PIRS/filings/4#:~:text=Pieris%20Pharmaceuticals%20Inc%20is%20a,a%20wide%20spectrum%20of%20molecules.",No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules.","https://www.redchip.com/stocks/PIRS/filings/4#:~:text=Pieris%20Pharmaceuticals%20Inc%20is%20a,a%20wide%20spectrum%20of%20molecules."
radiopharm theranostics ltd,2025-10-01 01:11:04,Yes,RV-01; 177Lu-RAD202,"B7H3, Immune Checkpoint Molecule; HER2, Human Epidermal Growth Factor Receptor 2",oncology,immune checkpoint,Phase 1,Yes,smallmolecules,https://au.linkedin.com/company/radiopharm-theranostics,Yes,peptides,https://au.linkedin.com/company/radiopharm-theranostics,No,,,Yes,monoclonalantibodies,https://au.linkedin.com/company/radiopharm-theranostics,No,,,No,,,No,,,No,,,No,,,No,,,Yes,radiopharmaceuticals,https://au.linkedin.com/company/radiopharm-theranostics
bone biologics corp,2025-07-27 00:00:00,Yes,NB1,"NELL-1, Neural Epidermal Growth Factor-Like 1",orthopedics; trauma; osteoporosis,other,Phase 1,No,,,No,,,Yes,"recombinant human protein growth factor, known as Nell-1",https://www.linkedin.com/company/bone-biologics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM),https://www.cnbc.com/quotes/BBLG
hcw biologics inc,2025-10-16 16:46:50,Yes,HCW9302,Not specified,oncology; autoimmune diseases; neurodegenerative diseases,immune checkpoint,Preclinical,No,,,No,,,Yes,cytokine fusion molecule HCW11‑006,https://www.stocktitan.net/news/HCWB/hcw-biologics-scientists-to-present-three-posters-during-the-40th-evnu09sdayk8.html,Yes,tetra‑specific pembrolizumab‑based immunotherapeutic,https://www.stocktitan.net/news/HCWB/hcw-biologics-scientists-to-present-three-posters-during-the-40th-evnu09sdayk8.html,No,,,Yes,cytokine fusion molecule HCW11‑006,https://www.stocktitan.net/news/HCWB/hcw-biologics-scientists-to-present-three-posters-during-the-40th-evnu09sdayk8.html,No,,,Yes,CAR‑T and lymphocyte support using HCW11‑006,https://www.stocktitan.net/news/HCWB/hcw-biologics-scientists-to-present-three-posters-during-the-40th-evnu09sdayk8.html,No,,,No,,,Yes,Enhanced Immune Cell Engagers,https://www.stocktitan.net/news/HCWB/hcw-biologics-scientists-to-present-three-posters-during-the-40th-evnu09sdayk8.html
cns pharmaceuticals inc,2025-10-15 16:01:04,Yes,TPI 287; Berubicin,"Disease Name, Glioblastoma Multiforme (GBM)",oncology; CNS,other,Phase 2,Yes,Berubicin chemical compound,https://www.linkedin.com/company/cnspharma,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zelluna asa,"Error: Connection failed - HTTPSConnectionPool(host='www.euronext.com', port=",Yes,ZI-MA4-1,"MAGE-A4, Melanoma-Associated Antigen A4",oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Developing allogeneic TCR-NK therapies for solid tumors,https://no.linkedin.com/company/zelluna,No,,,No,,,No,,
dynacure sas,2017-11-10 08:37:26,Yes,DYN101; danvatirsen; FTX-001,"STAT3, Signal Transducer and Activator of Transcription 3; MALAT-1, Metastasis Associated Lung Adenocarcinoma Transcript 1",rare diseases; oncology,other,Phase 2; IND ready,No,,,No,,,No,,,No,,,No,,,No,,,Yes,antisense drug,https://www.biopharmadive.com/news/dynacure-secures-rights-to-ionis-rare-disease-drug/510600/,No,,,No,,,No,,,No,,
ionis pharmaceuticals inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Pelacarsen,Lipoprotein(a),cardiovascular,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,Yes,RNA-targeted medicines,https://www.linkedin.com/company/ionis-pharmaceuticals,Yes,advancing new approaches in gene editing,https://www.linkedin.com/company/ionis-pharmaceuticals,No,,,No,,,No,,
ayuvis research inc,"Error: Connection failed - HTTPSConnectionPool(host='www.bio.org', port=443):",Yes,AVR-48,Disease Name,respiratory diseases; infectious diseases,other,Phase 1,Yes,small molecules,https://seed.nih.gov/portfolio/nih-portfolio-company-showcase/ayuvis-research,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
geneos therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.geneostx.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Personalized neoantigen vaccine,https://www.linkedin.com/company/geneos-therapeutics,No,,,No,,
lixa pty ltd,"Error: Connection failed - HTTPSConnectionPool(host='biotechdispatch.com.au',",Yes,NeoX-101,Not specified,infectious diseases,other,Phase 1,Yes,small antibiofilm molecule,https://www.ventureradar.com/organisation/Lixa%20Pty%20Ltd/7fb30309-f788-4f6f-9dbd-abc003f1e711,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,NeoX™ is Lixa's potent antibiofilm platform technology,https://www.ventureradar.com/organisation/Lixa%20Pty%20Ltd/7fb30309-f788-4f6f-9dbd-abc003f1e711
elmedix,"Error: Connection failed - HTTPSConnectionPool(host='pulse2.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,thermal therapy,https://financialpost.com/globe-newswire/elmedix-plans-series-a-round-based-on-strong-signals-in-a-clinical-study-for-pancreatic-cancer-patients-at-the-university-hospital-antwerp-belgium
connext co ltd,"Error: Connection failed - HTTPSConnectionPool(host='connext.co.kr', port=443",No,Not specified,Not specified,neurology; immunology & allergy; oncology; nephrology; CNS; rare diseases,Not specified,Not specified,No,,,No,,,Yes,CNT201 is an injectable recombinant collagenase,https://www.linkedin.com/company/connextbio,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
evecxia therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"5-HTP, the natural serotonin precursor, delivered via proprietary drug delivery technologies",https://www.linkedin.com/company/evecxia-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
biocardia inc,2025-10-01 19:06:13,No,BCDA-01; BCDA-02; BCDA-03,Not specified,cardiovascular,Not specified,Phase 3; Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,https://www.cnbc.com/quotes/BCDA,No,,,No,,,No,,
deuteroncology nv,"Error: Connection failed - HTTPSConnectionPool(host='deuteroncology.com', por",Yes,OMO-1,"MET, Mesenchymal Epithelial Transition; OCT-2, Organic Cation Transporter 2",oncology,kinases; enzyme,Phase 1,Yes,MET inhibitors intended to optimize oncology treatments and outcomes,https://www.eu-startups.com/directory/deuteroncology/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
clear creek bio inc,2018-06-07 00:00:00,Yes,PLpro inhibitors; brequinar,"PLpro, Papain-Like Protease; DHODH, Dihydroorotate Dehydrogenase",infectious diseases,enzyme,Preclinical,Yes,small molecule antiviral therapeutics targeting SARS-CoV-2 and other medically important viruses,https://www.linkedin.com/company/clear-creek-bio,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kuros biosciences ag,2025-10-16 14:37:20,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,biologics,https://www.linkedin.com/company/kurosbiosciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zumutor biologics inc,2025-08-25 15:02:56,Yes,ZM008,Not specified,oncology,immune checkpoint,Preclinical,No,,,No,,,No,,,Yes,"proprietary Human Antibody platform INABLR ® is the genesis to our wholly owned, first-in-class therapeutic antibodies",https://zumutor.com/,No,,,No,,,No,,,Yes,NK cell therapeutics,https://zumutor.com/,No,,,No,,,No,,
dupont danisco a/s,2018-06-30 11:17:01,No,Not specified,Not specified,diabetes; obesity; cardiovascular disease; rare blood disorders; endocrine disorders; chronic diseases,Not specified,Not specified,No,,,No,,,Yes,industrial enzymes,https://www.prnewswire.com/news-releases/dupont-successfully-completes-tender-offer-for-danisco-121878368.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
stemcyte inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,REGENECYTE,Not specified,blood disorders; immune system disorders; long COVID syndrome,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,advancing the development of cord blood cell therapies,https://www.linkedin.com/company/stemcyte,No,,,No,,,Yes,cell therapy to address currently incurable diseases,https://www.linkedin.com/company/stemcyte
pasithea therapeutics corp,2025-09-08 23:33:39,Yes,Alpha-5,Alpha-5 Integrin,neurology,other,Preclinical,Yes,"PAS-004, a macrocyclic mitogen-activated protein kinase, or MEK inhibitor. PAS-004 is a small molecule allosteric inhibitor of MEK 1 and 2 (MEK 1/2)",https://www.cnbc.com/quotes/KTTA,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aminex therapeutics inc,2025-10-02 14:22:53,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,novel small molecule combination therapy,https://www.linkedin.com/company/aminex-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
synimmune gmbh,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
liaoning biomedical materials r&d center co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.dlyinyi.com', port=4",No,Fruquintinib; Ryzneuta,"Disease Name, Metastatic Colorectal Cancer; Disease Name, Chemotherapy-Induced Neutropenia",oncology; hematology,Not specified,Approved,Yes,"Paclitaxel, Resveratrol, Argatroban, Probucol, Rapamycin, Sirolimus",https://patents.google.com/patent/CN203954432U/de,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
momenta pharmaceuticals inc,2025-03-27 16:32:04,Yes,Nipocalimab; M254; M230,"FcRn, Neonatal Fc Receptor; Fc gamma receptor system",autoimmune diseases; rare diseases,other,Phase 2/3; Phase 1,No,,,No,,,No,,,Yes,anti-FcRn antibody,https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-momenta-pharmaceuticals-inc-expanding-janssens-leadership-in-novel-treatments-for-autoimmune-diseases,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aridis pharmaceuticals inc,2025-10-16 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,non-antibiotic small molecule anti-infective candidate mechanism,https://www.stocktitan.net/news/ARDS/aridis-provides-corporate-mq8c1efkgdkc.html,No,,,No,,,Yes,advancing multiple clinical stage monoclonal antibodies (mAbs),https://www.stocktitan.net/news/ARDS/aridis-provides-corporate-mq8c1efkgdkc.html,No,,,No,,,No,,,No,,,Yes,AR-701 is a cocktail of fully human mAbs discovered from convalescent COVID-19 patients,https://www.stocktitan.net/news/ARDS/aridis-provides-corporate-mq8c1efkgdkc.html,No,,,No,,
immunomic therapeutics inc,2025-07-16 13:00:53,No,ITI-1000; ITI-3000,"pp65, Phosphoprotein 65; LT, Large T Antigen",oncology,other,Phase 2; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,Yes,nucleic acid immunotherapy platform,https://www.linkedin.com/company/immunomic-therapeutics-inc-,No,,,Yes,DNA Vaccines,https://www.linkedin.com/company/immunomic-therapeutics-inc-,No,,,No,,
galmed pharmaceuticals ltd,2025-05-22 08:01:44,Yes,Aramchol,"SCD1, Stearoyl-CoA Desaturase 1",liver diseases; cardiometabolic diseases; oncology,enzyme,Phase 3,Yes,"Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule","https://galmedpharma.investorroom.com/#:~:text=Galmed%20Pharmaceuticals%20Ltd.%20is%20a,liver%2C%20metabolic%20and%20inflammatory%20diseases.",Yes,"Amilo-5MER, a 5 amino acid synthetic peptide","https://galmedpharma.investorroom.com/#:~:text=Galmed%20Pharmaceuticals%20Ltd.%20is%20a,liver%2C%20metabolic%20and%20inflammatory%20diseases.",No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bio blast pharma ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.s,No,Trehalose; Not specified,"Cytokine Release Syndrome; p97, AAA-ATPase",rare diseases; immunology; oncology,cytokine; enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
g.st antivirals gmbh,2025-09-12 14:31:04,No,2-deoxy-D-glucose,Not specified,infectious diseases,enzyme,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
itb-med ab,"Error: Connection failed - HTTPSConnectionPool(host='nordic9.com', port=443):",Yes,Siplizumab,"CD2, Cluster of Differentiation 2; CD28, Cluster of Differentiation 28",immunology; transplantation,immune checkpoint,Preclinical,No,,,No,,,No,,,Yes,"antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab)",https://www.linkedin.com/company/itbmed?trk=public_jobs_jserp-result_job-search-card-subtitle,No,,,No,,,No,,,No,,,No,,,No,,,No,,
lysogene sas,"Error: Connection failed - HTTPSConnectionPool(host='live.euronext.com', port",Yes,LYS-SAF302; LYS-GM101,Sanfilippo syndrome type A; GM1 Gangliosidosis,rare diseases; neurodegenerative diseases,other,Phase 2/3; Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapies for the treatment of rare neurodegenerative diseases,https://www.marketscreener.com/quote/stock/LYSOGENE-33951021/news/Lysogene-placed-in-liquidation-and-delisted-43975184/,No,,,No,,,No,,
cephalon inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='ir.tevapharm.com', port=",No,ABX1100,"GYS1, Glycogen Synthase 1; CD71, Transferrin Receptor Protein 1",rare diseases; metabolic diseases,enzyme; other,Phase 1,Yes,"Actiq, Gabitril, and Provigil",https://www.justice.gov/civil/consumer-protection-branch/case/united-states-v-cephalon-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bond biosciences (inactive),Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,non-absorbed oral therapeutics,https://www.linkedin.com/company/bond-biosciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
deverra therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,Dilanubicel; DVX201,"Disease Name, Acute Myeloid Leukemia; Disease Name, COVID-19; Disease Name, High-Risk Myelodysplastic Syndrome",oncology; infectious diseases,other,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene and cell therapies for cancers, autoimmunity, infectious diseases, and genetic disorders",https://www.linkedin.com/company/deverra-therapeutics,No,,,No,,,Yes,"Producing Genetically Engineered, Cytokine-Secreting Allogeneic Monocytes from CD34+ Cord Blood Cells",https://www.linkedin.com/company/deverra-therapeutics
vanquish oncology inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",Yes,IO102-IO103,Not specified,oncology,immune checkpoint,Phase 3,Yes,"Vanquish Oncology is a biotechnology company which develops targeted, small-molecule oncology therapeutics",https://www.cbinsights.com/company/vanquish-oncology,No,,,Yes,"Procaspase combination therapy for glioblastoma; targeting a cellular enzyme, procaspase-3",https://www.cbinsights.com/company/vanquish-oncology,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
calidi biotherapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.calidibio.com', port",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
selecta biosciences inc,2023-12-13 00:00:00,No,Descartes-08; Descartes-15,"BCMA, B-cell maturation antigen",autoimmune diseases; multiple myeloma,other,Phase 2; Phase 1,No,,,No,,,Yes,Enzyme Therapy,https://www.linkedin.com/company/selecta-bio,No,,,No,,,No,,,No,,,Yes,Gene Therapy,https://www.linkedin.com/company/selecta-bio,No,,,No,,,No,,
rznomics inc,2025-06-13 00:19:47,Yes,RZ-001,Not specified,oncology,enzyme,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,Yes,RNA-based therapeutics,https://www.prnewswire.com/news-releases/rznomics-enters-global-licensing-agreement-with-eli-lilly-for-rna-editing-therapeutics-302456852.html,Yes,RNA-based gene therapy,https://www.skpharmteco.com/news-insights/news/sk-pharmteco-and-rznomics-explore-collaboration-for-rna-based-gene-therapy-development-and-manufacturing/,No,,,No,,,No,,
hutchison medipharma ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.hutch-med.com', port",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,ten cancer drug candidates from in-house discovery,https://www.linkedin.com/company/hutchmed,No,,,No,,,Yes,Antibody Targeted Therapy Conjugates platform,https://www.linkedin.com/company/hutchmed,Yes,Antibody Targeted Therapy Conjugates platform,https://www.linkedin.com/company/hutchmed,No,,,No,,,No,,,No,,,No,,,No,,
avrobio inc,"Error: Connection failed - HTTPSConnectionPool(host='leadiq.com', port=443): ",Yes,TX45,Not specified,rare diseases; cardiovascular,gpcr,Phase 1,No,,,No,,,Yes,GPCR-targeted therapeutic proteins,https://www.theavrobio.org/,No,,,No,,,No,,,No,,,Yes,hematopoietic stem cell gene therapies,https://www.marketbeat.com/stocks/NASDAQ/AVRO/,No,,,No,,,No,,
cancer prevention pharmaceuticals inc,2022-02-22 00:00:00,Yes,Flynpovi; CPP-1X; sulindac; SBP-101,Polyamine metabolism,oncology; rare diseases,enzyme,Phase 3,Yes,CPP-1X (eflornithine),https://www.globenewswire.com/news-release/2022/02/22/2389291/37414/en/Panbela-Therapeutics-Inc-to-Acquire-Cancer-Prevention-Pharmaceuticals-Inc.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zynerba pharmaceuticals inc,2023-10-11 08:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,synthetic cannabidiol,https://www.prnewswire.com/news-releases/harmony-biosciences-completes-acquisition-of-zynerba-pharmaceuticals-and-expands-pipeline-301953012.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
sparian biosciences inc,2024-11-14 22:10:30,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000,https://www.linkedin.com/company/sparian-biosciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
io biotech inc,2025-10-07 13:01:16,Yes,Cylembio,"IDO1, Indoleamine 2,3-Dioxygenase 1; PD-L1, Programmed Death-Ligand 1",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"immune-modulatory, off-the-shelf therapeutic cancer vaccines",https://www.linkedin.com/company/io-biotech/,No,,,No,,
fusion pharmaceuticals inc,2023-03-13 00:00:00,No,FPI-2265; FPI-1434; FPI-2059; FPI-1966; FPI-2068,"PSMA, Prostate Specific Membrane Antigen; IGF-1R, Insulin-like Growth Factor 1 Receptor; NTSR1, Neurotensin Receptor 1; FGFR3, Fibroblast Growth Factor Receptor 3; EGFR-cMET",oncology,other; other; gpcr; kinases; other,Phase 2/3; Phase 1; Phase 1; Phase 1; Preclinical,Yes,"RCs combine the precise targeting of antibodies, small molecules or peptides",https://www.prnewswire.com/news-releases/acquisition-of-fusion-pharmaceuticals-completed-302163794.html,Yes,"RCs combine the precise targeting of antibodies, small molecules or peptides",https://www.prnewswire.com/news-releases/acquisition-of-fusion-pharmaceuticals-completed-302163794.html,No,,,Yes,Fusion connects alpha particle emitting isotopes to antibodies,"https://www.linkedin.com/company/fusion-pharmaceuticals#:~:text=Fusion%20Pharmaceuticals%20is%20a%20clinical,generation%20radiopharmaceuticals%20as%20precision%20medicines.",Yes,Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules,"https://www.linkedin.com/company/fusion-pharmaceuticals#:~:text=Fusion%20Pharmaceuticals%20is%20a%20clinical,generation%20radiopharmaceuticals%20as%20precision%20medicines.",No,,,No,,,No,,,No,,,No,,,Yes,"Radioconjugates in oncology RCs combine the precise targeting of antibodies, small molecules or peptides with potent medical radioisotopes",https://www.prnewswire.com/news-releases/acquisition-of-fusion-pharmaceuticals-completed-302163794.html
inozyme pharma inc,2025-10-08 18:08:18,No,INZ-701,"ENPP1, Ectonucleotide Pyrophosphatase/Phosphodiesterase 1",rare diseases,enzyme,Phase 3,No,,,No,,,Yes,ENPP1 Fc fusion protein enzyme replacement therapy,https://www.linkedin.com/company/inozyme,No,,,No,,,Yes,ENPP1 Fc fusion protein enzyme replacement therapy,https://www.linkedin.com/company/inozyme,No,,,No,,,No,,,No,,,No,,
fusogen pharmaceuticals inc,2023-03-13 00:00:00,No,FPI-2265; FPI-1434; FPI-2059; FPI-2068,"PSMA, Prostate Specific Membrane Antigen; IGF-1R, Insulin-like Growth Factor 1 Receptor; NTSR1, Neurotensin Receptor 1; EGFR-cMET",oncology,other,Phase 2; Phase 1,No,,,No,,,No,,,Yes,Fusion connects alpha particle emitting isotopes to antibodies,https://www.linkedin.com/company/fusion-pharmaceuticals,Yes,Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules,https://www.linkedin.com/company/fusion-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,
visirna therapeutics hk ltd,2022-10-22 00:10:26,Yes,plozasiran; VSA001,"apoC-III, Apolipoprotein C-III",rare diseases; cardiometabolic diseases,enzyme,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,Yes,RNA interference (RNAi) therapeutics,https://globalgenes.org/raredaily/arrowhead-and-vivo-capital-launch-joint-venture-in-china-to-develop-rnai-based-therapies/,No,,,No,,,No,,,No,,
akamis bio ltd,2025-10-16 12:45:02,No,NG-350A; NG-7XX; NG-348,"CD40, Cluster of Differentiation 40; IL-12, Interleukin-12; IL-15, Interleukin-15; CD80, Cluster of Differentiation 80; anti-CD3 scFv, Single-chain Variable Fragment targeting CD3",oncology,immune checkpoint; cytokine; other,Phase 1,No,,,No,,,Yes,therapeutic proteins,https://www.akamisbio.com/,Yes,CD40 agonist monoclonal antibody,https://www.akamisbio.com/,No,,,No,,,No,,,Yes,tumor gene therapy,https://www.akamisbio.com/,No,,,No,,,Yes,"viral vector based, tumor gene therapies",https://www.akamisbio.com/
psioxus therapeutics ltd,2025-10-16 12:45:02,Yes,NG-350A; NG-7XX; NG-348; NG-641,"CD40, Cluster of Differentiation 40; IL-12, Interleukin-12; IL-15, Interleukin-15; Chemokine; Membrane bound CD80; Anti-CD3 scFv",oncology,immune checkpoint; cytokine; other,Phase 1,No,,,No,,,Yes,therapeutic proteins,https://www.akamisbio.com/,Yes,CD40 agonist monoclonal antibody,https://www.akamisbio.com/,No,,,No,,,No,,,Yes,tumor gene therapy,https://www.akamisbio.com/,No,,,No,,,Yes,oncolytic immunotherapy,https://www.linkedin.com/company/akamisbio
partner therapeutics inc,2018-06-27 17:26:02,No,CX-2051; CX-801,"EpCAM, Epithelial Cell Adhesion Molecule; IFN-α2b, Interferon Alpha-2b",oncology,enzyme; cytokine,Phase 1,No,,,No,,,Yes,Leukine (sargramostim) is a multi-lineage immuno-stimulant that promotes the growth and activation of a broad range of white blood cells,https://www.massbio.org/members/partner-therapeutics-inc/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
adiso therapeutics inc,2025-03-06 22:39:15,Yes,ADS051; ADS032; ADS024,"MRP2, Multidrug Resistance Protein 2; FPR1, Formyl Peptide Receptor 1; NLRP1, NOD-like Receptor Pyrin Domain Containing Protein 1; NLRP3, NOD-like Receptor Pyrin Domain Containing Protein 3",gastroenterology; respiratory diseases; dermatology; neuroinflammation,enzyme; other,Phase 2; IND Enabling; Preclinical,Yes,"ADS051 is a novel, oral, gut-restricted, small molecule",https://adisotx.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"ADS024 is an orally dosed, naturally occurring single strain live biotherapeutic product (SS-LBP)",https://adisotx.com/
ancora bio inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,ANC-501,"V1b, Vasopressin 1b receptor",CNS; depression; psychiatric disease,gpcr,Phase 2,Yes,selective vasopressin 1b receptor (V1b) antagonist (ANC-501),https://www.aditumbio.com/news/stephen-kanes-appointed-ceo-of-ancora-bio,No,,,No,,,Yes,supporting the clinical development of three multi-specific antibodies,https://www.linkedin.com/company/ancora-biotech,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mycomedica life sciences pbc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,EB-002; EB-003,"5HT2A, 5-Hydroxytryptamine Receptor 2A",neuropsychiatric disorders; women's health; CNS; neurodegenerative disorders,gpcr,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,psilocybin-based treatments,https://www.linkedin.com/company/mycomedica-life-sciences-pbc
avenzo therapeutics inc,2025-09-29 13:17:34,Yes,AVZO-103,"Nectin4, Nectin Cell Adhesion Molecule 4; TROP2, Tumor-Associated Calcium Signal Transducer 2",oncology,other,Phase 1/2,Yes,CDK4 selective inhibitor,https://www.linkedin.com/company/avenzotx,No,,,No,,,Yes,bispecific antibody-drug conjugate,https://www.linkedin.com/company/avenzotx,Yes,antibody-drug conjugate (ADC),https://www.linkedin.com/company/avenzotx,No,,,No,,,No,,,No,,,No,,,No,,
vico therapeutics bv,2024-09-13 07:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,Yes,antisense oligonucleotide (ASO) RNA modulating therapies,https://www.prnewswire.com/news-releases/vico-therapeutics-announces-positive-interim-phase-12a-clinical-data-of-vo659-in-treatment-of-huntingtons-disease-302247239.html,No,,,No,,,No,,,No,,
kyverna therapeutics inc,2025-10-14 20:08:27,No,KYV-101; KYV-102; KYV-201,"CD19, Cluster of Differentiation 19",autoimmune diseases; rare diseases,immune checkpoint,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR T-cell therapy,https://kyvernatx.com/,No,,,No,,,No,,
confo therapeutics,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,Not specified,"GPCR, G Protein-Coupled Receptor; GLP-1R, Glucagon-Like Peptide-1 Receptor; GPR75, Orphan G Protein-Coupled Receptor 75",rare endocrine diseases; obesity; metabolic diseases,gpcr,Phase 1,Yes,screen for both small molecules and antibodies,https://blog.vib.be/confo-therapeutics-unlocking-the-power-of-gpcrs-dhny2l,No,,,No,,,Yes,single-domain antibodies (VHHs),https://blog.vib.be/confo-therapeutics-unlocking-the-power-of-gpcrs-dhny2l,No,,,No,,,No,,,No,,,No,,,No,,,No,,
confo therapeutics sa,"Error: Connection failed - HTTPSConnectionPool(host='www.vubtechtransfer.be',",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
neurophth therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.neurophth.com', port",Yes,NFS-05; NR082; NFS-02,"OPA1, Optic Atrophy 1; mtND4, Mitochondrially Encoded NADH Dehydrogenase 4",ophthalmology; rare diseases,other,Phase 3; Phase 1/2; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene therapy, recombinant AAV as the vector to deliver the correct genes",https://www.cgtlive.com/view/neurophth-tackling-lhon-nd4-with-gene-therapy-nr082-phase-gold-trial,No,,,No,,,No,,
carrick therapeutics ltd,2022-12-01 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,CDK7 and CDK12/13 inhibitors,https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-raises-60-million-through-series-c-and-pfizer,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Cyclin-K glue-degrader,https://www.cancerresearchhorizons.com/news-and-events/our-news/carrick-therapeutics-raises-60-million-through-series-c-and-pfizer,No,,
mission therapeutics ltd,"Error: Connection failed - HTTPSConnectionPool(host='uk.linkedin.com', port=4",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
concept medical inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Nanocarrier based drug delivery technology,https://www.linkedin.com/company/conceptmedicals
excision biotherapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,EBT-107,"HBV, Hepatitis B Virus",infectious diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Developing CRISPR-based therapies intended to cure viral infectious diseases,https://www.linkedin.com/company/excisionbiotherapeutics,No,,,No,,,No,,
deka biosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='synapse.patsnap.com', po",Yes,Diakine™- DK4 10; Diakine™- DK2 10; Diakine™- DK12 10; Diakine™- DK15 10; Diakine™- DK7 10; Diakine™- DKalpha 10; Diakine™- DK12 7; Diakine™- DK12 alpha; Diakine™- DK2 10 (CD19); Diakine™- DK2 10 (CD20),"VEGFR2, Vascular Endothelial Growth Factor Receptor 2; MAdCAM, Mucosal Addressin Cell Adhesion Molecule; CD14, Cluster of Differentiation 14; IL-4Ra, Interleukin-4 Receptor Alpha; EGFR, Epidermal Growth Factor Receptor; CD19, Cluster of Differentiation 19; CD20, Cluster of Differentiation 20",inflammatory diseases; oncology; autoimmune diseases,cytokine; other,Phase 1,No,,,No,,,Yes,cytokines like IL-10 and IL-4,https://www.linkedin.com/company/deka-biosciences-inc,Yes,non-immunogenic scFv technology,https://www.linkedin.com/company/deka-biosciences-inc,No,,,Yes,Multispecific Cytokine Fusion Proteins,https://www.linkedin.com/company/deka-biosciences-inc,No,,,No,,,No,,,No,,,Yes,T cell engagers (TCEs),https://www.linkedin.com/company/deka-biosciences-inc
shanghai united cell biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.echemi.com', port=44",No,JS207,"PD-1, Programmed Cell Death Protein 1; VEGF, Vascular Endothelial Growth Factor",oncology,immune checkpoint; other,Phase 2/3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,genetically engineered vaccines,https://cn.linkedin.com/company/shanghai-united-cell-biotechnology-co-ltd,No,,,No,,
micell technologies inc,2017-10-19 00:00:00,No,MiStent SES,Not specified,cardiovascular,Not specified,Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,supercritical fluid technology,https://www.linkedin.com/company/micell-technologies
cascadian therapeutics inc (inactive),2022-10-13 00:00:00,No,tucatinib,"HER2, Human Epidermal Growth Factor Receptor 2",oncology,kinases,Phase 2,Yes,"investigational oral, small molecule tyrosine kinase inhibitor (TKI)",https://www.goodwinlaw.com/en/news-and-events/news/2018/01/01_31_18-cascadian-therapeutics-to-be-acquired,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
anheart therapeutics inc,2022-01-14 00:00:00,No,Not specified,Not specified,oncology,Not specified,Not specified,Yes,"Precision Oncology, NSCLC, GBM, Lung Cancer, ROS1, IDH1, and AXL",https://www.linkedin.com/company/anheart-therapeutics-official,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
laekna inc,2025-08-14 03:40:12,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,next-generation PI3Kα inhibitor and WRN Inhibitor,https://www.linkedin.com/company/laekna?trk=ppro_cprof,No,,,No,,,Yes,internally discovered monoclonal antibody against ActRIIB,https://www.linkedin.com/company/laekna?trk=ppro_cprof,No,,,No,,,No,,,No,,,No,,,No,,,No,,
laekna therapeutics shanghai co ltd,2025-08-14 03:40:12,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
guizhou taibang biological products co ltd,2018-06-29 03:29:26,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,plasma-based biopharmaceutical company,https://www.prnewswire.com/news-releases/china-biologic-acquires-full-ownership-of-guizhou-taibang-300351498.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
inregen,2019-01-14 09:00:00,No,QRX003,"SPINK5, Serine Protease Inhibitor Kazal Type 5",rare diseases; dermatology,enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,autologous cell therapy,https://www.prnewswire.com/news-releases/prokidney-announces-62-million-acquisition-of-inregen-300777588.html,No,,,No,,,Yes,"tissue repair, regeneration, and improved kidney function",https://www.ventureradar.com/organisation/inRegen/41185d66-d32b-494e-a6de-11e62bffd8fd
d3 bio inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,D3S-001; D3L-001,"KRAS G12C, Kirsten Rat Sarcoma Viral Oncogene Homolog G12C; HER2, Human Epidermal Growth Factor Receptor 2",oncology,kinases; other,Phase 2; Not specified,Yes,small molecule inhibitor for the mutant KRAS G12C protein,https://www.d3bio.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nocion therapeutics inc,2025-09-29 15:15:56,No,Not specified,Not specified,CNS,ion channels,Preclinical,Yes,unique molecular entities,https://www.linkedin.com/company/nocion-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mbx biosciences inc,2025-10-15 17:26:07,No,MBX 2109; MBX 1416; MBX 4291,"PTH, Parathyroid Hormone; PBH, Post-Bariatric Hypoglycemia; GLP-1/GIP Receptor",endocrine disorders; metabolic disorders; obesity,enzyme; other; gpcr,Phase 2; Phase 2; Phase 1,No,,,Yes,Precision Endocrine Peptides (PEPs™),https://www.linkedin.com/company/mbx-biosciences-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
vivet therapeutics sas,2019-03-20 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,protein replacement therapy,https://www.nvfund.com/portfolio/vivet-therapeutics-sas,No,,,No,,,No,,,No,,,Yes,gene therapy with adeno-associated vector technologies (AAVs),https://cima.cun.es/en/innovation/entrepreneurship/vivet-therapeutics,No,,,No,,,No,,
aristea therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,RIST4721,"CXCR2, C-X-C Motif Chemokine Receptor 2",dermatology; gastroenterology; rare diseases,gpcr,Phase 2,Yes,CXCR2 antagonist,https://globalgenes.org/raredaily/aristea-discontinues-lead-development-program-and-decides-to-dissolve-the-company/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aristea therapeutics inc (inactive),2021-07-27 14:17:22,No,RIST4721,"CXCR2, C-X-C Motif Chemokine Receptor 2",dermatology; rheumatology; rare diseases,gpcr,Phase 2,Yes,experimental inflammatory drug discovered by AstraZeneca,https://www.biopharmadive.com/news/an-astrazeneca-spinout-scores-a-buyout-option-from-arena/604014/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
vistagen therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,PH94B; PH10; AV-101,Not specified,CNS,Not specified,Phase 3; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,pherines,https://www.linkedin.com/company/vistagen
graviton bioscience corp,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,GV101,"ROCK2, Rho-associated coiled-coil containing protein kinase 2",CNS; autoimmune; fibrotic; inflammatory,kinases,Phase 1,Yes,ROCK2 inhibitors,https://www.prnewswire.com/news-releases/graviton-bioscience-announces-strategic-investment-from-sanofi-to-advance-development-of-the-next-generation-of-selective-rock2-inhibitors-302049773.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
morphic therapeutic inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,MORF-057,"α4β7, Integrin alpha-4 beta-7",gastroenterology; immunology,other,Phase 2,Yes,integrins have remained out of reach as small molecule drugs...until now,https://www.linkedin.com/company/morphic-therapeutic,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
neumedicines inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Selinexor; Eltanexor,"XPO1, Exportin 1",oncology,other,Phase 3; Approved,No,,,No,,,Yes,"recombinant human interleukin-12 (rHuIL-12), a heterodimeric glycoprotein and cytokine",https://www.linkedin.com/company/neumedicines,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
galecto inc,2020-10-25 00:00:00,No,GB0139; GB1211; BRM-1420,"Galectin-3; LOXL2, Lysyl Oxidase-Like 2",fibrosis; oncology,enzyme; other,Phase 2,Yes,novel small molecule therapeutics,https://www.linkedin.com/company/galecto-biotech/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
intekrin therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bioeq gmbh,Error: can't compare offset-naive and offset-aware dateti,No,FYB201; FYB202; FYB203; FYB206,Ranibizumab; Ustekinumab; Aflibercept; Not specified,ophthalmology; immunology; chronic diseases,cytokine; cytokine; cytokine; Not specified,Approved; Phase 1; Phase 3; Preclinical,No,,,No,,,No,,,Yes,biosimilar candidate for STELARA® (ustekinumab) and biosimilar candidate for LUCENTIS® (ranibizumab),https://www.bigmoleculewatch.com/2022/05/13/formycon-ag-acquires-biosimilar-assets-ustekinumab-and-ranibuzumab/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
sage therapeutics inc,2025-07-17 15:24:12,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain,"https://www.linkedin.com/company/sage-therapeutics#:~:text=Sage%20Therapeutics%20is%20a%20biopharmaceutical,debilitating%20disorders%20of%20the%20brain.",No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
fred hutchinson cancer research center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,STEAP1; NX-5948; NX-2127; NX-1607,"STEAP1, Six-transmembrane epithelial antigen of the prostate 1; Disease Name, Advanced B-cell malignancies; Disease Name, Advanced malignancies",oncology,immune checkpoint; other; other,Phase 1,No,,,No,,,Yes,bone marrow transplantation,https://bigtencrc.org/member-institutions/fred-hutch-cancer-center/,Yes,immunotherapy,https://bigtencrc.org/member-institutions/fred-hutch-cancer-center/,No,,,No,,,No,,,Yes,CAR-T cells,https://bigtencrc.org/member-institutions/fred-hutch-cancer-center/,Yes,COVID-19 vaccines,https://bigtencrc.org/member-institutions/fred-hutch-cancer-center/,No,,,No,,
chelsea therapeutics ltd,Error: Connection failed - HTTPSConnectionPool(host='www.pharmaceutical-techn,No,Northera; CH-1504; CH-4051,"Disease Name, Neurogenic Orthostatic Hypotension; Not specified",CNS; immunology; oncology,other,Phase 3,Yes,Northera™ (droxidopa),https://www.linkedin.com/company/chelsea-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
i-mab,2025-10-16 20:06:53,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"Bispecific antibodies, and Monoclonal antibodies",https://www.linkedin.com/company/i-mab,No,,,No,,,No,,,No,,,No,,,No,,,No,,
iecure,2025-10-16 14:47:41,No,GTP-506; ECUR-506,"PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9; OTC, Ornithine Transcarbamylase",rare diseases; metabolic diseases,enzyme,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,in vivo targeted gene insertion,https://www.linkedin.com/company/iecure,No,,,No,,,No,,
iecure inc,2025-10-16 14:47:41,No,GTP-506; ECUR-506,"PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9; OTC, Ornithine Transcarbamylase",rare diseases; metabolic diseases,enzyme,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,in vivo targeted gene insertion approach aims to restore the function of a missing or dysfunctional gene,https://www.linkedin.com/company/iecure,No,,,No,,,No,,
eyebiotech ltd,2024-11-22 20:34:17,Yes,EYE103; KSI-301; 601,"VEGF, Vascular Endothelial Growth Factor",retinal diseases; ophthalmology,cytokine,Phase 3,No,,,No,,,No,,,Yes,"investigational, potentially first-in-class tetravalent, tri-specific Wnt antibody",https://www.ophthalmologytimes.com/view/merck-completes-acquisition-of-eyebio,No,,,No,,,No,,,No,,,No,,,No,,,No,,
onl therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='onltherapeutics.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,Yes,small peptide Fas inhibitor,https://www.linkedin.com/company/onl-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ribon therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,ACR-368; ACR-2316,Not specified,oncology,kinases,Phase 2; Preclinical,Yes,first-in-class small molecule inhibitors,https://www.linkedin.com/company/ribon-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
attenuon llc,"Error: Connection failed - HTTPSConnectionPool(host='www.sbir.gov', port=443)",Yes,CTx-1301,Not specified,neurodevelopmental disorders; ADHD,Not specified,Phase 3,Yes,ATN-224 (choline tetrathiomolybdate) is an orally-available inorganic small molecule,https://pmc.ncbi.nlm.nih.gov/articles/PMC3227793/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
xylocor therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy,https://members.lifesciencespa.org/directory/Details/xylocor-therapeutics-inc-2798513,No,,,No,,,No,,
annexin pharmaceuticals ab,2025-09-25 07:03:44,No,ANXV,Annexin A5,ophthalmology,other,Phase 2,No,,,No,,,Yes,"human recombinant protein, Annexin A5",https://www.linkedin.com/company/annexin-pharmaceuticals/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
light sciences oncology inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,Olverembatinib; Lisaftoclax; ETX-19477; INS018_055; MTHFD2 inhibitor candidate; CP-383; VT3989; MZE829,Not specified,oncology; immunology; fibrosis; inflammatory and autoimmune diseases; obesity; renal and cardiometabolic diseases,Not specified,Phase 3; Phase 1; Phase 2; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
varmx bv,2025-10-14 09:40:35,Yes,VMX-C001,"Factor X, Coagulation Factor X",hematology; bleeding disorders,enzyme,Phase 3,No,,,No,,,Yes,therapeutic proteins to restore hemostasis,https://nl.linkedin.com/company/varmx,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
harpoon therapeutics inc,2024-01-08 12:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,bispecific antibodies,https://www.biopharmadive.com/news/merck-harpoon-acquire-deal-bispecific-lung-cancer/703880/,No,,,No,,,No,,,No,,,No,,,No,,,Yes,immune cell engagers,https://www.biopharmadive.com/news/merck-harpoon-acquire-deal-bispecific-lung-cancer/703880/
urovant sciences inc (inactive),2020-11-17 00:00:00,No,URO-902,Not specified,urology,Not specified,Phase 2,Yes,"vibegron, is an oral, once-daily small molecule beta-3 agonist",https://www.globenewswire.com/news-release/2021/03/29/2200741/0/en/Sumitovant-Biopharma-Completes-Acquisition-of-Urovant-Sciences.html,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"URO-902, is a novel gene therapy being developed for patients with OAB",https://www.globenewswire.com/news-release/2021/03/29/2200741/0/en/Sumitovant-Biopharma-Completes-Acquisition-of-Urovant-Sciences.html,No,,,No,,,No,,
scirhom gmbh,"Error: Connection failed - HTTPSConnectionPool(host='www.bio-m.org', port=443",Yes,SRS-878,"iRhom2; ADAM17, A Disintegrin And Metalloproteinase 17",immunology; autoimmune diseases,enzyme,Preclinical,No,,,No,,,No,,,Yes,first-in-class antibodies against iRhom2,https://www.linkedin.com/company/scirhom/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nura bio inc,2024-09-17 10:00:00,Yes,NB-4746,"SARM1, Sterile Alpha and TIR Motif Containing 1",neurology,enzyme,Phase 1,Yes,developing small molecule drugs for neurodegenerative conditions,https://www.biopharmadive.com/news/nura-bio-financing-sarm1-neurodegeneration-drug/727153/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
epicrispr biotechnologies inc,2025-03-26 08:00:00,Yes,EPI 321,"Disease Name, Facioscapulohumeral Muscular Dystrophy",rare diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CRISPR tools to stop errant expression of a gene implicated in the muscle-wasting condition,https://www.biopharmadive.com/news/epicrispr-fshd-series-b-financing-epigenetic-editing/743366/,No,,,No,,,Yes,"Epicrispr is advancing CRISPR-based epigenetic modulation, a precise, mutation-agnostic approach to treating complex diseases without cutting DNA",https://www.linkedin.com/company/epicrispr-biotechnologies
avalo therapeutics inc,2025-10-01 14:00:20,No,AVTX-009; quisovalimab; AVTX-008,"IL-1β, Interleukin-1 Beta; LIGHT, Tumor Necrosis Factor Superfamily Member 14; BTLA, B and T Lymphocyte Attenuator",immunology; inflammatory diseases,cytokine; cytokine; immune checkpoint,Phase 2,No,,,No,,,Yes,BTLA agonist fusion protein,https://www.linkedin.com/company/avalotx,Yes,anti-IL-1β mAb,https://www.linkedin.com/company/avalotx,No,,,Yes,BTLA agonist fusion protein,https://www.linkedin.com/company/avalotx,No,,,No,,,No,,,No,,,No,,
philogen spa,2025-09-24 08:13:19,Yes,Nidlegy,Not specified,oncology,Not specified,Phase 3,No,,,No,,,No,,,Yes,"human monoclonal antibodies, specific for a marker of angiogenesis",https://cy.linkedin.com/company/philogen?trk=ppro_cprof,Yes,Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer,https://cy.linkedin.com/company/philogen?trk=ppro_cprof,No,,,No,,,No,,,No,,,No,,,Yes,DNA-encoded chemical library-based discovery of OncoCAIX,https://cy.linkedin.com/company/philogen?trk=ppro_cprof
aerovate therapeutics inc,2025-04-21 08:00:39,Yes,AV-101,"PAH, Pulmonary Arterial Hypertension",cardiopulmonary diseases,other,Phase 2/Phase 3,Yes,"AV-101, an investigational, proprietary dry powder inhaled formulation of imatinib",https://www.aerovatetx.com/,No,,,No,,,Yes,"two undisclosed antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development",https://www.prnewswire.com/news-releases/aerovate-therapeutics-stockholders-approve-proposed-merger-with-jade-biosciences-and-all-related-proposals-302433012.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
avidity biosciences inc,2025-10-16 14:34:50,Yes,del-zota,"DMD44, Duchenne Muscular Dystrophy exon 44 skipping mutation",rare diseases; muscular dystrophy,other,Pre-BLA,No,,,No,,,No,,,Yes,monoclonal antibodies (mAbs),https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-closing-of-upsized-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302556671.html,Yes,Antibody Oligonucleotide Conjugates (AOCs™),https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-closing-of-upsized-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302556671.html,No,,,Yes,RNA therapeutics,https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-closing-of-upsized-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302556671.html,No,,,No,,,No,,,No,,
erydel spa,"Error: Connection failed - HTTPSConnectionPool(host='iedat-project.eu', port=",No,Dexamethasone 21-phosphate,"Disease Name, Ataxia Telangiectasia",rare diseases; neurology,other,Phase 3,Yes,dexamethasone sodium phosphate (DSP; a pro-drug),https://www.nasdaq.com/press-release/quince-therapeutics-completes-acquisition-of-erydel-s.p.a.-2023-10-23,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,autologous intracellular drug encapsulation (AIDE),https://www.nasdaq.com/press-release/quince-therapeutics-completes-acquisition-of-erydel-s.p.a.-2023-10-23
biotheryx inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Small Molecules,https://www.linkedin.com/company/biotheryx-inc.,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"protein degraders, bifunctional degraders, molecular glues",https://www.prnewswire.com/news-releases/biotheryx-announces-research-collaboration-and-license-agreement-with-incyte-for-discovery-of-targeted-protein-degraders-for-novel-oncology-targets-301790262.html,No,,
silexion therapeutics corp,"Error: Connection failed - HTTPSConnectionPool(host='il.linkedin.com', port=4",Yes,SIL-204; LODER,"KRAS, Kirsten Rat Sarcoma Viral Oncogene Homolog",oncology,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"RNA interference (RNAi), RNA-based therapeutics, siRNA",https://silexion.com/,No,,,No,,,No,,,Yes,"Targeted Drug Delivery, PLG microparticle product",https://silexion.com/
nls pharmaceutics ag,2025-09-30 11:13:13,Yes,Quilience; Mazindol ER; NLS-10,"NDRI, Norepinephrine-Dopamine Reuptake Inhibitor; Mu-opioid receptor; 5-HT1A receptor; Orexin-2 receptor",CNS; ADHD; narcolepsy; hypersomnia; substance use disorders,gpcr; other,Preclinical,Yes,CNS-focused small-molecule therapies,https://ch.linkedin.com/company/nls-pharmaceutics-ag,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Kadimastem’s advanced cell therapy programs for ALS (AstroRx®) and diabetes (IsletRx),https://ch.linkedin.com/company/nls-pharmaceutics-ag,No,,,No,,,No,,
tetra bio-pharma inc,"Error: Connection failed - HTTPSConnectionPool(host='ca.linkedin.com', port=4",Yes,Not specified,Not specified,pain; inflammation; oncology,Not specified,Not specified,Yes,cannabinoid-derived drug discovery and development,"https://www.cnbc.com/quotes/TBPMQ#:~:text=Tetra%20Bio%2DPharma%20Inc.,pain%2C%20inflammation%2C%20and%20oncology.",No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
annovis bio inc,2025-10-10 12:31:38,No,buntanetap; ANVS405; ANVS301,Amyloid Beta; Tau; Alpha-Synuclein; TDP43,CNS; neurodegenerative diseases,other,Phase 3,Yes,"small molecule, orally administered, brain penetrant compound",https://www.linkedin.com/company/annovis-bio-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
spectrumx holdings uk ltd,Error: Connection failed - HTTPSConnectionPool(host='www.proactiveinvestors.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
lobe sciences ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,Psilocin; L-130,Chronic Cluster Headache,CNS; rare diseases,other,Phase 1,Yes,"Conjugated Psilocin™, a patented analog of psilocin",https://ca.linkedin.com/company/lobe-sciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Psilocybin-based therapies,https://ca.linkedin.com/company/lobe-sciences
skinject inc,"Error: Connection failed - HTTPSConnectionPool(host='www.razabokhari.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
oncotartis inc,2018-01-11 00:00:00,Yes,OT-82,"NAMPT, Nicotinamide Phosphoribosyltransferase",oncology,enzyme,Phase 1,Yes,develop small molecules for treatment of malignancies,https://oncotartis.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
changchun beike biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,AdAPT-001; SRK-181; STP 707; SIS 201 CD; IOA-359; Elritercept; ISTH0036; TU-2218; AGMB-129; IO170; ES 014; SHR-1701; HEC585; RO7204239; ESN-Y,"TGF-β, Transforming Growth Factor Beta",oncology; fibrosis,cytokine,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,stem cell therapies,https://beikebiotech.com/beike-history/,No,,,No,,,No,,
cytovation as,2025-09-01 11:27:14,Yes,CY-101,"Wnt/β-catenin, Wnt/β-catenin signalling pathway",oncology; rare diseases,other,Phase 2,No,,,Yes,synthetic peptide engineered to selectively target tumor cells,https://www.linkedin.com/company/cytovation-asa/,No,,,No,,,No,,,No,,,No,,,No,,,Yes,in-situ vaccination,https://www.linkedin.com/company/cytovation-asa/,No,,,No,,
genvec llc,2018-06-26 14:51:22,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene delivery platform, adenoviral vectors, gene therapy",https://www.prnewswire.com/news-releases/intrexon-to-acquire-genvec-to-expand-industry-leading-gene-delivery-platform-300395556.html,Yes,"vaccines, adenoviral-based product candidates",https://www.linkedin.com/company/genvec,No,,,No,,
elixirgen therapeutics inc,2025-02-25 14:42:10,Yes,Not specified,Fanconi Anemia,rare diseases,Not specified,Phase 1; Phase 2; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,Yes,RNA therapeutics company focused on the discovery and development of innovative therapies,https://www.linkedin.com/company/elixirgen-therapeutics-inc,Yes,gene therapy aimed at lengthening telomeres and preventing bone marrow failure,https://www.linkedin.com/company/elixirgen-therapeutics-inc,No,,,No,,,Yes,Bobcat mRNA™ technology uses a proprietary mRNA design to deliver large payloads,https://www.linkedin.com/company/elixirgen-therapeutics-inc
eterna therapeutics inc,2025-03-25 12:30:00,Yes,ERNA-101,"IL-7, Interleukin-7; IL-15, Interleukin-15",oncology; rare diseases; autoimmune disorders,cytokine,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"cell therapy products, induced pluripotent stem cells (iPSCs), induced mesenchymal stem cells (iMSCs)",https://www.globenewswire.com/news-release/2025/03/25/3048736/0/en/Eterna-Therapeutics-Changes-Name-to-Ernexa-Therapeutics-to-Reflect-New-Strategic-Focus-on-Ovarian-Cancer-and-Autoimmune-Disease.html,No,,,No,,,No,,
qurient co ltd,2025-10-14 04:59:02,Yes,Namodenoson; YIV-906; TTI-101; STP707; BST02,"A3AR, A3 Adenosine Receptor; IL-6, Interleukin-6; NF-kappa-B, Nuclear Factor kappa-light-chain-enhancer of activated B cells; COX2, Cyclooxygenase-2; STAT3, Signal Transducer and Activator of Transcription 3; TGF-ß1, Transforming Growth Factor Beta 1",oncology,gpcr; cytokine; enzyme; other,Phase 3; Phase 2; Phase 1,Yes,"Adrixetinib is an orally administered, selective inhibitor of AXL, MER, and CSF1R kinases",https://kr.linkedin.com/company/quro-science-inc.,No,,,No,,,Yes,"QP101, a novel dual-payload antibody–drug conjugate (ADC)",https://kr.linkedin.com/company/quro-science-inc.,Yes,novel proteasome inhibitor (PI)-based ADC platform,https://kr.linkedin.com/company/quro-science-inc.,No,,,No,,,No,,,No,,,No,,,No,,
cage bio inc,2025-09-04 22:14:57,Yes,Not specified,"Disease Name, Cutaneous Graft-versus-Host Disease",immunology; dermatology,Not specified,Preclinical,Yes,"CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor",https://www.linkedin.com/company/cage-bio-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,ionic liquid technology,https://www.prnewswire.com/news-releases/cage-bio-announces-collaboration-to-advance-first-in-class-treatments-for-cutaneous-graft-versus-host-disease-302540347.html
general oncology inc,2025-10-08 14:23:04,Yes,GO-4,"BRCA, Breast Cancer Gene 2",oncology,other,Phase 2,Yes,Through new and repurposed drugs,https://www.generaloncology.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
medesis pharma sa,"Error: Connection failed - HTTPSConnectionPool(host='www.medesispharma.com', ",Yes,Aducanumab; AGB101; AR1001; AVP-786; AXS-05; Blarcamesine; BPDO-1603; Brexpiprazole; Caffeine; Donanemab; Donepezil; E2814; Escitalopram; Fosgonimeton; Gantenerumab; Guanfacine; Hydralazine hydrochloride; Icosapent ethyl,"Aβ, Amyloid beta; SV2A, Synaptic vesicle glycoprotein 2A; Neurotransmitter receptors; Sigma-1 receptor; Tau, Tau protein; Hepatocyte growth factor receptor; Alpha-2 adrenergic receptor; Oxidative stress; Free radicals",CNS; Alzheimer's disease,other; gpcr; other; other; other; other; other; other; other,Phase 3,No,,,Yes,Therapeutic peptides,https://ca.linkedin.com/company/medesis-pharma,No,,,No,,,No,,,No,,,Yes,Antisense oligonucleotides,https://ca.linkedin.com/company/medesis-pharma,No,,,No,,,No,,,No,,
onechain immunotherapeutics,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,OC-1,"CD7, Cluster of Differentiation 7",oncology; hematological malignancies,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies,https://www.linkedin.com/company/onechain-immunotherapeutics,No,,,No,,,No,,
orcosa inc,2025-02-07 00:00:00,Yes,ORAVEXX,Not specified,pain management; inflammation,other,Phase 1/2,Yes,ORAVEXX™ (cannabidiol),https://www.orcosa.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,next generation drug delivery technology – the Rapid Infusion Technology (RITe™) Platform,https://www.orcosa.com/
nuvox pharma llc,"Error: Connection failed - HTTPSConnectionPool(host='www.sbir.gov', port=443)",No,NanO2; Dodecafluoropentane emulsion (DDFPe),Hypoxia,oncology; stroke; acute ischemia; respiratory distress; ARDS; glioblastoma; sickle cell anemia,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"oxygen therapeutic, NanO₂™",https://seed.nih.gov/portfolio/nih-portfolio-company-showcase/nuvox-pharma
repertoire genesis inc,2019-10-30 00:00:00,Yes,ORGCAR19; MOTC; DUVAC; ORGCAR19.22; CAR-NK; RanTop; SVF-COV; AutoVac; Kyslecel™; Bioxome™; MSCP; Cartil-S/Chondroseal; SVF-CLI/ED; Rev-md; MSCKD; EVs,"CD19, Cluster of Differentiation 19; CD22, Cluster of Differentiation 22; HPV, Human Papillomavirus; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; Tumor Cell Antigens; TILs, Tumor-Infiltrating Lymphocytes; RNA, Ribonucleic Acid; miRNA, MicroRNA; AIPs, Artificial Islets of Pancreas",immuno-oncology; viral diseases; metabolic diseases; autoimmune diseases; vascular diseases; musculoskeletal diseases; kidney diseases,immune checkpoint; cytokine; enzyme; other,Preclinical; IND Enabling Studies; Clinical Trials; Clinical Use,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,TCR/BCR Repertoire Analysis developed by our company can clarify what kind of antigen individual T and B cells respond to,https://www.linkedin.com/company/repertoire-genesis-%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE,No,,,No,,,Yes,immune-diversity analysis technology,https://www.linkedin.com/company/repertoire-genesis-%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE
vigeo therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,VT1021; VT101,"TSP-1, Thrombospondin-1",oncology; inflammatory diseases; neurodegenerative diseases,cytokine,Phase 3,No,,,No,,,Yes,"TSP-1, a naturally occurring potent immune system regulatory protein",https://vigeotx.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
soligenix inc,2025-10-14 13:38:01,Yes,HyBryte; SGX945,"Disease Name, Cutaneous T-cell lymphoma; Disease Name, Behçet's Disease",oncology; rare diseases,other,Phase 3; Phase 2,Yes,"oral beclomethasone 17,21-dipropionate (BDP)",https://www.linkedin.com/company/soligenix-inc-,No,,,Yes,protein subunit vaccines for Ebola and related viruses,https://www.linkedin.com/company/soligenix-inc-,No,,,No,,,No,,,No,,,No,,,Yes,"RiVax®, a ricin toxin vaccine",https://www.linkedin.com/company/soligenix-inc-,No,,,Yes,"heat stabilization platform technology, known as ThermoVax®",https://www.linkedin.com/company/soligenix-inc-
theriva biologics sl,2025-06-07 00:00:00,Yes,VCN-01; SYN-004; SYN-020,Not specified,oncology,other,Phase 2; Phase 1,No,,,No,,,Yes,"SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP)",https://www.linkedin.com/company/theriva-biologics,No,,,No,,,No,,,No,,,Yes,acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients,https://www.linkedin.com/company/theriva-biologics,No,,,No,,,Yes,"oncolytic adenovirus platform designed for intravenous (IV), intravitreal and antitumoral delivery",https://www.linkedin.com/company/theriva-biologics
evoke pharma inc,2021-07-26 21:57:29,No,GIMOTI; Metoclopramide Nasal Spray,"Disease Name, Diabetic Gastroparesis",gastroenterology,other,Marketed,Yes,oral metoclopramide,https://evokepharma.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
novarock biotherapeutics ltd,2021-08-25 17:24:00,Yes,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,No,,,Yes,monoclonal and multi-specific antibody molecules,https://www.prnewswire.com/news-releases/novarock-biotherapeutics-announces-exclusive-license-agreement-and-strategic-partnership-with-flame-biosciences-301363104.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pharmicell co ltd,2014-05-07 00:00:00,Yes,GXHPC-1; LPCN-1148; Belapectin,"Disease Name; Disease Name; Galectin-3, Galectin-3 Protein",liver diseases; liver diseases; liver diseases,other; other; other,Phase 2; Phase 2; Phase 2/Phase 3,Yes,"Oligonucleotide synthesis, derivative of PEG medicine",https://www.pharmicell.com/eng/,No,,,No,,,No,,,No,,,No,,,Yes,Oligonucleotide synthesis,https://www.pharmicell.com/eng/,Yes,Bone marrow-derived mesenchymal stem cells and peripheral blood-derived hematopoietic stem cells,https://www.linkedin.com/company/pharmicell-co-ltd-,No,,,No,,,Yes,Exosome-based therapeutics (stem cell culture media cosmetics),https://www.pharmicell.com/eng/
sirnaomics ltd,2025-10-17 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
allyx therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.nia.nih.gov', port=4",Yes,ALX-001,"mGluR5, Metabotropic Glutamate Receptor 5",CNS,gpcr,Phase 1,Yes,mGluR5 modulator,https://www.linkedin.com/company/allyx-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nouscom ag,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Nous209,"Disease Name, Lynch Syndrome",oncology,other,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,viral vectored genetic vaccines based on neoantigens,https://www.swissbiotech.org/listing/nouscom-ag/,No,,,No,,
biodol therapeutics sas,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,FLT3 selective small-molecule extracellular antagonists,https://www.linkedin.com/company/biodol-therapeutics/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
hysensbio corp,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,HBO-001; KH001,Not specified,dental diseases; rare diseases,Not specified,Phase 2,No,,,Yes,novel peptide drug for dentin hypersensitivity,https://lu.linkedin.com/company/hysensbio,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
beijing joekai biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,AdAPT-001; SRK-181; STP 707; SIS 201 CD; IOA-359; Elritercept; ISTH0036; TU-2218; AGMB-129; IO170; ES 014; SHR-1701; HEC585; RO7204239; ESN-Y,"TGF-β, Transforming Growth Factor Beta",oncology; fibrosis,cytokine,Phase 3,No,,,Yes,Peptide Therapies,https://www.ventureradar.com/organisation/Beijing%20Joekai%20Biotechnology/03d03bc2-8a5d-4b8e-84e0-04cade6afc24,No,,,No,,,No,,,No,,,Yes,RNA,https://www.ventureradar.com/organisation/Beijing%20Joekai%20Biotechnology/03d03bc2-8a5d-4b8e-84e0-04cade6afc24,No,,,Yes,Vaccines,https://www.ventureradar.com/organisation/Beijing%20Joekai%20Biotechnology/03d03bc2-8a5d-4b8e-84e0-04cade6afc24,No,,,No,,
purinomia biotech inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,Not specified,Not specified,oncology; immunology; inflammatory disease; metabolic diseases,enzyme,Not specified,Yes,small molecule development,https://www.linkedin.com/company/purinomia-biotech,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cytoagents inc,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,Not specified,"CRS, Cytokine Release Syndrome; ICANS, Immune Effector Cell-Associated Neurotoxicity Syndrome",oncology,cytokine,Phase 2,Yes,"CTO1681, an oral small molecule immune modulator",https://www.linkedin.com/company/cytoagents,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
biorestorative therapies inc,2025-09-23 15:41:05,Yes,BRTX-100,Chronic Lumbar Disc Disease,chronic pain; metabolic disorders,other,Phase 2,No,,,No,,,Yes,"Secretome (novel exosome, growth factor/cytokine) biologics based technology for cosmetic applications",https://biorestorative.com/,No,,,No,,,No,,,No,,,Yes,"Developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells",https://biorestorative.com/,No,,,No,,,Yes,"Secretome (novel exosome, growth factor/cytokine) biologics based technology for cosmetic applications",https://biorestorative.com/
panoptes pharma gesmbh,Error: Connection failed - 403 Client Error: Forbidden for url: https://kiora,No,OKG-0801; SHG-112; NCOX-A1,Adenovirus; Herpes Simplex Virus,infectious diseases; ophthalmology,other,Phase 2; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
fate therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"iPSC-derived cellular immunotherapies, multiplexed-engineered iPSC lines, iPSC-derived natural killer (NK) cell and T-cell product candidates, chimeric antigen receptors (CARs)",https://www.linkedin.com/company/fate-therapeutics-inc,No,,,No,,,No,,
ichnos glenmark innovation,2025-07-10 00:00:00,No,ISB 2001; ISB 1342; ISB 1442; GRC 65327,"BCMA, B-cell Maturation Antigen; CD38, Cluster of Differentiation 38; CD3, Cluster of Differentiation 3; CD47, Cluster of Differentiation 47; Cbl-b, Casitas B-lineage lymphoma proto-oncogene-b",oncology,immune checkpoint; other,Phase 1; Preclinical,Yes,GRC 54276 - Hematopoietic progenitor kinase 1 inhibitor (NCE),https://www.prnewswire.com/in/news-releases/glenmark-and-ichnos-take-a-collaborative-leap-to-accelerate-innovation-in-cancer-treatment-with-their-alliance---ichnos-glenmark-innovation-302048031.html,No,,,No,,,Yes,Multispecifics™ including trispecific antibodies,"https://news.abbvie.com/2025-07-10-AbbVie-and-Ichnos-Glenmark-Innovation-IGI-Announce-Exclusive-Global-Licensing-Agreement-for-ISB-2001,-a-First-in-Class-CD38xBCMAxCD3-Trispecific-Antibody",No,,,No,,,No,,,No,,,No,,,No,,,No,,
curon biopharmaceutical (australia) co pty ltd,Error: Connection failed - HTTPSConnectionPool(host='www.biospectrumasia.com',No,CN201,"CD19, Cluster of Differentiation 19; CD3, Cluster of Differentiation 3",oncology; autoimmune diseases,immune checkpoint,Phase 1,Yes,Oral small molecule targeted therapies,https://trials.cancervic.org.au/details/feed-cta-trial307,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
curon biopharmaceutical ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,CN201,"Disease Name, B-cell associated diseases",oncology; autoimmune diseases,other,Phase 1,No,,,No,,,No,,,Yes,bispecific antibodies,https://www.goodwinlaw.com/en/news-and-events/news/2024/10/announcements-lifesciences-goodwin-advises-curon-biopharmaceutical,Yes,antibody-drug conjugates,https://www.goodwinlaw.com/en/news-and-events/news/2024/10/announcements-lifesciences-goodwin-advises-curon-biopharmaceutical,No,,,No,,,No,,,No,,,No,,,No,,
arvinas inc,2025-10-13 13:05:30,No,Vepdegestrant; ARV-393; ARV-102,"ER, Estrogen Receptor; ESR1, Estrogen Receptor 1; BCL6, B-Cell Lymphoma 6; LRRK2, Leucine-Rich Repeat Kinase 2",oncology; neurodegenerative disorders,nuclear receptors; other,Phase 3; Preclinical,Yes,"PROTACs (PROteolysis TArgeting Chimeras), pioneered by Arvinas, are a new class of small molecule investigational therapies",https://www.linkedin.com/company/arvinas,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Arvinas uses its PROTAC Discovery Engine to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders",https://www.linkedin.com/company/arvinas,No,,
loxo oncology inc,2019-01-07 06:30:00,Yes,AZD0486; EO2463; Abexinostat; ZE50-0134; NVG-111,"CD19, Cluster of Differentiation 19; CD3, Cluster of Differentiation 3; CD20, Cluster of Differentiation 20; CD22, Cluster of Differentiation 22; CD37, Cluster of Differentiation 37; CD268, BAFF receptor",oncology,immune checkpoint; other,Phase 1; Phase 2,Yes,"LOXO-292, an oral RET inhibitor; LOXO-305, an oral BTK inhibitor; Vitrakvi® (larotrectinib), an oral TRK inhibitor",https://www.prnewswire.com/news-releases/lilly-announces-agreement-to-acquire-loxo-oncology-300773673.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zion pharma co ltd,Error: Connection failed - HTTPSConnectionPool(host='www.pharmaceutical-techn,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
"alvine pharmaceuticals, inc. (inactive)","Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,AP01; AP02; AP03,Cytokines and Growth Factors; Multiple Tyrosine Kinases,pulmonary diseases,cytokine; kinases,Phase 2; Phase 1; Preclinical,No,,,No,,,Yes,biologics to target autoimmune and inflammatory diseases,https://www.flagshippioneering.com/companies/alvine-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
alchemia oncology pty ltd,2015-07-01 10:30:00,Yes,HA-Irinotecan; FAK inhibitors,"FAK, Focal Adhesion Kinase",oncology,kinases,Phase 3; Preclinical,Yes,new chemical entities with its proprietary platform VAST or Versatile Assembly on Stable Templates Drug Discovery Platform,https://www.globenewswire.com/news-release/2015/07/01/1238245/0/en/Panther-Biotechnology-Announces-the-Acquisition-of-Alchemia-Oncology-Pty-Limited.html,No,,,Yes,transferrin glycoproteins with Doxorubicin for targeted delivery to tumors,https://www.globenewswire.com/news-release/2015/07/01/1238245/0/en/Panther-Biotechnology-Announces-the-Acquisition-of-Alchemia-Oncology-Pty-Limited.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,HyACT Drug Delivery Platform,https://www.globenewswire.com/news-release/2015/07/01/1238245/0/en/Panther-Biotechnology-Announces-the-Acquisition-of-Alchemia-Oncology-Pty-Limited.html
kumquat biosciences inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,novel immuno-oncology small molecule inhibitor,https://www.prnewswire.com/news-releases/kumquat-biosciences-and-takeda-enter-into-strategic-collaboration-and-exclusive-global-license-agreement-to-advance-novel-oral-immuno-oncology-drug-candidate-302117294.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
delix therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,non-hallucinogenic versions of psychedelic compounds,https://www.linkedin.com/company/delix-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,neuroplastogen therapeutics,https://www.linkedin.com/company/delix-therapeutics
leyden laboratories bv,"Error: Connection failed - HTTPSConnectionPool(host='www.businesswire.com', p",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,Our company is developing nasal sprays containing antibodies that target respiratory viruses in the nasal mucosa.,https://leydenlabs.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tempero bio,2025-03-24 07:00:39,Yes,TMP-301,"mGluR5, Metabotropic Glutamate Receptor 5",substance use disorders,gpcr,Phase 2,Yes,"TMP-301 is a potent, orally available, metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM)",https://www.linkedin.com/company/tempero-bio-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
topas therapeutics gmbh,"Error: Connection failed - HTTPSConnectionPool(host='www.evotec.com', port=44",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
benaroya research institute at virginia mason,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Capivasertib; Tusamitamab Ravtansine; Zenocutuzumab; Zolbetuximab; Revumenib; Denileukin Diftitox,"AKT, Protein Kinase B; CEACAM5, Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; NRG1, Neuregulin 1; Claudin 18.2; KMT2A, Lysine Methyltransferase 2A; IL-2 Receptor",oncology; hematology; gastrointestinal diseases,kinases; other; other; other; other; cytokine,Approved; Phase 2; Phase 1/2; Phase 3; Phase 1/2; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
heidelberg pharma ag,2025-10-09 07:25:50,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,Selected antibodies are loaded with cytotoxic compounds,https://de.linkedin.com/company/heidelberg-pharma-ag,Yes,ADC technologies for the targeted and highly effective treatment of cancer,https://de.linkedin.com/company/heidelberg-pharma-ag,No,,,No,,,No,,,No,,,No,,,No,,
neurobo pharmaceuticals inc,2024-11-18 08:10:36,Yes,DA-1726; DA-1241; NB-01,"GLP1R, Glucagon-Like Peptide-1 Receptor; GCGR, Glucagon Receptor; GPR119, G-Protein-Coupled Receptor 119",obesity; metabolic diseases; neurodegenerative diseases,gpcr; gpcr; Not specified,Phase 1; Phase 2; Not specified,Yes,DA-1241 is a novel G-protein-coupled receptor 119 (GPR119) agonist,https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-strategic-realignment-ahead-of-important-clinical-milestones-with-name-change-to-metavia---reflecting-the-companys-focus-on-cardiometabolic-diseases-302308180.html,Yes,DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist,https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-announces-strategic-realignment-ahead-of-important-clinical-milestones-with-name-change-to-metavia---reflecting-the-companys-focus-on-cardiometabolic-diseases-302308180.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
sciwind biosciences co ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,XW003; XW004; XW014,"GLP-1, Glucagon-like peptide-1; Amylin, Islet Amyloid Polypeptide",metabolic diseases; obesity; type 2 diabetes; MASH,gpcr; other,Phase 3; Phase 1; Preclinical,Yes,oral small molecule GLP-1 receptor agonist XW014,https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-global-licensing-and-collaboration-agreement-for-metabolic-disease-portfolio-302347773.html,Yes,long-acting GLP-1 peptide analog Ecnoglutide injection,https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-global-licensing-and-collaboration-agreement-for-metabolic-disease-portfolio-302347773.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
chr. hansen holding as,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,infectious diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
hansa biopharma ab,2025-10-10 00:00:00,Yes,imlifidase; HNSA-5487,"IgG, Immunoglobulin G; AAVrh74, Adeno-Associated Virus rh74",rare diseases; immunology; gene therapy,enzyme; other,Marketed; Phase 1,No,,,No,,,Yes,antibody-cleaving enzymes imilfidase and HNSA-5487,https://www.hansabiopharma.com/,Yes,IgG antibodies,https://www.hansabiopharma.com/,No,,,No,,,No,,,Yes,Desensitization in gene therapy,https://www.hansabiopharma.com/,No,,,No,,,No,,
sqz biotechnologies co,2024-05-01 00:00:00,Yes,SQZ-PBMC-HPV; SQZ-AAC-HPV; SQZ-eAPC-HPV,E6 and E7 oncoproteins,oncology,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation,https://www.cnbc.com/quotes/SQZB,No,,,No,,,Yes,"technology that 'gently squeezes' cells, creating a temporary porousness in the cell membrane, and a chance to deliver materials directly into the cytoplasm",https://www.lifescienceleader.com/doc/where-are-they-now-sqz-biotech-0001
sqz biotechnologies co (inactive),2024-05-01 00:00:00,Yes,SQZ-PBMC-HPV; SQZ-AAC-HPV; SQZ-eAPC-HPV,HPV16+ advanced or metastatic solid tumors,oncology,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell therapies,https://brandsreviewmagazine.com/news/stemcell-technologies-successfully-acquires-all-assets-of-sqz-biotechnologies-company/,No,,,No,,,Yes,mechanoporation,https://brandsreviewmagazine.com/news/stemcell-technologies-successfully-acquires-all-assets-of-sqz-biotechnologies-company/
apogenix ag,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tvardi therapeutics inc,2025-09-12 15:49:48,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"novel, oral small molecule therapies targeting STAT3",https://www.linkedin.com/company/tvardi,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tvardi therapeutics inc.,2025-09-12 15:49:48,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"novel, oral small molecule therapies targeting STAT3",https://www.linkedin.com/company/tvardi,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
med discovery sa,2003-10-15 00:00:00,Yes,Not specified,Not specified,oncology; urology,Not specified,Not specified,No,,,No,,,Yes,protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways,https://www.linkedin.com/company/med-discovery-sa,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,proprietary technology platform to produce protease inhibitors,https://www.linkedin.com/company/med-discovery-sa
celltrion inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,YUFLYMA; CT-P17; adalimumab-aaty,"TNF-alpha, Tumor Necrosis Factor-alpha",immunology,cytokine,Marketed,Yes,small molecule products,https://www.linkedin.com/company/celltrioninc/,No,,,Yes,biologics,https://www.linkedin.com/company/celltrioninc/,Yes,biosimilars,https://www.linkedin.com/company/celltrioninc/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
wenling chuangxin biomedical technology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
alzecure pharma ab,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,ACD440; ACD856; TrkA-NAM,"TRPV1, Transient Receptor Potential Vanilloid 1; Not specified; Not specified",CNS; pain; Alzheimer's disease,ion channels; Not specified; Not specified,Phase 2; Phase 2; Research,Yes,Small molecules,https://alzecurepharma.se/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
genentech inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Tecentriq; Lurbinectedin,"PD-L1, Programmed Death-Ligand 1",oncology,immune checkpoint,Approved,Yes,Xofluza® (baloxavir marboxil),https://www.linkedin.com/company/genentech,No,,,No,,,Yes,first targeted antibody for cancer,https://www.roche.com/innovation/structure/genentech,No,,,No,,,No,,,No,,,No,,,No,,,No,,
genentech usa inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Tecentriq; Lurbinectedin,"PD-L1, Programmed Death-Ligand 1",oncology,immune checkpoint,Approved,Yes,Xofluza® (baloxavir marboxil),https://www.linkedin.com/company/genentech,No,,,Yes,Pulmozyme® (dornase alfa) Inhalation Solution,https://www.genentech-access.com/,Yes,"Herceptin® (trastuzumab), Rituxan® (rituximab), TECENTRIQ® (atezolizumab)",https://www.genentech-access.com/,Yes,"POLIVY® (polatuzumab vedotin-piiq), KADCYLA® (ado-trastuzumab emtansine)",https://www.genentech-access.com/,Yes,"PHESGO® (pertuzumab, trastuzumab, and hyaluronidase-zzxf)",https://www.genentech-access.com/,No,,,No,,,Yes,Xofluza® (baloxavir marboxil) initiative,https://www.linkedin.com/company/genentech,No,,,No,,
avicanna inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,dermatology; chronic pain; neurological disorders,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cannabinoid-based products,https://ca.linkedin.com/company/avicanna
glubio therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,Not specified,Not specified,oncology; sickle cell disease,Not specified,Preclinical,Yes,highly selective small-molecule degraders,https://www.linkedin.com/company/glubio-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,targeted protein degraders,https://www.linkedin.com/company/glubio-therapeutics-inc,Yes,molecular glue degraders,https://www.prnewswire.com/news-releases/glubio-completes-series-a-financing-of-22-million-to-advance-the-development-of-novel-tpd-drugs-301596564.html
tessa therapeutics ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,CD30 CAR-T,"CD30, Cluster of Differentiation 30",oncology,immune checkpoint,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developing autologous and allogeneic cell therapies for the treatment of cancer,https://sg.linkedin.com/company/tessa-therapeutics-ltd,No,,,No,,,Yes,oncolytic virus,https://www.geneonline.com/singapore-tessa-therapeutics-announces-liquidation/
vericel corp,2025-10-15 20:19:26,No,MACI; NexoBrid; anacaulase-bcdb,Cartilage and osteochondral defects of the knee; Cartilage and osteochondral defects of the ankle; Disease Name,sports medicine; severe burn care; rare diseases,other,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,autologous cell therapy products,https://www.linkedin.com/company/vericel-corporation,No,,,No,,,No,,
enanta pharmaceuticals inc,2025-10-09 15:49:24,Yes,Zelicapavir; EDP-323,"N-protein, Nucleocapsid Protein; L-protein, RNA Polymerase",infectious diseases,enzyme,Phase 2,Yes,discovery and development of small molecule drugs,https://www.massbio.org/members/enanta-pharmaceuticals-inc/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aicuris anti-infective cures ag,2025-10-16 09:01:35,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Helicase primase inhibitors (HPIs),https://pubmed.ncbi.nlm.nih.gov/40154924/,No,,,No,,,No,,,No,,,No,,,Yes,Antisense oligonucleotide targeting BK Virus,https://www.linkedin.com/company/aicuris,No,,,No,,,No,,,No,,
sparingvision sas,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,SPVN06,Not specified,rare diseases; ophthalmology,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene-agnostic gene therapy programs, SPVN06 and SPVN20",https://www.linkedin.com/company/sparingvision,No,,,No,,,No,,
nkure therapeutics pvt ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
abivax sa,"Error: Connection failed - HTTPSConnectionPool(host='www.linkedin.com', port=",No,Obefazimod,"miR-124, MicroRNA-124",immunology; inflammatory diseases,cytokine,Phase 3,Yes,"Obefazimod is an investigational, orally administered, once-daily therapy",https://www.linkedin.com/company/abivax/,No,,,No,,,No,,,No,,,No,,,Yes,"enhances the expression of microRNA-124 (miR-124), a natural regulator of the inflammatory response",https://www.linkedin.com/company/abivax/,No,,,Yes,therapeutic vaccines against severe and life threatening infectious diseases,https://www.cnbc.com/quotes/ABVX,No,,,No,,
celgene inc,"Error: Connection failed - HTTPSConnectionPool(host='news.bms.com', port=443)",Yes,AZD0486; EO2463; Abexinostat; ZE50-0134; NVG-111,"CD19, Cluster of Differentiation 19; CD3, Cluster of Differentiation 3; CD20, Cluster of Differentiation 20; CD22, Cluster of Differentiation 22; CD37, Cluster of Differentiation 37; CD268, BAFF receptor",oncology,immune checkpoint; other,Phase 1; Phase 2,Yes,Protein Homeostasis,https://www.linkedin.com/company/celgene,No,,,No,,,Yes,Immunooncology,https://www.linkedin.com/company/celgene,No,,,No,,,No,,,No,,,No,,,No,,,No,,
eleva gmbh,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,"Factor H (CPV-104), a recombinant version of human complement Factor H",https://www.linkedin.com/company/eleva-gmbh/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
iomx therapeutics ag,2025-10-02 10:42:02,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"OMX-0407, a first-in-class kinase inhibitor",https://de.linkedin.com/company/iomx-therapeutics,No,,,No,,,Yes,"IOMX-0675, our dual-targeting antibody against LILRB1 and LILRB2",https://de.linkedin.com/company/iomx-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,
shanghai grit biotechnology inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,GT101; GT201,"Tumor-Infiltrating Lymphocytes; IL-15, Interleukin-15",oncology,cytokine; other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Developing novel cell therapies to transform the lives of people with cancer,https://www.linkedin.com/company/grit-biotechnology,No,,,No,,,No,,
nascent biotech inc,2024-10-31 20:55:15,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"Pritumumab, a human monoclonal antibody",https://www.linkedin.com/company/nascent-biotech,No,,,No,,,No,,,No,,,No,,,No,,,No,,
xbiotech inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,True Human monoclonal antibodies,https://www.linkedin.com/company/xbiotech-usa-inc.,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cansino biologics inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"high-quality, innovative, and affordable vaccines",https://www.linkedin.com/company/%E5%BA%B7%E5%B8%8C%E8%AF%BA%E7%94%9F%E7%89%A9,No,,,No,,
kymera therapeutics inc,2025-06-25 00:00:00,Yes,Not specified,"CDK2, Cyclin-Dependent Kinase 2",oncology,kinases,Preclinical,Yes,focused on discovering and developing small molecule therapeutics,https://www.cnbc.com/quotes/KYMR,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,pioneering the field of targeted protein degradation (TPD),https://www.linkedin.com/company/kymeratherapeutics,No,,
tr1x inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,TRX319; TRX103,"CD19, Cluster of Differentiation 19; IL-10, Interleukin-10",neurology; immunology; inflammatory diseases,cytokine; other,Phase 1/2a,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,engineered Treg and CAR-Treg cell therapies,https://www.globenewswire.com/news-release/2025/04/04/3055913/0/en/Tr1X-Awarded-8-Million-CIRM-Grant-to-Support-TRX103-Phase-1-2a-Clinical-Trial-for-Graft-Versus-Host-Disease.html,No,,,No,,,No,,
forte biosciences inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.f,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aura biosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='www.annualreports.com', ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
arrivent biopharma inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"firmonertinib, a tyrosine kinase inhibitor",https://stockanalysis.com/stocks/avbp/,No,,,No,,,No,,,Yes,"MRG007, an Antibody Drug Conjugate",https://stockanalysis.com/stocks/avbp/,No,,,No,,,No,,,No,,,No,,,No,,
progenics pharmaceuticals inc,2018-09-01 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,RELISTOR® (methylnaltrexone bromide),https://investor.lantheus.com/news-releases/news-release-details/progenics-pharmaceuticals-announces-fda-approval-azedrar,No,,,No,,,No,,,Yes,PSMA-targeted imaging agents for prostate cancer,https://investor.lantheus.com/news-releases/news-release-details/progenics-pharmaceuticals-announces-fda-approval-azedrar,No,,,No,,,No,,,No,,,No,,,Yes,radiotherapeutic AZEDRA® (iobenguane I 131),https://investor.lantheus.com/news-releases/news-release-details/progenics-pharmaceuticals-announces-fda-approval-azedrar
moonlake immunotherapeutics,2025-10-17 11:07:36,No,sonelokimab,Not specified,immunology; autoimmune diseases,cytokine,Phase 3,No,,,No,,,No,,,Yes,Nanobody® technology,https://www.linkedin.com/company/moonlake-immunotherapeutics-ag/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
theratechnologies inc,2025-09-12 11:39:43,No,olezarsen; donidalorsen,"apoC-III, Apolipoprotein C-III; PKK, Prekallikrein",rare diseases; metabolic diseases,enzyme; other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mannkind corp,2025-10-15 15:30:08,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Clofazimine Inhalation Suspension: A Novel Formulation for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease,https://www.linkedin.com/company/mannkind-corporation,No,,,Yes,Afrezza (insulin human) Inhalation Powder,https://www.linkedin.com/company/mannkind-corporation,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ambrx biopharma inc,2023-06-24 00:00:00,Yes,ARX517; ARX788; ARX305,"PSMA, Prostate-Specific Membrane Antigen; HER2, Human Epidermal Growth Factor Receptor 2; CD-70, Cluster of Differentiation 70",oncology,immune checkpoint; immune checkpoint; immune checkpoint,Phase 1; Phase 1; Preclinical,No,,,No,,,Yes,engineered precision biologics,https://www.linkedin.com/company/ambrx,Yes,monoclonal antibodies,https://www.jnj.com/media-center/press-releases/johnson-johnson-to-acquire-ambrx-advancing-next-generation-antibody-drug-conjugates-to-transform-the-treatment-of-cancer,Yes,antibody-drug conjugates (ADCs),https://www.linkedin.com/company/ambrx,No,,,No,,,No,,,No,,,No,,,No,,
proqr therapeutics nv,2025-10-15 09:54:01,No,AX-0810; AX-2402; AX-2911; AX-1412,"NTCP, Sodium Taurocholate Cotransporting Polypeptide; MECP2, Methyl-CpG Binding Protein 2; PNPLA3, Patatin-Like Phospholipase Domain-Containing Protein 3; B4GALT1, Beta-1,4-Galactosyltransferase 1",liver diseases; CNS; rare diseases; cardiovascular diseases,enzyme; other; other; other,Phase 1; Preclinical; Preclinical; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"RNA therapeutics, RNA editing, Axiomer™ RNA-editing platform technology",https://www.linkedin.com/company/proqr-therapeutics,No,,,No,,,No,,,No,,
black diamond therapeutics inc,2025-08-19 12:01:42,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"BDTX-1535, a fourth-generation EGFR inhibitor targeting non-small cell lung cancer (NSCLC) and glioblastoma (GBM) and BDTX-4933, a RAF inhibitor targeting KRAS, NRAS and BRAF alterations",https://www.linkedin.com/company/black-diamond-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
georgiamune inc,2023-08-09 07:03:27,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,dual-functioning monoclonal antibody,https://www.prnewswire.com/news-releases/georgiamune-inc-achieves-us-fda-clearance-for-investigational-new-drug-ind-application-and-secures-75-million-in-series-a-financing-301896408.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
therini bio inc,2025-05-14 14:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,monoclonal antibody targeting the fibrin inflammatory epitope,https://www.globenewswire.com/news-release/2025/05/14/3081286/0/en/Therini-Bio-Raises-Additional-39M-Series-A-Financing-to-Advance-Clinical-Development-of-Neurodegenerative-Disease-Pipeline.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zentera therapeutics inc,2021-08-02 11:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,small molecule therapeutics targeting fundamental biological pathways of cancers,https://www.globenewswire.com/news-release/2021/08/02/2272699/0/en/Zentera-Therapeutics-Announces-Closing-of-75-Million-Series-B-Financing.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
antios therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,ATI-2173,"HBV, Hepatitis B Virus",infectious diseases,enzyme,Phase 2,Yes,small molecule R&D,https://ingm.org/en/2021/11/22/antios-therapeutics-announces-agreement-with-irbm-ingm-and-osr-to-acquire-fourth-generation-hbv-capsid-assembly-modulators-cams/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
elucida oncology inc,"Error: Connection failed - HTTPSConnectionPool(host='synapse.patsnap.com', po",Yes,ELU001,"FRα, Folate Receptor Alpha",oncology,other,Phase 1/2,No,,,No,,,No,,,No,,,Yes,Anti-Folate Receptor Alpha C’Dot Drug Conjugate,https://www.globenewswire.com/search/organization/Elucida%2520Oncology%CE%B4%2520Inc,No,,,No,,,No,,,No,,,No,,,No,,
accent therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,ATX-559; ATX-295,"DHX9, RNA and DNA/RNA Helicase; KIF18A, Mitotic Kinesin Motor Protein",oncology,enzyme; other,Phase 1/2,Yes,small molecule cancer therapeutics,https://www.massbio.org/news/recent-news/member-spotlight-accent-therapeutics-inc/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pellepharm inc,"Error: Connection failed - HTTPSConnectionPool(host='bridgebio.com', port=443",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
interius biotherapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.baincapital.com', po",Yes,INT2104,"CD7, Cluster of Differentiation 7",oncology,other,Phase 1,No,,,No,,,No,,,Yes,scFv targeting CD7 ('CD7 Binder'),https://www.linkedin.com/company/interius-biotherapeutics,No,,,No,,,No,,,Yes,in vivo CAR-T (and CAR-NK) therapy,https://www.linkedin.com/company/interius-biotherapeutics,No,,,No,,,No,,
cdr-life inc,2022-04-13 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"Antibody fragments, T cell engager (TCE) platform, M-gager®, antibody-derived TCE",https://ch.linkedin.com/company/cdr-life-inc-,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"T cell engagers, immune cell engagers",https://ch.linkedin.com/company/cdr-life-inc-
pheast therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,PHST001,"CD24, Cluster of Differentiation 24",oncology,immune checkpoint,Preclinical,No,,,No,,,No,,,Yes,humanized anti-CD24 monoclonal antibody,https://www.linkedin.com/company/pheast-therapeutics,Yes,modalities such as ADCs,https://www.linkedin.com/company/pheast-therapeutics,No,,,No,,,No,,,No,,,No,,,Yes,macrophage-directed therapies,https://www.linkedin.com/company/pheast-therapeutics
kbp biosciences co ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Ocedurenone,"MR, Mineralocorticoid Receptor",cardiovascular; kidney disease,nuclear receptors,Phase 3,Yes,Our discovery team is highly experienced in identifying new compounds with potential.,https://www.linkedin.com/company/kbp-biosciences,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zhejiang borui biopharmaceutical co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.globaldata.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ception therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,GT-02287,"GCase, Glucocerebrosidase",neurodegeneration; lysosomal storage disorders,enzyme,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
alvotech sa,2025-10-06 11:10:13,No,Gobivaz; AVT05,"TNF alpha, Tumor Necrosis Factor Alpha",immunology,cytokine,Approved,No,,,No,,,No,,,Yes,developing a pipeline of monoclonal antibodies,https://www.cnbc.com/quotes/ALVO,No,,,No,,,No,,,No,,,No,,,No,,,No,,
alvotech swiss ag,2025-10-06 11:10:13,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,"biosimilars developed and manufactured by Alvotech, referencing biologic treatments",https://www.linkedin.com/company/alvotechpr,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
palvella therapeutics llc,2024-12-13 19:55:00,No,QTORIN,"Disease Name, Microcystic Lymphatic Malformations; Disease Name, Angiokeratomas; Disease Name, Cutaneous Venous Malformations",rare diseases; dermatology,other,Phase 3,Yes,QTORIN™ rapamycin anhydrous gel,https://www.globenewswire.com/news-release/2024/12/13/2997010/0/en/Palvella-Therapeutics-Announces-Closing-of-Merger-with-Pieris-Pharmaceuticals-and-Concurrent-Private-Placement-of-78-9-Million.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
complexa inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,neurology; immunology & allergy; oncology; nephrology; central nervous system (CNS); rare disease,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pionyr immunotherapeutics inc,2020-06-23 00:00:00,Yes,PY314; PY159,"TREM2, Triggering Receptor Expressed on Myeloid Cells-2; TREM1, Triggering Receptor Expressed on Myeloid Cells-1",oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,Yes,antibody therapeutics,https://www.linkedin.com/company/pionyr-immunotherapeutics,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Myeloid Tuning™,https://www.linkedin.com/company/pionyr-immunotherapeutics
biofactura inc,"Error: Connection failed - HTTPSConnectionPool(host='sjpi.com', port=443): Ma",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,Monoclonal Antibody Drug Discovery,https://www.linkedin.com/company/biofactura-inc-,No,,,No,,,No,,,No,,,Yes,biodefense drugs against smallpox and Ebola,https://www.linkedin.com/company/biofactura-inc-,No,,,No,,
gmax biopharm llc,"Error: Connection failed - HTTPSConnectionPool(host='www.gmaxbiopharm.com', p",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
oncorus inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,ONCR-177,"IL-12, Interleukin-12; CCL4, Chemokine (C-C motif) ligand 4; FLT3LG, Fms-like tyrosine kinase 3 ligand; PD-1, Programmed Cell Death Protein 1; CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4",oncology,cytokine; cytokine; cytokine; immune checkpoint; immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,Yes,self-amplifying RNA medicines,https://www.linkedin.com/company/oncorus-inc.,No,,,No,,,No,,,Yes,self-amplifying RNA medicines,https://www.linkedin.com/company/oncorus-inc.
bold therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,BOLD-100,"GRP78, Glucose-Regulated Protein 78",oncology,enzyme,Phase 3,Yes,metal-based small molecule therapeutics,https://www.bold-therapeutics.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
magellan stem cells pty ltd,"Error: Connection failed - HTTPSConnectionPool(host='biotechdispatch.com.au',",No,MAG200,"Disease Name, Knee Osteoarthritis",musculoskeletal diseases,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,mesenchymal stem cells (MSCs) derived from adipose tissue,https://cells4life.com/us/2024/08/new-stem-cell-therapy-could-treat-osteoarthritis-study-finds/,No,,,No,,,Yes,"Stem Cell Therapies, Mesenchymal Stem Cells, Autologous Stem Cells, Allogeneic Stem Cells",https://au.linkedin.com/company/magellan-stem-cells
capella bioscience ltd,2025-10-17 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
contrafect corp,2023-01-13 00:00:00,Yes,Not specified,"JAK2, Janus Kinase 2",hematologic cancers,kinases,Preclinical,No,,,Yes,Amurin peptides are a novel class of DLAs which exhibit broad-spectrum activity against a wide range of antibiotic-resistant Gram-negative pathogens,https://www.linkedin.com/company/contrafect-corp,Yes,Lysins are a new class of DLAs which are recombinantly produced antimicrobial proteins,https://www.linkedin.com/company/contrafect-corp,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities",https://www.linkedin.com/company/contrafect-corp
immunewalk therapeutics inc,2025-05-07 13:55:06,Yes,IW-601,"MOSPD2, Motile Sperm Domain Containing Protein 2",immunology; inflammation,immune checkpoint,Phase 1,No,,,No,,,No,,,Yes,"IW-601, a first-in-class monoclonal antibody targeting myeloid cells",https://www.globenewswire.com/news-release/2025/05/07/3076269/0/en/ImmuneWalk-Therapeutics-Announces-7-Million-Seed-Financing-and-Upcoming-Presentations-of-Positive-Clinical-Results-at-Upcoming-Medical-and-Industry-Conferences.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
palobiofarma sl,"Error: Connection failed - HTTPSConnectionPool(host='medibiofarma.com', port=",Yes,PBF-999,"PDE10, Phosphodiesterase 10",metabolic diseases,enzyme,Phase 2,Yes,"laboratorio de química médica totalmente equipado, donde ambas compañías investigarán nuevos fármacos",https://www.linkedin.com/company/palobiofarma/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,estrategias innovadoras para potenciar la eficacia de la inmunoterapia,https://www.linkedin.com/company/palobiofarma/
eolo pharma,"Error: Connection failed - HTTPSConnectionPool(host='labplus.uy', port=443): ",Yes,SANA; MVD1,Creatine-dependent thermogenesis,obesity; metabolic diseases; cardiometabolic diseases,other,Phase 1,Yes,small molecules,https://www.linkedin.com/company/eolo-pharma,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
rnatics gmbh,"Error: Connection failed - HTTPSConnectionPool(host='www.munich-startup.de', ",Yes,Clofazimine; Haloperidol; Bacampicillin; Benzocaine; Ciclopirox; Ciclosporin; Co-dergocrine mesilate; Dicycloverine; Fludrocortisone; Fluticasone; Isoxicam; Lansoprazole; Levopropoxyphene; Lomustine; Metixene; Myricetin; Niclosamide; Nocodazole; Pentoxifylline; Sirolimus; Thiamazole; Tocainide; Tretinoin; Valproic acid; Zuclopenthixol,Not specified,infectious diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,Yes,nucleic acid therapies targeting disease-causing RNAs,https://informaconnect.com/bioeurope/sponsors/rnatics-gmbh/,No,,,No,,,No,,,No,,
ability pharmaceuticals sl,"Error: Connection failed - HTTPSConnectionPool(host='synapse.patsnap.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,ABTL0812 is the first cancer drug killing tumor cells through potent cytotoxic autophagy via inhibition of the Akt/mTOR axis,https://www.linkedin.com/company/abilitypharma/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cellcolabs clinical spv ltd,2025-10-17 14:23:15,Yes,A2B530; ADI-001; CB-010; DVX201; INB-400; P-BCMA-ALLO1; OmnImmune,"CD20, Cluster of Differentiation 20; CD19, Cluster of Differentiation 19; BCMA, B-cell Maturation Antigen; GMB, Glioblastoma; AML, Acute Myeloid Leukemia",oncology,immune checkpoint; other; Not specified,Phase 1; Phase 2; Phase 2/3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Mesenchymal Stem Cells (MSCs),https://se.linkedin.com/company/cellcolabs,No,,,No,,,No,,
ahammune biosciences pvt ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mustang bio inc,2025-03-06 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"CAR T therapies, CRISPR/Cas9-enhanced CAR T therapies, lentiviral gene therapy",https://www.linkedin.com/company/mustangbio,No,,,No,,,Yes,HSV-1 oncolytic virus,https://www.linkedin.com/company/mustangbio
find therapeutics inc,2024-09-16 07:00:00,Yes,CX-2051; CX-801,"EpCAM, Epithelial Cell Adhesion Molecule; IFN-α2b, Interferon alpha-2b",oncology,enzyme; cytokine,Phase 1,No,,,Yes,FTX-101 is a rationally designed therapeutic peptide,https://www.prnewswire.com/news-releases/find-therapeutics-announces-the-closing-of-a-convertible-note-financing-with-investissement-quebec-302247899.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
adalta ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.bio.org', port=443):",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,protein therapeutics addressing drug targets that are challenging for other technologies,https://www.cnbc.com/quotes/1AD,Yes,"anti-body-like molecule to inhibit malaria, babesia and toxoplasma invasion",https://au.linkedin.com/company/adalta-ltd,No,,,Yes,AD-214 is an Fc-Fusion protein,https://www.cnbc.com/quotes/1AD,No,,,Yes,cellular immunotherapies for solid cancers,https://au.linkedin.com/company/adalta-ltd,No,,,No,,,Yes,engineering human cells to produce living drugs,https://au.linkedin.com/company/adalta-ltd
jiangsu protelight pharmaceutical & biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,levonadifloxacin; alalevonadifloxacin; contezolid,Not specified,infectious diseases,enzyme,Approved,Yes,"For decades, small molecules have played a central role in cancer care.",https://www.linkedin.com/in/ervin-xu-zhu-7147a94a,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
jiangsu protelight pharmaceutical and biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kobiolabs inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,KBL982,"GLP-1, Glucagon-Like Peptide-1; Gut Microbiota",metabolic diseases; obesity,cytokine; other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Microbiome Therapeutics,https://www.linkedin.com/company/kobiolabs?trk=ppro_cprof
linnaeus therapeutics inc,2025-03-26 08:55:22,Yes,LNS8801,Not specified,oncology,Not specified,Phase 1,Yes,novel small molecule oncology therapeutics,https://www.prnewswire.com/news-releases/linnaeus-therapeutics-awarded-its-fourth-competitive-sbir-award-by-the-national-cancer-institute-bringing-total-sbir-funding-to-8-3-million-302412016.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
oncolix inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,CTX-009; CTX-471,"DLL4, Delta-like ligand 4; VEGF-A, Vascular Endothelial Growth Factor A; CD137, Cluster of Differentiation 137",oncology,other; other; cytokine,Phase 1; Phase 2,No,,,No,,,Yes,"Prolanta is a genetically modified form of human prolactin, a hormone associated with various types of cancers.",https://www.marketscreener.com/quote/stock/ONCOLIX-INC-120796719/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ology bioservices inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Sargramostim; Sotrovimab; SKYCovione; Tradipitant; XAV-19; MAD0004J08; RESP301; Niclosamide; Sinapultide; MAS-825; Maraviroc; Abivertinib; Ebselen; Duvelisib; TCB008,"SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; CCR5, C-C Chemokine Receptor Type 5; STAT3, Signal Transducer and Activator of Transcription 3; Interleukin 1 beta; Interleukin 18; Epidermal Growth Factor Receptor; Phosphatidylinositol 3 kinase delta; Phosphatidylinositol 3 kinase gamma",infectious diseases; respiratory diseases,cytokine; gpcr; enzyme; other,Phase 2; Phase 3; Registered,No,,,No,,,Yes,proprietary platform technologies that are used in the production of biologic products including proteins,https://www.linkedin.com/company/ology-bioservices,Yes,proprietary platform technologies that are used in the production of biologic products including monoclonal antibodies,https://www.linkedin.com/company/ology-bioservices,No,,,No,,,No,,,Yes,"Specialties include Gene Therapy, Viral Vectors",https://www.linkedin.com/company/ology-bioservices,Yes,proprietary platform technologies that are used in the production of biologic products including vaccines,https://www.linkedin.com/company/ology-bioservices,No,,,Yes,Specialties include Oncolytic Viruses,https://www.linkedin.com/company/ology-bioservices
primmune therapeutics inc,2021-12-04 00:00:00,Yes,PRTX007,"TLR7, Toll-Like Receptor 7",oncology; infectious diseases,cytokine,Phase 1,Yes,oral small molecule structure-based drug design,https://www.primmunerx.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
stealth biotherapeutics corp,2025-10-09 17:44:29,Yes,Elamipretide; Bevemipretide; SBT-255; SBT-589,"Cardiolipin, Inner Mitochondrial Membrane Phospholipid",rare diseases; ophthalmology; neurology; cardiology,other,Approved; Phase 3; Preclinical,Yes,novel compounds under evaluation for rare neurological and cardiac disease indications following promising preclinical data,https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-acceptance-of-elamipretide-nda-resubmission-302535179.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
stealth biotherapeutics inc,2025-10-09 17:44:29,Yes,Elamipretide; Bevemipretide,"Cardiolipin, Inner Mitochondrial Membrane Phospholipid",rare diseases; ophthalmology; neurology; cardiology,other,Approved; Phase 3,Yes,novel pipeline candidates,https://www.linkedin.com/company/stealth-biotherapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,mitochondria-targeted therapeutic,https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-accelerated-approval-of-forzinity-elamipretide-hcl-the-first-therapy-for-progressive-and-life-limiting-ultra-rare-genetic-disease-barth-syndrome-302562058.html
stealth biotherapeutics inc.,2025-10-09 17:44:29,Yes,Elamipretide; Bevemipretide,"Cardiolipin, Inner Mitochondrial Membrane Phospholipid",rare diseases; ophthalmology; neurology; cardiology,other,Approved; Phase 1,Yes,novel pipeline candidates,https://www.linkedin.com/company/stealth-biotherapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,mitochondria-targeted therapeutic,https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-accelerated-approval-of-forzinity-elamipretide-hcl-the-first-therapy-for-progressive-and-life-limiting-ultra-rare-genetic-disease-barth-syndrome-302562058.html
thor medical asa,2025-09-10 17:19:31,Yes,Thorium-228; Pb-212,Not specified,oncology,other,Preclinical,No,,,No,,,No,,,Yes,Antibodies,https://no.linkedin.com/company/thor-medical-asa,Yes,Radioimmunotherapy,https://no.linkedin.com/company/thor-medical-asa,No,,,No,,,No,,,No,,,No,,,Yes,Alpha-emitting radioligand therapies,https://no.linkedin.com/company/thor-medical-asa
kynos therapeutics ltd,2024-10-29 08:39:44,Yes,KNS366,"KMO, Kynurenine 3-Monooxygenase",immunology; inflammation; oncology,enzyme,Phase 1,Yes,"small molecules as medicines for the treatment of conditions including Alzheimer’s disease, multiple organ failure and fibrotic disease",https://kynos.rbln7.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
enthera srl,2025-05-28 11:15:18,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,We develop first-in-class biologics for several underserved autoimmune conditions.,https://www.linkedin.com/company/enthera-pharmaceuticals/,Yes,"Ebrasodebart, a monoclonal antibody targeting TMEM219.",https://www.linkedin.com/company/enthera-pharmaceuticals/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
beijing nuobot biotechnology co ltd,2022-04-26 00:00:00,No,UBT251,"GLP-1, Glucagon-Like Peptide-1; GIP, Glucose-Dependent Insulinotropic Polypeptide; Glucagon",metabolic diseases; obesity,gpcr,Phase 1,No,,,Yes,recombinant proteins and peptides,https://www.marketscreener.com/quote/stock/IMEIK-TECHNOLOGY-DEVELOPM-119082514/news/Beijing-Nuobote-Biotech-Co-Ltd-announced-that-it-expects-to-receive-CNY-56-million-in-funding-fro-40217213/,Yes,recombinant proteins,https://www.marketscreener.com/quote/stock/IMEIK-TECHNOLOGY-DEVELOPM-119082514/news/Beijing-Nuobote-Biotech-Co-Ltd-announced-that-it-expects-to-receive-CNY-56-million-in-funding-fro-40217213/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tikomed ab,2020-08-28 00:00:00,No,ILB,"HGF, Hepatocyte Growth Factor",CNS; neurodegenerative diseases,cytokine,Phase 2,Yes,ILB® is a patented Dextran Sulphate,https://tikomed.newswire.com/browse/about,No,,,No,,,No,,,No,,,No,,,No,,,Yes,an infusion product for improving outcomes in cell therapies (IBSOLVMIR® program),https://tikomed.newswire.com/browse/about,No,,,No,,,No,,
foundation of biomedical research of university hospital of asturias,2023-05-05 13:14:23,No,Capivasertib; Tusamitamab Ravtansine; Zenocutuzumab; Zolbetuximab; Revumenib; Denileukin Diftitox,"AKT, Protein Kinase B; CEACAM5, Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; NRG1, Neuregulin 1; Claudin 18.2; KMT2A, Lysine Methyltransferase 2A; IL-2R, Interleukin-2 Receptor",oncology,kinases; other; other; other; other; cytokine,Approved; Phase 2; Phase 1/2; Phase 3; Phase 1/2; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
novartis gene therapies,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,GT005; Zolgensma; RGX-202,"Disease Name, Geographic Atrophy secondary to AMD; SMN1, Survival Motor Neuron 1; Disease Name, Duchenne Muscular Dystrophy",ophthalmology; rare diseases; neuromuscular diseases,other; other; other,Phase 2; Marketed; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"CAR-T cell therapy, AAV-based therapies, CRISPR-based technologies",https://www.novartis.com/research-and-development/technology-platforms/cell-therapy,No,,,No,,,No,,
abionyx pharma sa,2025-02-28 12:52:58,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,apoA-I is a circulating protein very important in the human body due to its effects on reducing severe inflammation and protecting tissues and organs,https://www.linkedin.com/company/abionyx/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy",https://www.home.saxo/markets/stocks/abnx-xpar
thallion pharmaceuticals inc. (inactive),"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,dual antibody product for the treatment of Shiga toxin-producing E. coli bacterial infections,https://www.marketscreener.com/quote/stock/THALLION-PHARMACEUTICALS--1411950/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nrx pharmaceuticals inc,2025-10-17 13:55:27,No,NRX-101,Not specified,CNS,Not specified,Phase 2/Phase 3,Yes,preservative-free IV ketamine,https://www.linkedin.com/company/nrx-pharma,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
destiny pharma plc,2023-04-16 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"SPOR-COVTM, a novel, biotherapeutic product for the prevention of COVID-19 and other viral respiratory infections",https://uk.linkedin.com/company/destiny-pharma-ltd,No,,,Yes,novel microbiome-based biotherapeutics,https://uk.linkedin.com/company/destiny-pharma-ltd
prolacta bioscience inc,2025-10-16 13:00:28,No,Surgifort,Gastroschisis,rare diseases,Not specified,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
eupraxia pharmaceuticals inc,2025-10-09 21:07:59,No,EP-104GI,"Disease Name, Eosinophilic Esophagitis",gastrointestinal diseases,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Diffusphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery",https://ca.linkedin.com/company/eupraxia-pharmaceuticals-inc-
arrevus inc (inactive),2021-11-03 14:53:41,Yes,APX3330; APX2009; APX2014; emixustat hydrochloride; UGN-102; suvecaltamide; ELREXFIO™; fordadistrogene movaparvovec; HYQVIA®; Columvi®; lumateperone; AJOVY®; botensilimab; balstilimab; XEN-101; plozasiran; zodasiran; PTC518; azenosertib; ganaxolone; CEL383; MAR001; IAM1363; SF001; ALZ-801; BPT567; farxiga; AMT-130; SKYRIZI®; pitolisant; Vyvgart Hytrulo; Elevidys,"Ref-1, Reduction Oxidation Effector Factor-1; VEGFs; pro-inflammatory cytokines; RPE65, Retinal Pigment Epithelium-specific 65 kDa protein; T-type calcium channels; ANGPTL4, Angiopoietin-like protein 4; HER2, Human Epidermal Growth Factor Receptor 2; CDK2; CDK4; CD20xCD3; PD-L1, Programmed Death-Ligand 1; IL-18, Interleukin-18; FcRn, Neonatal Fc Receptor; IgG autoantibodies",diabetic retinopathy; retinal conditions; age-related macular degeneration; bladder cancer; essential tremor; multiple myeloma; Duchenne muscular dystrophy; chronic inflammatory demyelinating polyneuropathy; diffuse large B-cell lymphoma; major depressive disorder; migraine; colorectal cancer; obesity; cardiovascular disorders; Huntington’s disease; solid tumors; gynecological cancers; refractory status epilepticus; inflammatory diseases; cardiometabolic diseases; oncology; invasive fungal infections; Alzheimer’s disease; type 2 diabetes; ulcerative colitis; Crohn’s disease; narcolepsy; generalized myasthenia gravis,enzyme; cytokine; other; ion channels; other; other; immune checkpoint; other; cytokine; immune checkpoint; cytokine; other; immune checkpoint; immune checkpoint; other; other; other; other; other; other; cytokine; other; other; other; other; other; other,Phase 2; Phase 1; Phase 3; Phase 2; Phase 3; Phase 2; Phase 2; Phase 3; Phase 3; Phase 3; Phase 3; Phase 1; Phase 3; Phase 3; Phase 1; Phase 3; Phase 3; Phase 2; Phase 1; Phase 3; Phase 2; Phase 1; Phase 1; Phase 3; Phase 3; Phase 3; Phase 3; Phase 3; Approved,Yes,"ARV-1801 (now ACG-721), an oral, small molecule treatment",https://globalgenes.org/raredaily/aceragen-acquires-arrevus-expands-late-stage-rare-disease-pipeline/,No,,,Yes,ACG-801 is an investigational form of recombinant human acid ceramidase (rhAC),https://globalgenes.org/raredaily/aceragen-acquires-arrevus-expands-late-stage-rare-disease-pipeline/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
gyroscope therapeutics holdings ltd,2021-12-22 00:00:00,Yes,GT005,"CFI, Complement Factor I",ophthalmology,enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy seeks to treat dry AMD by safely and effectively delivering a functioning gene to the eye using Adeno-Associated Virus (AAV) technology,https://www.synconaltd.com/portfolio/previous-portfolio-companies/gyroscope-therapeutics/,No,,,No,,,No,,
gyroscope therapeutics holdings plc,2021-12-22 00:00:00,Yes,GT005,"CFI, Complement Factor I",ophthalmology,enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"AAV2-based, one-time investigational gene therapy",https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness,No,,,No,,,No,,
biotheus inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
immunitybio inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,AZD0486; EO2463; Abexinostat; ZE50-0134; NVG-111,"CD19, Cluster of Differentiation 19; CD3, Cluster of Differentiation 3; CD20, Cluster of Differentiation 20; CD22, Cluster of Differentiation 22; CD37, Cluster of Differentiation 37; CD268, BAFF receptor",oncology,immune checkpoint; cytokine,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,Yes,Fusion Proteins,https://www.linkedin.com/company/immunitybio,No,,,Yes,"Natural Killer, T Cell, Cell Therapy",https://www.linkedin.com/company/immunitybio,Yes,"Vaccines, Vaccine",https://www.linkedin.com/company/immunitybio,No,,,No,,
vaccinogen inc (inactive),2018-06-28 15:03:18,No,OncoVax,Disease Name,oncology,Not specified,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,personalized cancer vaccine,https://www.prnewswire.com/news-releases/vaccinogen-closes-second-tranche-of-80-million-financing-at-550-per-unit-300026886.html,No,,,No,,
nanjing bioheng biotech co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.bioheng.com', port=4",No,CTD402; RD06-03; RD13-02,"CD7, Cluster of Differentiation 7; CD19, Cluster of Differentiation 19",oncology; autoimmune diseases,immune checkpoint,Phase 1; Phase Ib/II,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,universal CAR-T therapies,https://www.linkedin.com/company/bioheng-therapeutics-co-ltd,No,,,No,,,No,,
a2 biotherapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,A2B694; A2B395; A2B543; A2B356; A2B530,"MSLN, Mesothelin; EGFR, Epidermal Growth Factor Receptor; IL-12, Interleukin-12; Undisclosed",oncology,immune checkpoint; other; cytokine; Not specified,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,precision CAR T-cell therapies,https://www.a2bio.com/,No,,,No,,,No,,
"viacyte, inc.","Error: Connection failed - HTTPSConnectionPool(host='www.baincapital.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Cell Therapy,https://www.linkedin.com/company/viacyte-formerly-novocell-,No,,,No,,,No,,
hanchorbio inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,HCB101; HCB301; HCB303,"CD47, Cluster of Differentiation 47",oncology,immune checkpoint,Phase 2,No,,,No,,,Yes,Fc-based designer biologics (FBDB™) platform enables unique biologics,https://www.linkedin.com/company/hanchorbio-inc,No,,,No,,,Yes,"SIRPα Fc-fusion protein, HCB101",https://www.prnewswire.com/news-releases/hanchorbio-and-henlius-sign-major-licensing-deal-for-hcb101-to-expand-global-immuno-oncology-reach-302495363.html,No,,,No,,,No,,,No,,,Yes,Tri-specific fusion proteins disrupt PD-L1/CD47 pathways,https://www.linkedin.com/company/hanchorbio-inc
vtv therapeutics inc,2025-10-17 18:55:05,Yes,Cadisegliatin,Glucokinase,metabolic diseases,enzyme,Phase 3,Yes,"small-molecule, liver-selective glucokinase activator (GKA)",https://www.cnbc.com/quotes/VTVT,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,oral RAGE (Receptor for Advanced Glycation End-products) antagonist,https://www.linkedin.com/company/vtv_therapeutics
lexeo therapeutics llc,2025-10-17 03:33:47,No,LX2006; LX2020,"Frataxin; PKP2, Plakophilin-2",rare diseases; cardiovascular,other,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy candidates for Friedreich ataxia (FA) cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy (PKP2-ACM),https://www.linkedin.com/company/lexeo-therapeutics,No,,,No,,,No,,
lexeo therapeutics inc,2025-10-17 03:33:47,No,LX2006; LX2020,"Friedreich Ataxia; PKP2, Plakophilin-2",cardiovascular; rare diseases,other,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,genetic medicine company dedicated to reshaping heart health by applying pioneering science,https://www.linkedin.com/company/lexeo-therapeutics,No,,,No,,,No,,
aclaris therapeutics inc,2025-10-16 13:00:02,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,KINect drug discovery platform,https://www.linkedin.com/company/aclaris-therapeutics-inc-,No,,,No,,,Yes,progress in developing monoclonal and bispecific antibodies,https://www.linkedin.com/company/aclaris-therapeutics-inc-,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kiniksa pharmaceuticals international plc,2025-09-29 20:40:20,No,KPL-387,"IL-1R1, Interleukin-1 Receptor 1",cardiovascular,cytokine,Phase 2/3,No,,,No,,,No,,,Yes,monoclonal antibody that binds human interleukin-1 receptor 1,https://www.nasdaq.com/articles/kiniksa-pharmaceuticals-says-fda-grants-orphan-drug-designation-kpl-387-treat-pericarditis,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kiniksa pharmaceuticals ltd,2025-09-29 20:40:20,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,monoclonal antibody that binds human interleukin-1 receptor 1,https://www.nasdaq.com/articles/kiniksa-pharmaceuticals-says-fda-grants-orphan-drug-designation-kpl-387-treat-pericarditis,No,,,No,,,No,,,No,,,No,,,No,,,No,,
crossbow therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,CBX-250; CBX-663,"Cathepsin G, Cathepsin G Peptide-HLA Complex; TERT, Telomerase Reverse Transcriptase Peptide-HLA Complex",oncology; hematologic malignancies,enzyme; other,Phase 1; Preclinical,No,,,Yes,targeting peptide-MHC complexes on cancer cells,https://www.massbio.org/members/crossbow-therapeutics-inc/,No,,,Yes,"develop highly potent, highly accurate antibodies, targeting tumor-specific peptides presented by Major Histocompatibility Complex (MHC)",https://www.crossbowtx.com/,No,,,No,,,No,,,No,,,No,,,No,,,Yes,T-Bolt™ molecules strike tumor cells like a crossbow shoots bolts at its target,https://www.crossbowtx.com/
marengo therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://pitch,Yes,TriSTAR0701; Invikafusp alfa; STAR0602,"Nectin-4, Nectin-like molecule 4; TCRβ, T Cell Receptor Beta Chain; Vβ T Cell Subsets",oncology; inflammation; immunology,immune checkpoint; other,Preclinical; Phase 2,Yes,small molecules,https://www.prnewswire.com/news-releases/marengo-therapeutics-bolsters-advisory-strength-with-appointment-of-dr-mikael-dolsten-to-its-board-of-directors-and-dr-josep-tabernero-to-its-scientific-advisory-board-302518213.html,No,,,No,,,Yes,novel TCR-targeting antibodies,https://www.prnewswire.com/news-releases/marengo-therapeutics-bolsters-advisory-strength-with-appointment-of-dr-mikael-dolsten-to-its-board-of-directors-and-dr-josep-tabernero-to-its-scientific-advisory-board-302518213.html,No,,,Yes,multi-specific antibody-fusion platform,https://www.prnewswire.com/news-releases/marengo-therapeutics-bolsters-advisory-strength-with-appointment-of-dr-mikael-dolsten-to-its-board-of-directors-and-dr-josep-tabernero-to-its-scientific-advisory-board-302518213.html,No,,,No,,,Yes,vaccines—including leading Pfizer's scientific response to the COVID-19 pandemic,https://www.prnewswire.com/news-releases/marengo-therapeutics-bolsters-advisory-strength-with-appointment-of-dr-mikael-dolsten-to-its-board-of-directors-and-dr-josep-tabernero-to-its-scientific-advisory-board-302518213.html,No,,,Yes,immune cell engagers (BiTEs),https://www.prnewswire.com/news-releases/marengo-therapeutics-bolsters-advisory-strength-with-appointment-of-dr-mikael-dolsten-to-its-board-of-directors-and-dr-josep-tabernero-to-its-scientific-advisory-board-302518213.html
ionctura sa,2024-06-20 00:00:00,Yes,roginolisib;cambritaxestat,"PI3Kδ, Phosphoinositide 3-kinase delta;Autotaxin",oncology,kinases;enzyme,Phase 2;Phase 1,Yes,precision oral small molecules,https://www.cancerresearchhorizons.com/news-and-events/our-news/ionctura-announces-eu80m-series-b-financing-progress-pipeline-through,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
karuna therapeutics inc,Error: Connection failed - HTTPSConnectionPool(host='karuna-pharmaceuticals.s,No,KarXT,M1 and M4 muscarinic receptors,CNS,gpcr,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
northsea therapeutics bv,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,structurally engineered fatty acids (SEFAs),https://www.linkedin.com/company/northseatherapeutics/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cyteir therapeutics inc,2021-03-11 00:00:00,No,CYT-0851,Not specified,oncology,other,Phase 1/2,Yes,"CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters",https://www.linkedin.com/company/cyteir-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
turnstone biologics inc,2024-11-12 21:15:30,Yes,TIDAL-01,Disease Name,oncology,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Selected tumor-infiltrating lymphocyte (Selected TIL) therapy,https://www.linkedin.com/company/turnstone-biologics,No,,,No,,,Yes,Oncolytic Virus,https://www.linkedin.com/company/turnstone-biologics
calluna pharma inc,Error: can't compare offset-naive and offset-aware dateti,Yes,CAL101; CAL102,"S100A4, Damage-Associated Molecular Pattern Protein; Oxidized Phospholipids",immunology; fibrotic diseases; respiratory diseases,other; other,Phase 3; Preclinical,No,,,No,,,No,,,Yes,pipeline of selective antibodies,https://respiratory-therapy.com/disorders-diseases/chronic-pulmonary-disorders/asthma/calluna-pharma-launches-e75m-inflammatory-fibrotic-disease-therapies/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tisento therapeutics inc,2025-09-25 12:05:01,No,Zagociguat,"sGC, Soluble Guanylate Cyclase",rare diseases; CNS,enzyme,Phase 2,Yes,oral zagociguat 15 mg or 30 mg,https://www.globenewswire.com/news-release/2025/08/20/3136285/0/en/First-PRIZM-Study-Participant-Enrolled-in-Tisento-Therapeutics-Open-Label-Extension-Study-in-MELAS.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
edge therapeutics inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,VERSAMUNE; PDS01ADC,"PD-L1, Programmed Death-Ligand 1",oncology,immune checkpoint,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
atacama therapeutics inc,2022-04-21 00:00:00,Yes,AT-5214; dexmecamylamine,Acetylcholine Nicotinic Receptor,dermatology,ion channels,Phase 2,Yes,"AT-5214 (dexmecamylamine) is the S-enantiomer of mecamylamine, a selective inhibitor of the acetylcholine nicotinic receptor.",https://www.cbinsights.com/company/atacama-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
lava therapeutics nv,2025-05-14 12:29:39,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,bispecific gamma delta T cell engagers,https://www.globenewswire.com/news-release/2025/10/17/3168778/7281/en/XOMA-Royalty-and-LAVA-Therapeutics-Announce-Amendment-to-Purchase-Agreement.html,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gamma delta T cell engagers,https://www.globenewswire.com/news-release/2025/10/17/3168778/7281/en/XOMA-Royalty-and-LAVA-Therapeutics-Announce-Amendment-to-Purchase-Agreement.html
maxvax biotechnology llc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,Not specified,"HPV, Human Papillomavirus",infectious diseases; women's health,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,therapeutic HPV vaccine candidate,https://www.gatesfoundation.org/about/committed-grants/2023/09/inv-061191,No,,,No,,
concert pharmaceuticals inc,Error: can't compare offset-naive and offset-aware dateti,No,DPTX3186; CTP-543,"Beta-catenin; JAK, Janus Kinase",oncology; autoimmune diseases; dermatology,other; kinases,Preclinical; Phase 2,Yes,novel small molecule drugs,https://www.flagshippioneering.com/companies/concert-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cour pharmaceuticals development co inc,2024-12-03 11:30:00,Yes,CNP-103; CNP-108; CNP-104,"PD-L1, Programmed Death-Ligand 1; CD206, Mannose Receptor; Disease Name",immunology; autoimmune diseases; rare diseases,immune checkpoint; other; Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,tolerogenic nanoparticle treatments,https://www.globenewswire.com/news-release/2024/12/03/2990410/0/en/COUR-Pharmaceuticals-Enters-Collaboration-and-Licensing-Agreement-with-Genentech-to-Develop-and-Commercialize-Tolerogenic-Therapy-for-the-Treatment-of-an-Autoimmune-Disease.html
imara inc,2025-02-22 21:19:12,No,IMR-687; tovinontrine,Not specified,rare diseases; oncology,Not specified,Phase 2; Not specified,Yes,"IMR-687, lead product candidate, is a therapeutic candidate for the treatment of sickle cell disease and other hemolytic anemias",https://dcfmodeling.com/blogs/history/imra-history-mission-ownership?srsltid=AfmBOoquTQZfbaoq84GIz3mkejQHjQ4Bt_LDYTtoifXGsmn8D94yXk9D,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
eledon pharmaceuticals inc,2025-10-17 15:35:05,No,tegoprubart,"CD40L, CD40 Ligand",transplantation; autoimmune diseases; neurodegenerative diseases,immune checkpoint,Phase 2,No,,,No,,,No,,,Yes,anti-CD40L antibody,https://eledon.com/,No,,,No,,,No,,,No,,,No,,,No,,,Yes,xenotransplantation,https://eledon.com/
x4 pharmaceuticals inc,2025-07-17 17:10:23,No,mavorixafor; X4P-003; X4P-002,"CXCR4, C-X-C Chemokine Receptor Type 4",rare diseases; immunology; oncology,gpcr,Approved; Phase 3; Preclinical,Yes,small-molecule selective antagonist of chemokine receptor CXCR4,https://www.cnbc.com/quotes/XFOR,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cormedix inc,2025-10-14 19:59:27,No,DefenCath; REZZAYO,Disease Name,infectious diseases,other,Phase 3; Approved,Yes,"DefenCath™, a novel, antibacterial and antifungal solution",https://www.linkedin.com/company/cormedix-inc-,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mediar therapeutics inc,2025-10-14 14:00:01,Yes,MTX-463; MTX-474; SMOC2,"WISP1, WNT1-inducible signaling pathway protein-1; EphrinB2, Ephrin ligand B2; SMOC2, Secreted Modular Calcium-binding Protein 2",fibrosis; idiopathic pulmonary fibrosis; systemic sclerosis; renal fibrosis,cytokine; other; other,Phase 2; Phase 1; Preclinical,No,,,No,,,No,,,Yes,MTX-463 is a first-in-class human IgG1 antibody designed to neutralize WISP1-mediated fibrotic signaling,https://www.prnewswire.com/news-releases/mediar-therapeutics-enters-into-global-licensing-agreement-with-lilly-to-advance-first-in-class-wisp1-antibody-for-the-treatment-of-idiopathic-pulmonary-fibrosis-ipf-302347905.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ansun biopharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,multi-function sialidase fusion protein,https://www.linkedin.com/company/ansun-biopharma,No,,,No,,,Yes,multi-function sialidase fusion protein,https://www.linkedin.com/company/ansun-biopharma,No,,,No,,,No,,,No,,,No,,
citryll bv,2024-12-09 07:00:00,Yes,CIT-013,"NETs and EETs, Neutrophil Extracellular Traps and Eosinophil Extracellular Traps",immunology; dermatology,other,Phase 2,No,,,No,,,No,,,Yes,monoclonal antibody CIT-013,https://www.globenewswire.com/news-release/2024/12/09/2993455/0/en/Citryll-Raises-EUR-85-Million-Series-B-to-Advance-Novel-NET-Targeting-Therapy-for-Immune-Mediated-Inflammatory-Disorders.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
lassen therapeutics 1 inc,2024-01-19 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mbrace therapeutics inc,2025-09-30 15:52:38,Yes,MBRC-101,"EphA5, Ephrin Type-A Receptor 5",oncology,kinases,Phase 1,No,,,No,,,No,,,Yes,humanized anti-EphA5 antibody,https://abzena.com/articles/news/adc-using-thiobridge-technology/,Yes,antibody-drug conjugates (ADCs),https://www.linkedin.com/company/mbrace-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,
instil bio inc,2021-01-29 00:00:00,No,AXN-2510,"PD-L1xVEGF, Programmed Death-Ligand 1 and Vascular Endothelial Growth Factor",oncology,immune checkpoint; cytokine,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,PD1 x VEGF,https://www.linkedin.com/company/instil-bio,No,,,No,,,No,,
oncternal therapeutics,2021-01-09 00:00:00,Yes,ONCT-534; CAR T,"Androgen Receptor; ROR1, Receptor Tyrosine Kinase-Like Orphan Receptor 1",oncology; hematological malignancies; prostate cancer,nuclear receptors; kinases,Phase 1/2,Yes,"TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins",https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,Yes,"cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor",https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,No,,,Yes,CAR-T therapy that targets ROR1 currently in preclinical development,https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,No,,
oncternal therapeutics inc,2021-01-09 00:00:00,Yes,ONCT-808; ONCT-534; zilovertamab; ONCT-216,"ROR1, Receptor Tyrosine Kinase-Like Orphan Receptor 1; Disease Name",oncology; hematological malignancies; prostate cancer,kinases; other,Phase 1; Phase 2,Yes,"TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins",https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,Yes,"cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor",https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,No,,,Yes,CAR-T therapy that targets ROR1 currently in preclinical development,https://www.linkedin.com/company/oncternal-therapeutics,No,,,No,,,No,,
magenta therapeutics inc,2021-06-12 00:00:00,Yes,DNTH212; Claseprubart,"BDCA2, Blood Dendritic Cell Antigen 2; BAFF/APRIL, B-cell Activating Factor/A Proliferation-Inducing Ligand; C1s, Complement Component 1s",immunology; autoimmune diseases,cytokine; enzyme,Phase 1; Phase 2,No,,,No,,,Yes,bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2,https://dianthustx.com/,Yes,monoclonal antibody engineered to selectively target the classical pathway,https://dianthustx.com/,No,,,Yes,bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2,https://dianthustx.com/,No,,,No,,,No,,,No,,,No,,
eiger biopharmaceuticals inc,"Error: Connection failed - HTTPSConnectionPool(host='www.abladvisor.com', por",No,Lonafarnib; Peginterferon Lambda; Avexitide; Zokinvy,"HDV, Hepatitis Delta Virus; HI, Congenital Hyperinsulinism; Progeria, Progeria and Processing-Deficient Progeroid Laminopathies",infectious diseases; rare diseases; metabolic diseases,other,Phase 3; Phase 3; Phase 3 ready; Marketed,Yes,"Lonafarnib, an orally available, farnesylation inhibitor",https://stockanalysis.com/quote/otc/EIGRQ/,No,,,Yes,"Peginterferon Lambda (lambda), which is in clinical development for HDV",https://stockanalysis.com/quote/otc/EIGRQ/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
eiger biopharmaceuticals inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='www.sfnet.com', port=443",No,Lonafarnib; Peginterferon Lambda,Not specified,infectious diseases; rare diseases,Not specified,Phase 3; Discontinued,Yes,Zokinvy ® (lonafarnib),https://www.globenewswire.com/news-release/2024/04/01/2855277/0/en/eiger-biopharmaceuticals-files-for-voluntary-chapter-11-protection.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
arthex biotech sl,2025-10-17 18:26:43,Yes,Arthex-01,Not specified,rare diseases; neuromuscular diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Developing microRNA modulators for diseases with unmet medical needs,https://es.linkedin.com/company/arthex-pharma,No,,,No,,,No,,,No,,
vyne therapeutics inc,No timestamp found,Yes,VYN201; VYN202; repibresib,"BD2, Bromodomain-containing protein 2",dermatology; immunology,other,Phase 2,Yes,small molecule pan-bromodomain and extra-terminal (BET) inhibitor,https://www.nasdaq.com/market-activity/stocks/vyne,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
prevail therapeutics inc,2020-12-15 06:15:00,Yes,PR001; PR006,"GBA1, Glucosylceramidase Beta 1; GRN, Granulin",rare diseases; neurodegenerative diseases,enzyme; other,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders,https://www.linkedin.com/company/prevail-therapeutics,No,,,No,,,No,,
zymogenetics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://news.,No,Zanubrutinib; Tislelizumab; Sonrotoclax; Tarlatamab; Zanidatamab; BGB-16673; Blinatumomab; Pamiparib; BG-68501; BGB-21447; BGB-43395; BGB-A3055; BGB-B455; BG-C9074; BGB-B2033; BG-C137; BGB-53038; BG-C477; BG-89894; BGB-58067; BGB-B3227; BG-60366; BGB-26808; BGB-C354,"BTK, Bruton Tyrosine Kinase; PD-1, Programmed Cell Death Protein 1; BCL2, B-cell Lymphoma 2; DLL3, Delta-like Ligand 3; HER2, Human Epidermal Growth Factor Receptor 2; CD19, Cluster of Differentiation 19; PARP1/2, Poly (ADP-ribose) Polymerase; CDK2, Cyclin-Dependent Kinase 2; CDK4, Cyclin-Dependent Kinase 4; CCR8, C-C Chemokine Receptor 8; CLDN6, Claudin 6; B7-H4, B7 Homolog 4; GPC3, Glypican-3; FGFR2b, Fibroblast Growth Factor Receptor 2b; KRAS, Kirsten Rat Sarcoma; CEA, Carcinoembryonic Antigen; MAT2A, Methionine Adenosyltransferase 2A; PRMT5, Protein Arginine Methyltransferase 5; MUC1, Mucin 1; EGFR, Epidermal Growth Factor Receptor; HPK1, Hematopoietic Progenitor Kinase 1; B7-H3, B7 Homolog 3",oncology; hematology; immunology; inflammation; lung cancers; gastrointestinal cancers; breast/gynecologic cancers; solid tumors,kinases; immune checkpoint; enzyme; other,Approved; Phase 3; Phase 2; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
minerva neurosciences inc,2020-01-18 00:00:00,No,Not specified,Not specified,CNS,Not specified,Not specified,Yes,proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases,https://www.cnbc.com/quotes/NERV,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
"novacea, inc. (inactive)","Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",No,Not specified,"STING, Stimulator of Interferon Genes",oncology; immunology,immune checkpoint,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
quralis corporation,2023-03-09 05:00:00,Yes,QRL-101,"Kv7.2/7.3, Voltage-Gated Potassium Channel",CNS; neurodegenerative diseases,ion channels,Phase 1,Yes,small molecule programs,https://www.massbio.org/members/quralis-corporation/,No,,,No,,,No,,,No,,,No,,,Yes,antisense oligonucleotides (ASOs),https://www.umassmed.edu/news/news-archives/2025/05/umass-chan-licenses-rna-based-treatment-for-fragile-x-syndrome-to-quralis-corporation/,No,,,No,,,No,,,No,,
agomab therapeutics nv,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,AGMB-129; AGMB-447,"ALK5, Activin Receptor-Like Kinase 5",gastrointestinal diseases; pulmonary diseases,kinases,Phase 2,Yes,oral gastrointestinal (GI)-restricted small molecule inhibitor of ALK5 (TGFβ RI or ALK5),https://agomab.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
genmab as,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Petosemtamab,"EGFRxLGR5, Epidermal Growth Factor Receptor x Leucine-rich Repeat-containing G-protein Coupled Receptor 5",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,Yes,innovative and differentiated antibody therapeutics,https://www.linkedin.com/company/genmab,Yes,antibody-drug conjugates,https://www.linkedin.com/company/genmab,No,,,No,,,No,,,No,,,No,,,Yes,"bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies",https://www.linkedin.com/company/genmab
merus nv,"Error: Connection failed - HTTPSConnectionPool(host='ir.genmab.com', port=443",Yes,Petosemtamab; Bizengri; MCLA-129; ONO-4685; INCA33890; MCLA-145; MCLA-158; MCLA-117,"EGFR, Epidermal Growth Factor Receptor; LGR5, Leucine-rich Repeat Containing G-protein-coupled Receptor 5; HER2, Human Epidermal Growth Factor Receptor 2; HER3, Human Epidermal Growth Factor Receptor 3; c-MET, Hepatocyte Growth Factor Receptor; PD-1, Programmed Cell Death Protein 1; CD3, Cluster of Differentiation 3; TGFBr2, Transforming Growth Factor Beta Receptor 2",oncology,gpcr; other; other; other; other; immune checkpoint; other; other,Phase 3; Approved; Phase 1/2; Not specified; Not specified; Phase 1; Phase 3; Terminated,No,,,No,,,No,,,Yes,bispecific antibody therapeutics,https://www.linkedin.com/company/merus,No,,,No,,,No,,,No,,,No,,,No,,,No,,
haemostatix ltd,"Error: Connection failed - HTTPSConnectionPool(host='ergomedgroup.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
artax biopharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.prnewswire.com', por",Yes,AX-158; AX-194,"Nck, Non-catalytic region of tyrosine kinase",immunology; autoimmune diseases,kinases,Phase 2; Preclinical,Yes,first-in-class oral small molecules,https://www.prnewswire.com/news-releases/artax-biopharma-raises-8-million-ahead-of-phase-2a-data-expected-in-q4-2024-302214540.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ray therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cirm.ca.gov', port=4",Yes,RTX-015,Retinal Ganglion Cells,retinal diseases,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,optogenetic gene therapy,"https://www.linkedin.com/company/ray-therapeutics-inc#:~:text=Founded%20in%202021%2C%20Ray%20Therapeutics,diseases%20independent%20of%20genetic%20mutation.",No,,,No,,,Yes,optogenetics,"https://www.linkedin.com/company/ray-therapeutics-inc#:~:text=Founded%20in%202021%2C%20Ray%20Therapeutics,diseases%20independent%20of%20genetic%20mutation."
aim immunotech inc,2025-10-15 13:14:25,Yes,Ampligen; Alferon N Injection,Not specified,oncology; infectious diseases; immunology,cytokine; other,Phase 2,No,,,No,,,Yes,Interferon Alfa-N3,https://www.linkedin.com/company/aimimmuno,No,,,No,,,No,,,Yes,large macromolecular RNA (ribonucleic acid) molecules,https://www.linkedin.com/company/aimimmuno,No,,,No,,,No,,,Yes,natural interferon to enhance the natural antiviral defense system,https://www.linkedin.com/company/aimimmuno
aptevo therapeutics inc,2025-09-16 19:04:01,No,APVO436; APVO452; APVO451,"CD123, Interleukin-3 receptor alpha chain; CD3, Cluster of Differentiation 3; PSMA, Prostate-Specific Membrane Antigen; CD40, Tumor Necrosis Factor Receptor Superfamily Member 5; Nectin-4, Poliovirus Receptor-Related Protein 4",oncology; hematology,immune checkpoint; cytokine; other,Phase 1,No,,,No,,,Yes,Protein Engineering,https://www.linkedin.com/company/aptevo-therapeutics-inc,Yes,Bispecific antibodies,https://www.linkedin.com/company/aptevo-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Immune cell engagers (BiTEs),https://www.linkedin.com/company/aptevo-therapeutics-inc
cero therapeutics inc,2025-10-15 12:47:00,Yes,CER-1236,"TIM4L, T-cell Immunoglobulin and Mucin Domain-containing Protein 4 Ligand",oncology; hematology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"engineered cell therapies, Chimeric Engulfment Receptor T cells (CER-T), CAR-T therapy",https://www.linkedin.com/company/cero-therapeutics,No,,,No,,,No,,
uro-1 inc,"Error: Connection failed - HTTPSConnectionPool(host='www.ncbiotech.org', port",No,64 Cu-SAR-bisPSMA,"PSMA, Prostate-Specific Membrane Antigen",oncology,enzyme,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bioeclipse therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cirm.ca.gov', port=4",No,CRX100,Not specified,oncology,cytokine; other,Phase 1,No,,,No,,,No,,,Yes,targeted immunotherapies,https://www.linkedin.com/company/bioeclipse-therapeutics-inc,No,,,No,,,No,,,Yes,cell therapies,https://www.linkedin.com/company/bioeclipse-therapeutics-inc,No,,,No,,,No,,
alopexx oncology llc (inactive),2018-06-30 14:06:43,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,"DI-Leu16-IL2 is a novel antibody-cytokine fusion protein (or immunocytokine) targeting the B cell antigen, CD20.",https://www.prnewswire.com/news-releases/alopexx-oncology-announces-licensing-agreement-with-beijing-shenogen-pharma-group-for-development-and-commercialization-of-novel-immunocytokine-for-the-treatment-of-b-cell-lymphomas-in-chinaasia-301016101.html,Yes,"DI-Leu16-IL2 is a de-immunized form of an anti-CD20 antibody, Leu16, genetically fused to the cytokine, interleukin 2 (IL2).",https://www.prnewswire.com/news-releases/provenance-biopharmaceuticals-corp-announces-8m-financing-arrangement-136096363.html,No,,,Yes,"DI-Leu16-IL2 is a novel antibody-cytokine fusion protein (or immunocytokine) targeting the B cell antigen, CD20.",https://www.prnewswire.com/news-releases/alopexx-oncology-announces-licensing-agreement-with-beijing-shenogen-pharma-group-for-development-and-commercialization-of-novel-immunocytokine-for-the-treatment-of-b-cell-lymphomas-in-chinaasia-301016101.html,No,,,No,,,Yes,"As a result of this vaccine-like effect, long-term anti-cancer activity should continue and future cancer cells could be destroyed even without the need for re-dosing.",https://www.prnewswire.com/news-releases/alopexx-oncology-announces-licensing-agreement-with-beijing-shenogen-pharma-group-for-development-and-commercialization-of-novel-immunocytokine-for-the-treatment-of-b-cell-lymphomas-in-chinaasia-301016101.html,No,,,No,,
thrombolytic science international llc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,HisproUK; tPA,Not specified,cardiovascular; CNS,enzyme,Phase 2,No,,,No,,,Yes,"mutant prourokinase, a recombinant fibrinolytic pro-enzyme",https://www.tsillc.net/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bioatla inc,2025-09-08 19:04:45,No,Ozuriftamab Vedotin; Mecbotamab Vedotin; Evalstotug; BA3182,"ROR2, Receptor Tyrosine Kinase-like Orphan Receptor 2; AXL, AXL Receptor Tyrosine Kinase; CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4; EpCAM, Epithelial Cell Adhesion Molecule; CD3, Cluster of Differentiation 3",oncology,kinases; kinases; immune checkpoint; other; other,Phase 2; Phase 2; Phase 2; Phase 1,No,,,No,,,Yes,protein evolution and engineering,https://www.linkedin.com/company/bioatla,Yes,monoclonal antibodies,https://www.linkedin.com/company/bioatla,Yes,CAB-ROR2-ADC,https://www.linkedin.com/company/bioatla,No,,,No,,,No,,,No,,,No,,,Yes,Bispecific T Cell Engager,https://www.linkedin.com/company/bioatla
phio pharmaceuticals corp,2025-10-08 17:54:28,No,PH-762,"PD-1, Programmed Cell Death Protein 1",oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,Yes,INTASYL siRNA technology,https://www.linkedin.com/company/phio-pharmaceuticals-corp,No,,,No,,,No,,,No,,
silver creek pharmaceuticals inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Serplulimab; Vobramitamab duocarmazine; RYZ101,"PD-1, Programmed Death-1; B7-H3; SSTR2, Somatostatin Receptor Type 2",oncology,immune checkpoint; other; other,Phase III; Phase II; Phase I,No,,,No,,,Yes,Smart Growth Factor™ technology,https://www.linkedin.com/company/silver-creek-pharmaceuticals-inc-,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
conjupro biotherapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
advaxis inc,"Error: Connection failed - HTTPSConnectionPool(host='www.iposcoop.com', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,small molecule therapeutics,https://public.com/stocks/adxs,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Listeria Monotygenes-based Immuno-Oncology Programs,https://public.com/stocks/adxs
advaxis,"Error: Connection failed - HTTPSConnectionPool(host='www.iposcoop.com', port=",Yes,ADXS-NEO; Advaxis-HOT,Neo-antigens; Tumor-associated antigens,oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,multi-neoantigen vector (ADXS-503),https://www.precisionformedicine.com/news-feed/advaxis-presents-updated-clinical-and-immunogenicity-data-from-ongoing-phase-1/2-trial-of-adxs-503-in-metastatic-non-small-cell-lung-cancer-nsclc,No,,,Yes,Lm-based antigen delivery products,https://www.precisionformedicine.com/news-feed/advaxis-presents-updated-clinical-and-immunogenicity-data-from-ongoing-phase-1/2-trial-of-adxs-503-in-metastatic-non-small-cell-lung-cancer-nsclc
regenacy pharmaceuticals llc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,Ricolinostat,"HDAC6, Histone Deacetylase 6",neurology,enzyme,Phase 2,Yes,"Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6",https://www.linkedin.com/company/regenacy-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
expression therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='www.sbir.gov', port=443)",Yes,OT-101,"TGF-β, Transforming Growth Factor Beta",oncology; inflammatory diseases,cytokine,Phase 3,No,,,No,,,Yes,recombinant proteins,https://www.qualio.com/customers/expression-therapeutics-case-study,No,,,No,,,No,,,No,,,Yes,"gene and cell therapy company developing novel, potentially curative, therapeutics",https://www.qualio.com/customers/expression-therapeutics-case-study,No,,,No,,,No,,
blueprint medicines corp,2025-06-02 09:49:46,No,AYVAKIT; BLU-808; elenestinib; BLU-222,"KIT, Proto-oncogene receptor tyrosine kinase",allergy; inflammation; oncology; hematology,kinases,Phase 3; Phase 1; Approved,Yes,"access to rare immunology disease medicine avapritinib, marketed as Ayvakit or Ayvakyt",https://www.investopedia.com/blueprint-medicines-stock-soars-as-biotech-agrees-to-over-9b-sanofi-takeover-11746204,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
kinoxis therapeutics pty ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,KNX100,Not specified,CNS; neuropsychiatric disorders; dementia; substance use disorders,other,Phase 2,Yes,"Kinoxis’ lead candidate, KNX100, is being developed for the treatment of behavioural and psychological symptoms in neuropsychiatric disorders",https://au.linkedin.com/company/kinoxis-therapeutics-pty-ltd,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pinotbio inc,2023-05-21 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Medicinal Chemistry,https://www.linkedin.com/company/bionetix-inc/,No,,,No,,,No,,,Yes,ADC 제조 분석 및 팀리더,https://www.linkedin.com/company/bionetix-inc/,No,,,No,,,No,,,No,,,No,,,No,,
revelation biosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='www.revbiosciences.com',",No,Gemini; PHAD,"HMGB-1, High Mobility Group Box Protein-1; LPS, Lipopolysaccharide",inflammatory diseases; infectious diseases; nephrology,cytokine; other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bioregen biomedical (changzhou) co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
rigenerand srl,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,RR001,"Disease Name, Pancreatic Cancer",oncology,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell therapy products from induced pluripotent stem cells (iPSCs),https://www.labiotech.eu/trends-news/evotec-completes-acquisition-of-rigenerand/,No,,,No,,,No,,
mage biologics inc,"Error: Connection failed - HTTPSConnectionPool(host='tvm-capital.com', port=4",Yes,MB-001,"Disease Name, Ulcerative Colitis",gastroenterology,other,Phase 1,No,,,No,,,No,,,Yes,humanized monoclonal antibody (mAb) bioengineered for optimal potency and tissue penetration,https://www.labiotech.eu/trends-news/mage-bio-oral-antibody-therapy-ulcerative-colitis/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
aribio,Error: Connection failed - HTTPSConnectionPool(host='www.pharmaceutical-techn,No,AR1001,"PDE5, Phosphodiesterase 5",CNS,enzyme,Phase 3,Yes,"AR1001, a promising Phase 3 Alzheimer's therapy",https://www.linkedin.com/company/aribio-official,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
orphan technologies ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,ELC-100; QRX003,"Neuroendocrine tumors; SPINK5, Serine Protease Inhibitor Kazal Type 5",oncology; rare diseases; dermatology,other; enzyme,Phase 1; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
affimed gmbh,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,AFM13,"CD30, Tumor Necrosis Factor Receptor Superfamily Member 8",oncology,immune checkpoint,Phase 2,No,,,No,,,No,,,Yes,bispecific antibodies,https://de.linkedin.com/company/affimed-ag,No,,,No,,,No,,,Yes,NK cell therapies,https://de.linkedin.com/company/affimed-ag,No,,,No,,,Yes,Innate Cell Engagers (ICE®),https://de.linkedin.com/company/affimed-ag
bambusa therapeutics inc,2025-02-14 08:56:37,Yes,BBT002; BBT001; BBT003; BBT004,Not specified,respiratory; dermatology; gastroenterology; inflammatory skin diseases; inflammatory bowel disease; rheumatological conditions,cytokine,Phase 1,Yes,"across biologics, ADCs, small molecules, and cell and gene therapies",https://www.linkedin.com/company/bambusatherapeutics,No,,,No,,,Yes,developing bispecific antibodies for immunological and inflammatory (I&I) disorders,https://www.prnewswire.com/news-releases/bambusa-therapeutics-raises-approximately-90-million-in-series-a-financing-to-advance-next-generation-bispecific-antibodies-for-immunology--inflammation-diseases-302376866.html,Yes,"across biologics, ADCs, small molecules, and cell and gene therapies",https://www.linkedin.com/company/bambusatherapeutics,No,,,No,,,Yes,"across biologics, ADCs, small molecules, and cell and gene therapies",https://www.linkedin.com/company/bambusatherapeutics,No,,,No,,,No,,
convergent therapeutics inc,2023-05-03 08:00:00,No,CONV01-α,"PSMA, Prostate-Specific Membrane Antigen",oncology,other,Phase 2,Yes,PSMA-targeted beta emitting small molecule,https://www.linkedin.com/company/convergent-therapeutics,No,,,No,,,Yes,monoclonal antibody linked to actinium-225,https://www.linkedin.com/company/convergent-therapeutics,Yes,radioantibody platform combining clinically validated antibodies with the alpha particle emitting isotope actinium-225,https://www.linkedin.com/company/convergent-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,
duality biologics (shanghai) co ltd,2021-06-19 00:00:00,Yes,AVZO-1418; DB-1418; DB-1324; AVZO-021,"EGFR, Epidermal Growth Factor Receptor; HER3, Human Epidermal Growth Factor Receptor 3; CDK2, Cyclin-Dependent Kinase 2; Gastrointestinal Cancer Target",oncology; autoimmune diseases,other; kinases,Phase 1; Preclinical,No,,,No,,,Yes,novel protein engineering,https://www.linkedin.com/company/duality-biologics-shanghai-co-ltd/,Yes,Antibody/ADC discovery,https://www.linkedin.com/company/duality-biologics-shanghai-co-ltd/,Yes,Antibody-Drug Conjugate (ADC) therapeutics,https://www.linkedin.com/company/duality-biologics-shanghai-co-ltd/,No,,,No,,,No,,,No,,,No,,,No,,
forge biologics inc,2025-10-17 12:00:59,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy manufacturing and therapeutics development,https://www.linkedin.com/company/forge-biologics,No,,,No,,,No,,
attovia therapeutics inc,2025-04-15 11:30:00,Yes,ATTO-1310; ATTO-3712; ATTO-004,"IL-31, Interleukin-31; IL-13, Interleukin-13",immune-mediated diseases; inflammatory diseases; pruritus; atopic dermatitis; inflammatory bowel disease,cytokine,Phase 1,No,,,No,,,No,,,Yes,"ATTOBODY®, a proprietary biologics platform for multispecifics",https://www.linkedin.com/company/attovia-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bright peak therapeutics ag,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,BPT567,"PD-1, Programmed Death-1; IL-18, Interleukin-18",oncology,immune checkpoint; cytokine,Phase 1/2a,No,,,No,,,Yes,world-class protein engineering capabilities,https://brightpeaktx.com/,Yes,any therapeutic antibody at any stage of development can be conjugated with Bright Peak’s cytokine payloads,https://www.linkedin.com/company/bright-peak-therapeutics,Yes,"creating bespoke, novel and proprietary 'Bright Peak Immunocytokines'",https://www.linkedin.com/company/bright-peak-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,
chu de quebec universite laval research center,Error: can't compare offset-naive and offset-aware dateti,No,Capivasertib; Tusamitamab Ravtansine; Zenocutuzumab; Zolbetuximab; Revumenib; Denileukin Diftitox,"AKT, Protein Kinase B; CEACAM5, Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; NRG1, Neuregulin 1; Claudin 18.2; KMT2A, Lysine Methyltransferase 2A; IL-2R, Interleukin-2 Receptor",oncology; breast cancer; non-small cell lung cancer; pancreatic cancer; gastric cancer; acute myeloid leukemia; cutaneous T-cell lymphoma,kinases; other; other; other; other; cytokine,Approved; Phase 2; Phase 1/2; Phase 3; Phase 1/2; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
the lundquist institute,"Error: Connection failed - HTTPSConnectionPool(host='ctsi.ucla.edu', port=443",Yes,VX-01,"CotH, Fungal Cell Surface Protein",infectious diseases,other,Preclinical,Yes,dalbavancin as a potential treatment for complicated Staphylococcus aureus,https://www.linkedin.com/company/thelundquistinstitute,No,,,No,,,Yes,Vitalex Bioscience 's VX-01 monoclonal antibody program targeting mucormycosis,https://www.linkedin.com/company/thelundquistinstitute,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nanjing huanglong biotechnology co ltd,2022-12-23 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"research and development, registration and application of small molecule chemicals",https://www.marketscreener.com/quote/stock/XINJIANG-BAI-HUA-CUN-PHAR-9949882/news/Nanjing-Huanglong-Biotechnology-Co-Ltd-announced-that-it-expects-to-receive-CNY-90-million-in-fun-42619331/,Yes,development of peptide drugs,https://www.marketscreener.com/quote/stock/XINJIANG-BAI-HUA-CUN-PHAR-9949882/news/Nanjing-Huanglong-Biotechnology-Co-Ltd-announced-that-it-expects-to-receive-CNY-90-million-in-fun-42619331/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ocuphire pharma inc,Error: Connection failed - HTTPSConnectionPool(host='www.fightingblindness.or,No,APX3330; Phentolamine Ophthalmic Solution 0.75%; OPGx-LCA5,"Ref-1; LCA5, Leber Congenital Amaurosis 5",ophthalmology; inherited retinal diseases; diabetic retinopathy; presbyopia,enzyme; other,Phase 3; Phase 1/2,Yes,"APX3330, an oral small-molecule inhibitor of Ref-1 for the treatment of non-proliferative diabetic retinopathy",https://www.globenewswire.com/news-release/2024/10/22/2967317/0/en/Ocuphire-Pharma-Announces-Acquisition-of-Opus-Genetics.html,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa",https://www.globenewswire.com/news-release/2024/10/22/2967317/0/en/Ocuphire-Pharma-Announces-Acquisition-of-Opus-Genetics.html,No,,,No,,,No,,
treadwell therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,novel small molecule drugs,https://www.linkedin.com/company/treadwell-therapeutics-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
the lunenfeld-tanenbaum research institute,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,semaglutide; tirzepatide; RP-6306,"GLP-1, Glucagon-Like Peptide 1; PKMYT1, Membrane-Associated Tyrosine/Threonine Kinase",diabetes; obesity; cardiovascular; renal diseases; oncology,gpcr; kinases,Phase 1; Approved; Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
revance therapeutics inc,2025-02-06 08:39:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,DaxibotulinumtoxinA-lanm,https://stockanalysis.com/stocks/rvnc/company/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
infinity pharmaceuticals inc,2021-03-12 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,small molecule,https://www.linkedin.com/company/ipi,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
elevation oncology inc,2025-06-09 08:01:09,Yes,EO-3021; EO-1022,"Claudin 18.2; HER3, Human Epidermal Growth Factor Receptor 3",oncology,other,Phase 1; Preclinical,No,,,No,,,No,,,No,,,Yes,antibody drug conjugate (ADC),https://www.linkedin.com/company/elevation-oncology,No,,,No,,,No,,,No,,,No,,,No,,
newleos therapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.b,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"oral small molecules targeting GABAA-γ1, V1a, TAAR1 and GABAA-α5",https://www.linkedin.com/company/newleos-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
achillion pharmaceuticals inc (inactive),Error: Connection failed - 403 Client Error: Forbidden for url: https://www.f,Yes,ACH-4471; ACH-5228,Factor D,rare diseases; complement-mediated diseases,enzyme,Phase 2; Phase 1,Yes,clinical-stage portfolio of orally administered factor D inhibitors,https://www.linkedin.com/company/achillion-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
chimerix inc,2025-03-05 07:00:51,No,Dordaviprone; ONC206; CHM CDH17; CHM CLTX; CHM CORE NK,"ClpP, Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit; DRD2, Dopamine Receptor D2; H3 K27M-mutant diffuse glioma; Gastric Cancer; Neuroendocrine Cancer; Colorectal Cancer; Glioblastoma; AML, Acute Myeloid Leukemia",oncology; CNS; rare diseases; blood cancer,enzyme; gpcr; other,Phase 3; Phase 1,Yes,"dordaviprone, a novel first-in-class small molecule treatment",https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-acquire-chimerix-further-diversifying-oncology-portfolio-302393029.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
corbus pharmaceuticals holdings inc,2025-10-16 14:30:13,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,"CRB-913, a highly peripherally restricted CB1 receptor inverse agonist for the treatment of obesity",https://www.linkedin.com/company/corbus-pharmaceuticals,No,,,No,,,Yes,"CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells",https://www.linkedin.com/company/corbus-pharmaceuticals,Yes,"CRB-701, a next-generation antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload",https://www.linkedin.com/company/corbus-pharmaceuticals,No,,,No,,,No,,,No,,,No,,,No,,
memgen inc,"Error: Connection failed - HTTPSConnectionPool(host='www.linkedin.com', port=",No,MEM-288,Not specified,oncology,other,Phase 1,No,,,No,,,Yes,the powerful cytokine interferon beta,https://www.linkedin.com/company/memgen-inc,No,,,Yes,"combining MEM-288 with other therapeutic classes, including antibody–drug conjugates (ADCs)",https://www.globenewswire.com/news-release/2025/08/25/3138854/0/en/Memgen-Announces-First-Patient-Dosed-in-Phase-1-Combination-Cohort-of-MEM-288-Plus-Docetaxel-in-Advanced-Non-Small-Cell-Lung-Cancer.html,No,,,No,,,No,,,Yes,"Memgen's vaccine adjuvant, MemVax, is designed to be used in combination with other vaccines",https://www.linkedin.com/company/memgen-inc,No,,,Yes,oncolytic virus engineered to selectively target cancer cells,https://www.linkedin.com/company/memgen-inc
albireo pharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.ipsen.com', port=443",No,A4250; Volixibat,"ASBT, Apical Sodium-Dependent Bile Acid Transporter",rare diseases; hepatology; gastrointestinal diseases,other,Phase 3; Phase 2,Yes,novel bile acid modulators,https://www.massbio.org/members/albireo-pharma/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
albireo ab,"Error: Connection failed - HTTPSConnectionPool(host='www.ipsen.com', port=443",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
elastagen pty ltd,2018-02-12 07:09:01,Yes,Not specified,Not specified,dermatology; wound care,other,Clinical,No,,,No,,,Yes,"Tropoelastin, polymerized to form elastin, is a critical component of tissues in the human body which require the ability to stretch and recoil, such as the skin, lungs, arteries and elastic ligaments, and plays a key role in repair and regeneration.",https://au.linkedin.com/company/elastagen-pty-ltd,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
stelis biopharma ltd,2024-10-30 04:44:54,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,oral technologies like soft gelatin capsules,https://chambers.com/articles/listing-of-onesource-specialty-pharma-limited-formerly-known-as-stelis-biopharma-limited,Yes,"comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing and fill/finish of proteins and peptides",https://au.linkedin.com/company/stelisbiosource,Yes,"comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing and fill/finish of proteins and peptides",https://au.linkedin.com/company/stelisbiosource,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
wuhan neophth biotechnology co ltd,2023-08-11 09:00:00,Yes,esonadogene mvoparvovec; NR082; NFS-02,"ND4, NADH Dehydrogenase Subunit 4; ND1, NADH Dehydrogenase Subunit 1",ophthalmology; rare diseases,enzyme,Phase 3; Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene therapy,https://globalgenes.org/raredaily/neurophth-secures-95-million-for-gene-therapy-clinical-trials/,No,,,No,,,No,,
wuhan neurophth biological technology ltd,2023-08-11 09:00:00,Yes,NR082,"Disease Name, Leber's Hereditary Optic Neuropathy (LHON)",CNS; rare diseases,other,Phase 1/2/3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene therapy, AAV platform, genomic medicines, NR082 (rAAV2-ND4), NFS-02, autosomal dominant optic atrophy, vascular retinopathy, optic neuropathy",https://www.prnewswire.com/news-releases/neurophth-secures-nearly-95-million-usd-in-series-c-financing-for-gene-therapy-clinical-trials-301898549.html,No,,,No,,,No,,
andalusian initiative for advanced therapies,No timestamp found,Yes,Not specified,Critical Limb Ischemia; Multiple Sclerosis; Amyotrophic Lateral Sclerosis,cardiology; neurology; immunology; hematology; peripheral vascular diseases,Not specified,Phase 3; Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"stem cell therapies, cell therapy, regenerative medicine, genetically modified stem cells, induced pluripotent stem cells",https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/,No,,,No,,,Yes,"nanomedicine, tissue engineering, artificial corneas generated from limbal stem cells, scaffold and technology",https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/
iniciativa andaluza en terapias avanzadas,No timestamp found,Yes,amlitelimab; rocatinlimab; GSK1070806; zasocitinib; icotrokinra; XTANDI,"OX40, T cell activation complex; IL-18, Interleukin-18; IL-17, Interleukin-17; IL-23 R, Interleukin-23 Receptor; Androgen Receptor",dermatology; oncology,immune checkpoint; cytokine; other,Phase 3; Approved; Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"cell therapy and regenerative medicine, clinical genetics and genomic medicine, and nanomedicine",https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/,No,,,No,,,Yes,"stem cell therapies, tissue engineering field, artificial corneas generated from limbal stem cells",https://pmc.ncbi.nlm.nih.gov/articles/PMC3659837/
rezolute inc,2025-10-15 12:11:46,No,RZ358; ersodetug,Insulin Receptor,rare diseases; oncology; metabolic diseases,other,Phase 3,No,,,No,,,No,,,Yes,"antibody therapy, ersodetug",https://www.stocktitan.net/news/RZLT/rezolute-to-participate-in-upcoming-investor-kj186jrxnocb.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,
antios therapeutics inc (inactive),"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Not specified,Hepatitis D,infectious diseases,Not specified,Not specified,Yes,Active Site Polymerase Inhibitor Nucleotide (ASPIN),https://www.prnewswire.com/news-releases/antios-therapeutics-announces-notice-of-allowance-for-us-patent-on-phosphoramidates-for-the-treatment-of-hepatitis-b-virus-301532379.html,No,,,No,,,No,,,No,,,No,,,Yes,"GalNAc delivered RNAi therapeutic, AB-729",https://www.aislingcapital.com/news/p9,No,,,No,,,No,,,Yes,capsid assembly modulators (CAMs),https://www.prnewswire.com/news-releases/antios-therapeutics-announces-notice-of-allowance-for-us-patent-on-phosphoramidates-for-the-treatment-of-hepatitis-b-virus-301532379.html
pyrotech (beijing) biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.biocentury.com', por",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,Several of the company’s small molecule and biologic immune modulators are advancing quickly into clinical studies,https://www.linkedin.com/company/pyrotech-therapeutics/,No,,,Yes,Several of the company’s small molecule and biologic immune modulators are advancing quickly into clinical studies,https://www.linkedin.com/company/pyrotech-therapeutics/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
pharnext sa,2021-07-07 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,molecules that are already tested for other diseases,https://live.euronext.com/en/product/equities/FR001400N1P4-ALXP,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
spero therapeutics inc,2025-10-14 13:34:06,No,tebipenem HBr; SPR206; SPR720,Complicated Urinary Tract Infection; Acute Pyelonephritis; Nontuberculous Mycobacterial Pulmonary Disease,infectious diseases; rare diseases,other,Phase 3; Phase 2,Yes,"Tebipenem HBr is in Phase 3 development, with the potential to be the first broad-spectrum oral carbapenem",https://www.linkedin.com/company/spero-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
saniona ab,2025-10-01 14:15:22,Yes,SAN2355; SAN711; SAN2465; SAN2219; SAN2668; Tesofensine; Tesomet; SAN903,Epilepsy; Absence Seizures; Refractory Focal Onset Seizures; Acute Repetitive Seizures; Major Depressive Disorder; Obesity; Rare Eating Disorders; Inflammatory Bowel Disease,CNS; metabolic diseases; rare diseases; gastrointestinal diseases,ion channels,Preclinical; Phase 1; Phase 2; Approved,Yes,"drugs targeting ion channels to develop therapeutics for pain, central nervous system, and inflammatory or autoimmune diseases",https://www.cnbc.com/quotes/SANION-SE,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,ion channel modulation for the treatment of epilepsy and other neurological disorders,https://www.linkedin.com/company/saniona
perfuse therapeutics inc,2025-10-15 18:56:04,No,PER-001,Not specified,ophthalmology,other,Phase 2,Yes,"PER-001 is a novel (new chemical entity), first-in-class small molecule endothelin receptor antagonist.",https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-positive-results-from-the-completed-phase-12a-clinical-trial-of-per-001-intravitreal-implant-in-patients-with-glaucoma-302446082.html,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
vidac pharma,2025-09-16 07:51:13,No,Not specified,"VDAC1, Voltage-Dependent Anion Channel 1",oncology,ion channels,Not specified,Yes,first-in-class medicines,https://il.linkedin.com/company/vidac-pharma,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Exosome-based therapeutics, Oncolytic viruses, Cancer metabolism, Warburg effect",https://il.linkedin.com/company/vidac-pharma
biochemics inc (inactive),Error: can't compare offset-naive and offset-aware dateti,No,STRO-003; rinatabart sesutecan; ARV-766; EP262; EP547; clemizole hydrochloride; ripretinib; vimseltinib,"ROR1, Receptor Tyrosine Kinase-like Orphan Receptor 1; FRα, Folate Receptor Alpha; AR, Androgen Receptor; MRGPRX2, Mas-related Protein-coupled Receptor X2; MRGPRX4, Mas-related Protein-coupled Receptor X4; SCN1A, Sodium Channel Na v 1.1; Not specified",oncology; dermatology; CNS; rare diseases; immune disorders,kinases; enzyme; gpcr; other; Not specified,Preclinical; Phase 1; Phase 2; Phase 3; Approved; Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
agalimmune ltd,2018-06-26 19:17:08,Yes,AGI-134,"Alpha-Gal, Alpha-Galactosyl antigen",oncology,other,Preclinical,Yes,small molecule targeting DNA damage response,https://www.prnewswire.com/news-releases/biolinerx-announces-acquisition-of-agalimmune-ltd-to-accelerate-expansion-of-immuno-oncology-pipeline-616907734.html,No,,,No,,,Yes,Anti-alpha-Gal antibodies,https://www.prnewswire.com/news-releases/biolinerx-announces-acquisition-of-agalimmune-ltd-to-accelerate-expansion-of-immuno-oncology-pipeline-616907734.html,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"immuno-oncology assets, innovative anti-cancer immunotherapy pipeline",https://www.linkedin.com/company/kode-agalimmune
humabs biomed sa,2025-10-18 05:05:52,Yes,Not specified,Zika virus,infectious diseases,other,Preclinical,No,,,No,,,No,,,Yes,"discovery, engineering, and early development of human monoclonal antibodies to fight infectious diseases",https://www.swissbiotech.org/listing/58855/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nantcell inc,Error: Connection failed - HTTPSConnectionPool(host='cdek.pharmacy.purdue.edu,No,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,nanoparticle chemotherapeutic agent Abraxane,https://nantworks.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
oxular ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.f,No,Reproxalap; AR-15512,"RASP, Reactive Aldehyde Species; TRPM8, Transient Receptor Potential Melastatin 8",ophthalmology,enzyme; ion channels,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Gene therapy,https://uk.linkedin.com/company/oxular,No,,,No,,,No,,
perha pharmaceuticals sas,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Leucettinibs,"DYRK1A, Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A",cognitive disorders; hearing loss,kinases,Preclinical,Yes,low molecular weight kinase inhibitors,https://go-ds21.eu/partner/perha-pharmaceuticals-sas/,No,,,Yes,Protein kinases are a large family of enzymes,https://go-ds21.eu/partner/perha-pharmaceuticals-sas/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
shanghai xinshi biological medicine co ltd,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",Yes,JS207; LOQTORZI; toripalimab; disitamab vedotin; ongericimab,"PD-1, Programmed Death-1; VEGFA, Vascular Endothelial Growth Factor A; HER2, Human Epidermal Growth Factor Receptor 2; PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9",oncology; immunology; cardiovascular; metabolic diseases,immune checkpoint; cytokine; enzyme,Phase 2/3; Approved; Marketed,Yes,"Junshi expanded its innovation to the R&D of more types of drugs, including small molecule drugs",https://www.linkedin.com/company/shanghai-junshi-biosciences,No,,,Yes,"Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs",https://www.linkedin.com/company/shanghai-junshi-biosciences,Yes,China’s first domestically produced and independently developed anti-PD-1 monoclonal antibody,https://junshi-bioscience-v2-umb.azurewebsites.net/en/investors/,Yes,"Junshi expanded its innovation to the R&D of more types of drugs, including small molecule drugs and antibody drug conjugates (or ADCs)",https://www.linkedin.com/company/shanghai-junshi-biosciences,No,,,No,,,No,,,Yes,"Junshi Biosciences actively shouldered the social responsibilities of a Chinese pharmaceutical company through its involvement in developing etesevimab, MINDEWEI, and other novel therapies for the prevention and treatment of COVID-19",https://junshi-bioscience-v2-umb.azurewebsites.net/en/investors/,No,,,No,,
transcenta holding ltd,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",Yes,Catumaxomab,"EpCAM, Epithelial Cell Adhesion Molecule; CD3, Cluster of Differentiation 3",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,Yes,"antibody-based biotherapeutics discovery, research, development and manufacturing",https://www.linkedin.com/company/transcenta,Yes,An ADC Candidate Targeting a Validated Tumor Antigen,https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html,No,,,Yes,strategic alliance with a company specialized in siRNA drug substance synthesis,https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html,No,,,No,,,No,,,No,,
canbridge life sciences ltd,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",Yes,Gaurunning; Livmarli; Hunterase; CAN106; CAN103; CAN108; CAN101; CAN201; CAN202; CAN203,"GBA, Glucocerebrosidase; IBAT, Ileal Bile Acid Transporter; IDS, Iduronate-2-Sulfatase; C5, Complement Component 5; Not specified",rare diseases; rare oncology; lysosomal storage disorders; complement-mediated diseases; metabolic disorders; rare cholestatic liver diseases; neuromuscular diseases,enzyme; enzyme; enzyme; other; Not specified,Marketed; Marketed; Marketed; Phase 1; Phase 2; Marketed; Marketed; Preclinical; Preclinical; Preclinical,Yes,NERLYNX® (neratinib),https://www.linkedin.com/company/canbridgepharma,No,,,Yes,"Hunterase®, an enzyme replacement therapy",https://www.linkedin.com/company/canbridgepharma,No,,,No,,,No,,,Yes,StitchR™ RNA Assembly Technology,https://www.canbridgepharma.com/,Yes,gene therapy can have the greatest impact in patients with rare genetic diseases,https://www.canbridgepharma.com/,No,,,No,,,No,,
edimer pharmaceuticals inc,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zymtech production as,"Error: Connection failed - HTTPSConnectionPool(host='not%20found', port=443):",No,STRO-003; rinatabart sesutecan; ARV-766; EP262; EP547; ripretinib; vimseltinib; ORKA-001; ORKA-002; clemizole hydrochloride,"ROR1, Receptor Tyrosine Kinase-like Orphan Receptor 1; FRα, Folate Receptor Alpha; AR, Androgen Receptor; MRGPRX2, Mas-related Protein-coupled Receptor X2; MRGPRX4, Mas-related Protein-coupled Receptor X4; SCN1A, Sodium Channel Na v 1.1; IL-23p19, Interleukin-23p19; IL-17A/F, Interleukin-17A/F",oncology; dermatology; CNS; rare diseases; immune disorders,kinases; enzyme; gpcr; cytokine; other,Preclinical; Phase 1; Phase 2; Phase 3; Approved,No,,,Yes,short peptides,https://amizate.com/the-product/,Yes,high value protein hydrolysate,https://amizate.com/about-us/about-us/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
amphera bv,"Error: Connection failed - HTTPSConnectionPool(host='www.euroquity.com', port",No,Pegargiminase; Volrustomig; Tremelimumab; TAK-500; RSO-021,"ASS1, Argininosuccinate Synthase; PD-1, Programmed Cell Death Protein 1; CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4; STING, Stimulator of Interferon Genes; PRX3, Peroxiredoxin 3",oncology,enzyme; immune checkpoint; immune checkpoint; other; enzyme,Preregistration; Phase 3; Phase 2; Phase 1/2; Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,dendritic cell therapies to treat cancer,https://www.linkedin.com/company/amphera,No,,,No,,,No,,
lipogems international spa,2022-12-23 00:00:00,No,Lipogems,Not specified,regenerative medicine; orthopedic surgery; plastic reconstructive surgery; aesthetic medicine,other,Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,adipose tissue solutions,https://www.linkedin.com/company/lipogems-international-spa
red de terapia celular,"Error: Connection failed - HTTPConnectionPool(host='www.csic.es', port=80): M",Yes,Umbilical cord derived mesenchymal stem cells; Stem Cell Educator therapy,Not specified,infectious diseases,other,Phase 2/III,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"therapy celular, trasplante de células autólogas y heterólogas de diferentes poblaciones de células (adultas, embrionarias o IPSC)",https://icor.cat/es/investigacion/pertenencia-a-redes/red-tercel_programa-cardiocell.html,No,,,No,,,No,,
cellprothera sas,2025-08-29 00:00:00,Yes,ProtheraCytes,"Disease Name, Post-Acute Myocardial Infarction; Disease Name, Ischemic Stroke",cardiovascular; neurology,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,therapies cellulaires régénératives,https://ca.linkedin.com/company/cellprothera,No,,,No,,,No,,
cellaion sa,"Error: Connection failed - HTTPSConnectionPool(host='newtonbiocapital.com', p",No,CT-P70; CT-P71; CT-P72,"Disease Name, Non-small cell lung cancer; Disease Name, Bladder cancer; Disease Name, Tumor-selective targeting",oncology,other,Preclinical,No,,,No,,,No,,,Yes,Antibodies,https://be.linkedin.com/company/cellaion,No,,,No,,,No,,,Yes,Cell therapy,https://be.linkedin.com/company/cellaion,No,,,No,,,No,,
Synimmune GmbH (inactive),"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,Monalizumab; NKTR-214; ALT-803; ALECSAT; PNK-007; CellProtect; NK-92,"NKG2A, Natural Killer Group 2A receptor; CD122, Interleukin-2 receptor beta subunit; NK ligand",oncology; hematological malignancies; autoimmune disorders; CNS,immune checkpoint; cytokine; other,Phase 3; Phase 2; Phase 1,No,,,No,,,No,,,Yes,Fc-enhanced Anti-FLT3 antibody,https://www.linkedin.com/posts/veraxa-biotech-gmbh_veraxa-biotech-acquires-synimmune-activity-7157700927074787330-pB-G,Yes,ADC (anti-CD33 mAb X calicheamicin),https://pmc.ncbi.nlm.nih.gov/articles/PMC10031751/,No,,,No,,,No,,,No,,,No,,,No,,
invios gmbh,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,INV501; INV441; APN401; INV451,Not specified,oncology,Not specified,Preclinical; Phase 1,Yes,INV501 first-in-class orally available small molecule,https://oncodaily.com/blog/167578,No,,,No,,,No,,,No,,,No,,,Yes,INV441 uses tumor-infiltrating lymphocytes (TILs) that are modified via siRNA inhibiting the immune checkpoint Cbl-b,https://oncodaily.com/blog/167578,Yes,INV441 cell therapy. INV441 uses tumor-infiltrating lymphocytes (TILs) that are modified via siRNA inhibiting the immune checkpoint Cbl-b,https://oncodaily.com/blog/167578,No,,,No,,,No,,
surface oncology inc,Error: can't compare offset-naive and offset-aware dateti,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,anti-CCR8 antibody,https://www.globenewswire.com/search/organization/Surface%2520Oncology%CE%B4%2520Inc%C2%A7,No,,,No,,,No,,,No,,,No,,,No,,,No,,
small pharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,SPL026; SPL028,Not specified,CNS,Not specified,Phase 2; Phase 1,Yes,developing short-duration psychedelic-assisted treatments for under-served mental health conditions,https://uk.linkedin.com/company/small-pharma-inc,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,short-duration psychedelic therapies for mental health conditions,https://www.marketscreener.com/quote/stock/SMALL-PHARMA-INC-49479475/company/
alloplex biotherapeutics inc,2025-09-26 05:32:08,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cellular therapeutic platform for treating cancer,https://www.linkedin.com/company/alloplex-biotherapeutics,Yes,developing an off-the-shelf anti-tumor vaccine,https://www.massbio.org/members/alloplex-biotherapeutics-inc/,No,,,Yes,ENLIST cell training platform,https://lnkd.in/exCcV4fE
bristar immunotech biotechnology co ltd,Error: Connection failed - HTTPSConnectionPool(host='en.bristarimmunotech.com,Yes,LILRB4 STAR-T; HXYT-001,"LILRB4, Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 4; CD19/CD20",oncology,immune checkpoint,Preclinical; Phase 1,No,,,No,,,No,,,Yes,nano-antibodies that bind to different epitopes,https://www.prnewswire.com/news-releases/bristar-immunotech-to-present-its-novel-cell-therapy-for-acute-myeloid-leukemia-at-the-aacr-special-conference-on-aml-and-mds-301726507.html,No,,,No,,,No,,,Yes,STAR-T cell therapy technology platform,https://www.prnewswire.com/news-releases/bristar-immunotech-to-present-its-novel-cell-therapy-for-acute-myeloid-leukemia-at-the-aacr-special-conference-on-aml-and-mds-301726507.html,No,,,No,,,No,,
marino biotechnology co ltd,2025-10-02 08:24:33,Yes,Aucatzyl,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Approved,Yes,highly promising drug candidates fail during development due to low solubility in aqueous formulations,https://at.linkedin.com/company/marinomed-biotech-ag,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Marinosolv® technology significantly improves the solubility and bioavailability of hardly soluble compounds,https://at.linkedin.com/company/marinomed-biotech-ag
novatim immune therapeutics (zhejiang) co ltd,"Error: Connection failed - HTTPConnectionPool(host='en.novatim-zj.com', port=",No,RB-601; KY-0301,"c-MET, Mesenchymal-Epithelial Transition Tyrosine Kinase Receptor; EGFR, Epidermal Growth Factor Receptor",oncology,kinases,Phase 1,No,,,No,,,No,,,Yes,Bifunctional Antibody Platform,https://www.linkedin.com/company/novatim-immune-therapeutics,Yes,Nano Dual Antibody ADC Platform,https://www.linkedin.com/company/novatim-immune-therapeutics,No,,,No,,,Yes,Enhanced Dual Target CAR-T Platform,https://www.linkedin.com/company/novatim-immune-therapeutics,No,,,No,,,No,,
abata therapeutics,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,engineered Treg cell therapies,https://www.linkedin.com/company/abata-therapeutics,No,,,No,,,No,,
exo biologics sa,"Error: Connection failed - HTTPSConnectionPool(host='www.exobio.be', port=443",Yes,Exo-srIκB,"NF-κB, Nuclear Factor kappa-light-chain-enhancer of activated B cells",inflammatory diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,Yes,successful loading by EXO Biologics of mRNA and DNA into exosomes,https://be.linkedin.com/company/exo-biologics,No,,,No,,,No,,,Yes,exosome-based therapeutics,https://be.linkedin.com/company/exo-biologics
nkmax co ltd,2024-03-25 00:00:00,No,Troculeucel,"Disease, Alzheimer's Disease",Neurodegenerative disorders; Oncology,Other,Phase 2,No,,,No,,,No,,,Yes,monoclonal antibodies,https://www.marketscreener.com/quote/stock/NKMAX-CO-LTD-26375900/company-governance/,No,,,No,,,No,,,Yes,NK cell therapies,https://www.globenewswire.com/news-release/2025/09/09/3146867/0/en/NKGen-Biotech-Inc-Announces-Completion-of-NKMax-Co-Ltd-Acquisition-Gains-Full-Control-of-Global-Manufacturing-and-Intellectual-Property-Assets.html,No,,,No,,,No,,
kangstem biotech co ltd,2025-10-17 00:00:00,Yes,OSCA,Not specified,osteoarthritis,Not specified,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,Yes,nucleic acid aptamers,https://www.linkedin.com/company/kangstem?trk=ppro_cprof,Yes,"stem cell therapy products including Furestem-AD, Furestem-RA, Furestem-CD",https://uk.marketscreener.com/quote/stock/KANGSTEM-BIOTECH-CO-LTD-27329670/company/,No,,,No,,,Yes,"Exosome-based therapeutics, artificial organs using aptamers, stem cell-derived islet organoids",https://www.linkedin.com/company/kangstem?trk=ppro_cprof
boryung vigencell inc,2024-12-18 00:00:00,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,development of cell therapy business,https://www.marketscreener.com/quote/stock/VIGENCELL-INC-126415396/news/Gaeun-Global-Co-Ltd-completed-the-acquisition-of-11-36-stake-in-ViGenCell-Inc-from-Boryung-Corpor-48865781/,No,,,No,,,Yes,"vitier platform as an antigen-specific killing t cell treatment, viranger platform as a gammadelta t cell gene therapy, vimedier platform-based technology as a myeloid suppressor cell therapy derived from umbilical cord blood",https://www.marketscreener.com/quote/stock/VIGENCELL-INC-126415396/news/Gaeun-Global-Co-Ltd-completed-the-acquisition-of-11-36-stake-in-ViGenCell-Inc-from-Boryung-Corpor-48865781/
famicordtx sa,2025-09-18 00:00:00,Yes,FCTX CL 19 1,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developing cell and gene immunotherapies,https://pl.linkedin.com/company/famicordtx,No,,,No,,,Yes,"CAR-T therapy uses a patient’s own T-cells, which are genetically modified in a laboratory",https://www.nextcellpharma.com/press-releases/nextcell-invests-in-car-t-technology
shanghai saibiman biotechnology co ltd,Error: Connection failed - HTTPSConnectionPool(host='www.symraybiopharma.com',No,Not specified,Not specified,oncology,Not specified,Not specified,No,,,Yes,99% Purity Peptides Cagrilintide Mazdutide Epithalon Selank Semax Nad+,https://shxmn-biotech.en.made-in-china.com/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
allife medical science and technology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='crisprmedicinenews.com',",Yes,Not specified,Not specified,oncology,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"cell therapy, gene therapy, CAR-NK cell injection, iPSC-derived endothelial progenitor cell (EPC) cell drugs",https://informaconnect.com/bioeurope-spring/sponsors/allife-medicine-inc/,No,,,No,,,No,,
anhui kedgene biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='crisprmedicinenews.com',",No,Growth Hormone Drug; Atosiban Acetate Injection,Not specified,endocrinology; reproductive health,Not specified,Clinical Trial; Marketed,No,,,No,,,Yes,Human Growth Hormone (HGH),https://www.linkedin.com/company/anhui-anke-biotechnology-group-co-ltd-/,Yes,Trastuzumab Injection,https://www.linkedin.com/company/anhui-anke-biotechnology-group-co-ltd-/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
chengdu medgencell biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='crisprmedicinenews.com',",No,CA-170; YPD-30; MAX-10181; GS-4224; BMS-202; BMS-986189,"PD-1, Programmed Cell Death Protein 1; PD-L1, Programmed Death-Ligand 1; VISTA, V-domain Ig Suppressor of T Cell Activation; CTLA-4, Cytotoxic T-Lymphocyte-Associated Protein 4; TIM-3, T Cell Immunoglobulin and Mucin-3; LAG-3, Lymphocyte Activation Gene 3",oncology,immune checkpoint,Phase 2b/3; Phase 1; Phase 2; Phase 1; Preclinical; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Cell- and Tissue-Based Therapy / methods*,https://pubmed.ncbi.nlm.nih.gov/33434513/,Yes,Cancer Vaccines / therapeutic use,https://pubmed.ncbi.nlm.nih.gov/33434513/,No,,,No,,
asc therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='crisprmedicinenews.com',",Yes,ASC35,"GLP-1R, Glucagon-Like Peptide-1 Receptor; GIPR, Glucose-Dependent Insulinotropic Polypeptide Receptor",metabolic diseases; obesity,gpcr,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene, CRISPR and allogeneic cell therapies",https://www.linkedin.com/company/asc-therapeutics,No,,,No,,,No,,
r-biopharm ag,2025-10-16 12:01:05,No,Obefazimod; Zunsemetinib; BIIB800; '1805,Not specified,autoimmune diseases; oncology; rheumatoid arthritis,Not specified,Phase II; Phase III,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bluebird bio inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.f,No,Lyfgenia,Not specified,rare diseases,Not specified,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"curative gene therapies, lentiviral vector technologies, ex-vivo gene therapy",https://www.linkedin.com/company/bluebirdbio,No,,,No,,,No,,
dendright pty ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.uq.edu.au', port=443",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
anocca ab,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,T-cell receptor-engineered T cell (TCR-T) therapies,https://se.linkedin.com/company/anocca-ab,Yes,work on vaccines,https://se.linkedin.com/company/anocca-ab,No,,,No,,
amniotics ab,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,PulmoStem; NK003,Not specified,pulmonary diseases; oncology,cytokine; other,Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developing innovative therapies based on mesenchymal stem cells from amniotic fluid,https://www.inderes.dk/en/releases/magle-group-and-amniotics-merge-to-create-a-leader-in-high-quality-life-changing-healthcare-innovations-with-a-broadened-cdmo-offering-1,No,,,No,,,No,,
cellpoint bv,2022-04-06 08:30:00,Yes,GLPG5101; GLPG5201; GLPG5301; GLPG3667,"Non-Hodgkin lymphoma; Chronic lymphocytic leukemia; Richter transformation; BCMA, B-cell maturation antigen; Systemic lupus erythematosus; Dermatomyositis",oncology; immunology,immune checkpoint; other,Phase 1; Phase 2,No,,,No,,,No,,,Yes,fully human single domain antibody discovery platform,https://www.prnewswire.com/news-releases/pregene-enters-into-innovative-partnership-with-cellpoint-to-develop-anti-bcma-car-t-cell-therapy-in-europe-and-the-us-301518944.html,No,,,No,,,No,,,Yes,developing CAR-T therapeutics for use at the point-of-care (POC),https://www.prnewswire.com/news-releases/pregene-enters-into-innovative-partnership-with-cellpoint-to-develop-anti-bcma-car-t-cell-therapy-in-europe-and-the-us-301518944.html,No,,,No,,,No,,
beijing anlong biomedical co ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"RNAi, mRNA therapeutics",https://www.linkedin.com/company/anlongbio/,Yes,"lentivirus, AAV, Gene Therapy, CRISPR, Gene Editing, Ocular Gene Therapy",https://www.linkedin.com/company/anlongbio/,No,,,No,,,No,,
altheia science srl,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,neurology,Not specified,Phase 3,Yes,first-in-class molecules controlling the PD-L1 pathway,https://www.linkedin.com/company/altheia-science,No,,,Yes,modulation of PD-L1 expression at the molecular and protein level,https://www.linkedin.com/company/altheia-science,No,,,No,,,No,,,No,,,Yes,lentiviral vector-based engineering of patients’ hematopoietic stem cells,https://www.linkedin.com/company/altheia-science,No,,,No,,,No,,
aleta biotherapeutics inc,2025-09-26 19:40:55,Yes,ALETA-001,"CD19, Cluster of Differentiation 19; CD20, Cluster of Differentiation 20",oncology,immune checkpoint,Phase 1/2,No,,,No,,,Yes,Engager proteins,https://www.linkedin.com/company/aletabio,Yes,bispecifics,https://www.linkedin.com/company/aletabio,No,,,No,,,No,,,Yes,CAR T cells,https://www.linkedin.com/company/aletabio,No,,,No,,,Yes,Immune cell engagers,https://www.linkedin.com/company/aletabio
affyimmune therapeutics inc,2024-11-25 13:02:12,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR T therapy for cancer,https://www.linkedin.com/company/affyimmune,No,,,No,,,No,,
bluerock therapeutics llc,2025-10-16 14:30:35,No,OpCT-001; bemdaneprocel,Primary Photoreceptor Diseases; Parkinson's Disease,ophthalmology; neurology,other,Phase 1; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"cell therapy, iPSC-derived cell therapy candidate",https://www.linkedin.com/company/bluerocktx,No,,,No,,,No,,
ascidian therapeutics inc,2025-10-16 15:24:11,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,"resulting in full-length, functional proteins at the right levels",https://www.linkedin.com/company/ascidian-therapeutics,No,,,No,,,No,,,Yes,rewriting RNA,https://www.linkedin.com/company/ascidian-therapeutics,Yes,redefining the treatment of disease by rewriting RNA,https://www.linkedin.com/company/ascidian-therapeutics,No,,,No,,,No,,
aavantgarde bio srl,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,AAVB-039; AAVB-081,"ABCA4, ATP-binding cassette sub-family A member 4",inherited retinal diseases,other,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Gene Therapy,https://www.linkedin.com/company/aavantgarde-bio,No,,,No,,,No,,
accuredit therapeutics (suzhou) co ltd,2025-10-07 02:40:17,Yes,ART001; ART002,"TTR, Transthyretin; PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9",rare diseases; cardiovascular,enzyme; enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,in vivo gene editing therapy,https://www.prnewswire.com/news-releases/accuredit-therapeutics-art001-becomes-chinas-first-gene-editing-therapy-to-receive-fda-regenerative-medicine-advanced-therapy-rmat-designation-302468037.html,No,,,No,,,Yes,lipid nanoparticle (LNP)-delivered in vivo gene editing therapies,https://www.prnewswire.com/news-releases/accuredit-therapeutics-art001-becomes-chinas-first-gene-editing-therapy-to-receive-fda-regenerative-medicine-advanced-therapy-rmat-designation-302468037.html
steminent biotherapeutics inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Stemchymal,Spinocerebellar Ataxia,CNS,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Stem cell therapy Stemchymal® for Spinocerebellar Ataxia (SCA),https://www.reprocell.com/news/announcement-by-steminent-biotherapeutics-phase-ii-clinical-trial-results-in-taiwan-for-spinocerebellar-ataxia-treatment-stemchymal,No,,,No,,,No,,
tmunity therapeutics inc,2022-12-20 11:49:00,Yes,Aucatzyl,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T uses genetically engineered T cells to help the body fight diseases like cancer.,https://www.biopharmadive.com/news/gilead-tmunity-car-t-acquisition-cell-therapy/639192/,No,,,No,,,No,,
allocure inc. (inactive),"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,TTFields,"Disease Name, Pancreatic Adenocarcinoma",oncology,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,innovative cell therapies for the treatment of acute kidney injury,https://matr.net/news/with-support-from-utah-fund-of-funds-allocure-inc-closes-14-5-million-series-a-financing-round/,No,,,No,,,No,,
precision biosciences inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,PBGENE-HBV; PBGENE-DMD; PBGENE-PMM; Azer-Cel,"HBV, Hepatitis B Virus; DMD, Duchenne Muscular Dystrophy; PMM, Primary Mitochondrial Myopathy; CD19, Cluster of Differentiation 19",infectious diseases; rare diseases; oncology,other; other; other; immune checkpoint,Phase 1; Preclinical; Preclinical; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"ARCUS genome editing platform, gene knock out, gene insertion, gene repair",https://www.linkedin.com/company/precision-biosciences-inc-,No,,,No,,,No,,
juno therapeutics inc,2014-09-05 00:00:00,No,Relmacabtagene Autoleucel,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell therapy,https://www.linkedin.com/company/juno-therapeutics,No,,,No,,,No,,
quell therapeutics ltd,No timestamp found,Yes,QEL-001; QEL-005; QEL-002; QEL-003,"HLA-A2, Human Leukocyte Antigen-A2",transplantation; autoimmune diseases; type 1 diabetes; inflammatory bowel disease,immune checkpoint,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,engineered T-regulatory (Treg) cell therapies,https://www.synconaltd.com/portfolio/clinical-companies/quell-therapeutics/,No,,,No,,,No,,
hopstem biotechnology llc,2025-06-16 03:08:18,Yes,Donanemab; Lecanemab; E2814; Gantenerumab; LY3372993; ABBV-916; Canakinumab,Amyloid Plaques; Neurofibrillary Tangles; Tau Protein; Beta-Amyloid,CNS; Alzheimer's Disease,other,Pre-registration; Phase 3; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"iPSC-derived cell therapy products, iPSC reprogramming patent, iPSC-derived cell product manufacturing, gene editing of human iPSCs",https://www.linkedin.com/company/hopstem,No,,,No,,,Yes,"3D brain organoids, Organ-on-chips",https://www.linkedin.com/company/hopstem
neuroplast bv,2021-12-17 00:00:00,Yes,Neuro-Cells®,Not specified,neurodegenerative diseases; spinal cord injury; traumatic brain injury; frontotemporal dementia,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"stem cell therapy, Neuro-Cells®, autologous platform stem cell therapy",https://www.neuroplast.com/,No,,,No,,,No,,
repertoire immune medicines inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,RPTR-1-201,Not specified,oncology,other,Phase 1,No,,,No,,,No,,,Yes,our lead TCR bispecific antibody which is entering the clinic for the treatment of solid tumors,https://www.linkedin.com/company/repertoire-immune-medicines,No,,,No,,,No,,,Yes,Torque was developing a new class of cellular immunotherapy that directed the immune response against solid and hematologic tumors,https://www.flagshippioneering.com/companies/repertoire-immune-medicines,Yes,multi-year strategic collaboration with Bristol Myers Squibb to develop tolerizing vaccines for up to three autoimmune diseases,https://www.prnewswire.com/news-releases/repertoire-immune-medicines-and-bristol-myers-squibb-announce-multi-year-strategic-collaboration-to-develop-tolerizing-vaccines-for-autoimmune-diseases-302127861.html,No,,,Yes,"Deep-Primed T-cell therapeutics, which would allow doctors to non-genetically modify specific subsets of a patient’s own immune cells",https://www.flagshippioneering.com/companies/repertoire-immune-medicines
novadip biosciences sa,2025-10-14 09:52:47,No,NVD-003,"Disease Name, Osseous Non-Union Indications",rare diseases; musculoskeletal conditions,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,autologous therapy derived from ASCs,https://be.linkedin.com/company/novadip-biosciences-s-a-,No,,,No,,,Yes,"regenerative tissue products, tissue regeneration technology platform",https://be.linkedin.com/company/novadip-biosciences-s-a-
hopstem biotechnology inc,2025-06-16 03:08:18,Yes,Not specified,Not specified,ocular diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"iPSC-derived cell therapy products, cell therapy products and pipelines, targeting CNS diseases, optical diseases and tumor",https://www.linkedin.com/company/hopstem,No,,,No,,,Yes,"3D brain organoids, Organ-on-chips, knockout, knockin and gene editing of human iPSCs",https://www.linkedin.com/company/hopstem
lion tcr pte ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,Aucatzyl,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Approved,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Exciting developments in RNA therapeutics at the 2025 Nucleic Acid Therapeutics Initiative (NATi) RNA Symposium,https://sg.linkedin.com/company/lion-tcr,Yes,mRNA-encoded TCR-T cell therapy for solid tumors,https://sg.linkedin.com/company/lion-tcr,No,,,No,,,No,,
edigene inc,2025-04-20 12:07:36,No,ET-01,Not specified,Not specified,Not specified,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,Yes,LEAPER-based in vivo RNA base editing,https://www.linkedin.com/company/edigene/,Yes,"ex vivo gene-editing hematopoietic stem cells, ex vivo gene-editing T cells for allogeneic CAR-T",https://www.linkedin.com/company/edigene/,No,,,No,,,No,,
hrain biotechnology co ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Aucatzyl; bb2121; UCART19; UCART123; CMD-501; CMD-502,"CD19, Cluster of Differentiation 19; BCMA, B-cell Maturation Antigen; GD2, Disialoganglioside GD2; CD20, Cluster of Differentiation 20; CD22, Cluster of Differentiation 22; Claudin18.2",oncology,immune checkpoint,Approved; Phase 1; Preclinical,No,,,No,,,No,,,Yes,single-chain variable fragment (scFv) derived from human antibody (41D12),https://pubmed.ncbi.nlm.nih.gov/38637886/,No,,,No,,,No,,,Yes,chimeric antigen receptor T (CAR-T) cells,https://pubmed.ncbi.nlm.nih.gov/38637886/,No,,,No,,,Yes,nanobody-based CD70 CAR-T cells,https://pubmed.ncbi.nlm.nih.gov/38637886/
synthekine inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,SYNCAR-001; STK-009,"CD19, Cluster of Differentiation 19; IL-2, Interleukin-2",autoimmune diseases; oncology,immune checkpoint; cytokine,Phase 1,No,,,No,,,Yes,engineered cytokine therapeutics,https://www.linkedin.com/company/synthekine,No,,,No,,,No,,,No,,,Yes,cytokine-enabled cell therapy regimen,https://www.linkedin.com/company/synthekine,No,,,No,,,No,,
metcela inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,MET-097i; MET-233i; MET-224 o; MET-097 o,"GLP-1, Glucagon-like Peptide-1 receptor; Amylin",metabolic diseases,gpcr; other,Phase 1/2; IND-CTA Enabling,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"specific fibroblast cells we call “VCF”, that we obtain from the patient’s own heart",https://www.linkedin.com/company/metcela-inc/?trk=ppro_cprof,No,,,No,,,No,,
carisma therapeutics inc,2025-06-23 19:26:40,Yes,CT-0525; CT-2401; CT-1119,"HER2, Human Epidermal Growth Factor Receptor 2; Mesothelin; GPC3, Glypican-3",oncology; fibrosis,other; other; other,Phase 1; Preclinical; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors,"https://www.linkedin.com/company/carisma-therapeutics#:~:text=Carisma%20Therapeutics%20Inc.%20is%20a,cancer%20and%20other%20serious%20diseases.",No,,,No,,,Yes,"engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response","https://www.linkedin.com/company/carisma-therapeutics#:~:text=Carisma%20Therapeutics%20Inc.%20is%20a,cancer%20and%20other%20serious%20diseases."
scg cell therapy pte ltd,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,Yes,"develops a broad and unique pipeline of T cell therapies, antibodies",https://sg.linkedin.com/company/scgcell,No,,,No,,,Yes,advance ribonucleic acid (RNA)-based therapeutic manufacturing process development and clinical translation,https://www.prnewswire.com/apac/news-releases/scg-cell-therapy-partners-astar-to-accelerate-rna-based-therapeutic-development-in-singapore-302337988.html,Yes,RNA-based cell and gene therapy,https://www.prnewswire.com/apac/news-releases/scg-cell-therapy-partners-astar-to-accelerate-rna-based-therapeutic-development-in-singapore-302337988.html,Yes,mRNA vaccine manufacturing process development,https://www.prnewswire.com/apac/news-releases/scg-cell-therapy-partners-astar-to-accelerate-rna-based-therapeutic-development-in-singapore-302337988.html,No,,,No,,
medinno inc,2023-11-16 00:00:00,Yes,Not specified,Not specified,musculoskeletal diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"Gene therapy, Neural stem cell, Mesenchymal stem cell",https://www.linkedin.com/company/medinno,No,,,No,,,No,,
american gene technologies international inc,Error: Connection failed - 403 Client Error: Forbidden for url: https://www.c,No,AGT103-T,Gag-specific CD4 T cells,infectious diseases,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,gene and cell therapies for infectious diseases,https://www.globenewswire.com/news-release/2025/07/22/3119612/0/en/American-Gene-Technologies-Announces-Promising-Results-from-AGT103-T-HIV-Functional-Cure-Program-Presented-as-Late-Breaker-at-International-AIDS-Society-2025.html,No,,,No,,,No,,
beijing immunochina pharmaceuticals co ltd,"Error: Connection failed - HTTPConnectionPool(host='imunopharm.com', port=80)",Yes,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell therapy drugs,https://www.bloomberg.com/profile/company/1692609D:CH,No,,,No,,,No,,
imunopharm technology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T cell therapies for hematologic malignancies and solid tumors,https://chambers.com/articles/junhe-aids-imunopharm-and-huadong-medicine-in-im19-injection-partnership,No,,,No,,,No,,
guangzhou reforgene medicine co ltd,2025-01-30 00:00:00,Yes,Not specified,Not specified,genetic disorders; complex diseases; oncology,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"gene-editing therapeutics, CRISPR and genomic technologies",https://www.linkedin.com/company/reforgene,No,,,No,,,No,,
ingenium pharmaceuticals gmbh,2007-07-03 00:00:00,Yes,Gengleucel,"MRD, Measurable Residual Disease",oncology; hematologic malignancies,other,Phase 2,Yes,innovative oral drugs for the treatment of major age related diseases,https://www.linkedin.com/company/ingenium-pharmaceuticals-ag,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
utc therapeutics inc,2022-02-01 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bioncart gmbh,"Error: Connection failed - HTTPSConnectionPool(host='www.bm-t.de', port=443):",No,MesemCart,"Disease Name, Knee Cartilage Repair",regenerative medicine; musculoskeletal disorders,other,Phase 1/2a,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"stem cell-based medicinal products for clinical use in humans – with a focus on innovative, allogeneic therapy concepts",https://www.linkedin.com/company/bioncart,No,,,No,,,No,,
shenzhen wingor biotechnology co ltd,2025-08-25 06:32:00,Yes,W-iNKT; MSC-EVs,Solid Tumors; Not specified,oncology; neurological diseases; degenerative diseases,immune checkpoint; other,Phase 1,Yes,exosome-conjugated small nucleic acid drug,https://www.prnewswire.com/news-releases/wingor-bio-lands-tens-of-millions-in-initial-funding-with-round-still-open-forges-ahead-on-stem-cell-drug-and-clinical-programs-302537579.html,No,,,No,,,No,,,No,,,No,,,Yes,exosome-conjugated small nucleic acid drug,https://www.prnewswire.com/news-releases/wingor-bio-lands-tens-of-millions-in-initial-funding-with-round-still-open-forges-ahead-on-stem-cell-drug-and-clinical-programs-302537579.html,Yes,specializing in cell and gene therapy,https://www.prnewswire.com/news-releases/wingor-bio-lands-tens-of-millions-in-initial-funding-with-round-still-open-forges-ahead-on-stem-cell-drug-and-clinical-programs-302537579.html,No,,,No,,,Yes,exosome therapy,https://www.prnewswire.com/news-releases/wingor-bio-lands-tens-of-millions-in-initial-funding-with-round-still-open-forges-ahead-on-stem-cell-drug-and-clinical-programs-302537579.html
genoimmune therapeutics biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,Novel tumor-specific polypeptide and use thereof,https://www.cbinsights.com/company/genoimmune,No,,,No,,,No,,,No,,,Yes,neoantigen-targeting T cell therapies,https://www.cbinsights.com/company/genoimmune,No,,,No,,,No,,
zhongsheng kangyuan biotechnology (beijing) co ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,DX126-262,"HER2, Human Epidermal Growth Factor Receptor 2",oncology,other,Phase 2,No,,,No,,,No,,,Yes,antibody drug discovery,https://www.bloomberg.com/profile/company/1950860D:CH,No,,,No,,,No,,,Yes,engineered cell lines development,https://www.bloomberg.com/profile/company/1950860D:CH,No,,,No,,,Yes,"cancer cell panel profiling, biomarker discovery",https://www.bloomberg.com/profile/company/1950860D:CH
rimo therapeutics inc,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",No,GT-02287; LINE-1 RT Inhibitors,"LINE-1 RT, LINE-1 Reverse Transcriptase; GBA, Glucocerebrosidase",neurodegenerative diseases; autoimmune diseases,enzyme,Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,radio-immuno metal-organic technology for cancer treatment,https://www.cbinsights.com/company/rimo-therapeutics
cell and gene therapy catapult,2025-10-17 11:30:02,Yes,TCB008,Not specified,oncology,Not specified,Compassionate Use,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell and gene therapy technologies,https://uk.linkedin.com/company/cgt-catapult,No,,,No,,,No,,
reneuron group plc,2015-08-10 00:00:00,Yes,CustomEX,Not specified,CNS,Not specified,Preclinical,Yes,"Targeted delivery of RNA, proteins, and small molecule therapeutics",https://www.reneuron.com/,No,,,Yes,"Targeted delivery of RNA, proteins, and small molecule therapeutics",https://www.reneuron.com/,No,,,No,,,No,,,Yes,Targeted delivery of RNA,https://www.reneuron.com/,Yes,"Built on a foundation of proprietary, conditionally immortalised stem cell lines and iPSCs",https://www.reneuron.com/,No,,,No,,,Yes,Developing the next generation of Engineered Exosomes,"https://uk.linkedin.com/company/reneuron#:~:text=ReNeuron%20is%20a%20biotechnology%20company,technologies%20into%20clinically%20meaningful%20solutions."
achilles therapeutics plc,2022-08-21 00:00:00,No,ATL001,Clonal Neoantigens,oncology,other,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Personalised T cell therapies targeting clonal neoantigens,https://uk.linkedin.com/company/achillestx.com,No,,,No,,,No,,
cefo co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.investkorea.org', po",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,Yes,Enzyme,https://www.cefobio.biz/,No,,,No,,,No,,,No,,,Yes,developing stem cell therapy,"https://www.ventureradar.com/organisation/CEFO%20Co_%5Bdot%5D_,%20Ltd/39c010a7-c078-41f2-a857-1562775664d7",No,,,No,,,No,,
oricell therapeutics (shanghai) co ltd,Error: Connection failed - 404 Client Error: Not Found for url: https://www.p,Yes,Ori-C101; OriCAR-017; OriBs-001,"GPC3, Glypican-3; GPRC5D, G-protein coupled receptor family C group 5 member D; PD-L1/4-1BB, Programmed Death-Ligand 1/4-1BB",oncology,other; gpcr; immune checkpoint,Phase 2; Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"CAR-T cells, Bispecific CAR-T, Multi-specific CAR-T",https://www.linkedin.com/company/oricell-therapeutics-co-ltd/,No,,,No,,,No,,
hasumi international research foundation,2025-10-14 00:52:38,No,iNATURE,Neoantigens,oncology,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Investigation of Cellular and Humoral Immune Responses to Tumor-Associated Antigens and Survival of Patients with Advanced Cancers Treated with Combined Radiation and Immunotherapy,https://hasumifoundation.org/,No,,,No,,
qilu cell therapy technology co ltd,"Error: Connection failed - HTTPConnectionPool(host='yfswjt.com', port=80): Ma",Yes,MHB-088C,"CD276, B7-H3",oncology,immune checkpoint,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,induced pluripotent stem cells (iPSC)-derived chimeric antigen receptor macrophages (CAR-iMAC) for cancer immunotherapy,https://www.labiotech.eu/trends-news/cellorigin-biotech-and-qilu-pharmaceutical-to-develop-car-imac-cell-therapy/,No,,,No,,,No,,
erciyes university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,ChAdOx1-S; Ad5-nCoV,"SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2",infectious diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Bone Marrow Transplant and Stem Cell Therapy Center,https://www.topuniversities.com/universities/erciyes-university,No,,,No,,,No,,
university of california irvine,"Error: Connection failed - HTTPSConnectionPool(host='www.latimes.com', port=4",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of minnesota,Error: Connection failed - 403 Client Error: Forbidden for url: https://hoodl,No,Daporinad; FK866; GMX-1778; ABT-737,"NAMPT, Nicotinamide Phosphoribosyltransferase",oncology,enzyme,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
istanbul university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Guselkumab; Risankizumab; Mirikizumab; V565; SAR441566; Etrasimod; Zasocitinib; Brepocitinib; Ritlecitinib; VTX958; Tulisokibart; RVT-3101; Duvakitug; ABX464; MBF-118; E6011; AGMB-129; MORF-057; AZD7798,"IL-23/p19 subunit; TNFα, Tumor Necrosis Factor Alpha; S1P1, Sphingosine-1-Phosphate Receptor 1; S1P4, Sphingosine-1-Phosphate Receptor 4; S1P5, Sphingosine-1-Phosphate Receptor 5; TYK2, Tyrosine Kinase 2; JAK1, Janus Kinase 1; TL1A, TNF-like Ligand 1A; MiR-124, MicroRNA-124; PPARγ, Peroxisome Proliferator-Activated Receptor Gamma; CX3CL1, Fractalkine; TGFβRI/ALK5, Transforming Growth Factor Beta Receptor I/Activin Receptor-Like Kinase 5; α4β7, Alpha4 Beta7 Integrin Receptor; CCR9, C-C Motif Chemokine Receptor 9",gastroenterology; inflammatory bowel disease; Crohn's disease,cytokine; cytokine; cytokine; cytokine; cytokine; gpcr; kinases; kinases; kinases; kinases; cytokine; cytokine; cytokine; other; nuclear receptors; cytokine; enzyme; gpcr; gpcr,Phase III; Phase III; Phase III; Phase II; Phase II; Phase II/III; Phase II; Phase II; Phase II; Phase II; Phase IIa; Phase II; Phase IIb; Phase IIb; Phase IIa; Phase II; Phase IIa; Phase II; Phase IIa,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mahidol university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of illinois at chicago,"Error: Connection failed - HTTPSConnectionPool(host='www.uillinois.edu', port",No,K102; K110,Not specified,neurology; autoimmune diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of calgary,2025-10-18 12:57:37,No,TREMFYA,"IL-23, Interleukin-23; CD64, Fc-gamma receptor I",immunology; dermatology; rheumatology; gastroenterology,cytokine,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
huazhong university of science & technology,"Error: Connection failed - HTTPSConnectionPool(host='hust.cucas.cn', port=443",No,IBI363; IBI343; Sintilimab; IBI354; IBI130,"PD-1, Programmed Cell Death Protein 1; IL-2α, Interleukin-2 alpha; CLDN18.2, Claudin 18.2; HER2, Human Epidermal Growth Factor Receptor 2; TROP2, Trophoblast Cell Surface Antigen 2",oncology; autoimmune; gastrointestinal cancer; hematologic malignancies,immune checkpoint; cytokine; other; other; other,Phase 3; Phase 1; Phase 1b; Phase 1; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of alabama at birmingham,"Error: Connection failed - HTTPSConnectionPool(host='www.uab.edu', port=443):",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of southern california,2025-10-03 10:00:00,No,K102; K110,"ERβ, Estrogen Receptor Beta",CNS; neurodegenerative diseases,nuclear receptors,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
hubei science and technology department,"Error: Connection failed - HTTPSConnectionPool(host='www.digiedupro.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
osaka university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,HS-001,Not specified,cardiovascular,Not specified,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
sun yat-sen university,2025-10-14 00:00:00,No,CPXM1; FLT4; INSR; CPZ; PXDN,"CPXM1, Carboxypeptidase X Member 1; FLT4, Fms Related Tyrosine Kinase 4; INSR, Insulin Receptor; CPZ, Carboxypeptidase Z; PXDN, Peroxidasin",ophthalmology,enzyme; kinases; enzyme; enzyme; enzyme,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of montpellier,"Error: Connection failed - HTTPSConnectionPool(host='www.umontpellier.fr', po",No,SPM001,Myddosome complex,immunology; oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ludwig-maximilians-university munich,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,bedaquiline; delamanid; pretomanid; rifapentine; moxifloxacin; gatifloxacin,"Disease Name, Tuberculosis",infectious diseases,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of edinburgh ,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Glioblastoma; Colorectal Cancer Liver Metastases; Hepatocellular Carcinoma; Non-Small Cell Lung Carcinoma,oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,developed a genetically engineered vaccine against Hepatitis B,https://www.topuniversities.com/universities/university-edinburgh,No,,,No,,
hokkaido university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Ensitrelvir; S-217622,"3CL protease, SARS-CoV-2 3CL Protease",infectious diseases,enzyme,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
base therapeutics,"Error: Connection failed - HTTPSConnectionPool(host='www.biospace.com', port=",Yes,BEAM-201,"CD7, Cluster of Differentiation 7; TRAC, T-cell receptor alpha constant; PDCD1, Programmed Cell Death Protein 1; CD52, Cluster of Differentiation 52",oncology,immune checkpoint,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,next-generation gene-editing and cell therapies,https://gobi.vc/companies/base-therapeutics-2/,No,,,No,,,Yes,AccuBase® base editing system and in vivo prime-editing platform,https://gobi.vc/companies/base-therapeutics-2/
shenzhen hemogen gene biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='www.globaldata.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
shanghai bendao gene technology co ltd,"Error: Connection failed - HTTPConnectionPool(host='www.ennovationvc.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
axovia therapeutics ltd,"Error: Connection failed - HTTPSConnectionPool(host='tracxn.com', port=443): ",Yes,AXV101,"BBS1, Bardet-Biedl Syndrome 1",rare diseases; ophthalmology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,AAV gene therapies,https://uk.linkedin.com/company/axoviatherapeutics,No,,,No,,,No,,
"wake forest university;national autonomous university of nicaragua;ministry of health, nicaragua",2026-05-17 00:00:00,No,Not specified,Not specified,infectious diseases,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
rush university medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,developing and testing the effectiveness and safety of new therapies,https://www.linkedin.com/company/rush-university-medical-center,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
netherlands organisation for health research and development,"Error: Connection failed - HTTPSConnectionPool(host='www.glopid-r.org', port=",Yes,Bempegaldesleukin; Tiragolumab; Adavosertib; Teclistamab; Talquetamab; Glofitimab; Magrolimab; Pirtobrutinib; Mosunetuzumab; Zilovertamab Vedotin; Elacestrant; Mirvetuximab Soravtansine; Telisotuzumab Vedotin,"BTK, Bruton Tyrosine Kinase; CD20, Cluster of Differentiation 20; CD3, Cluster of Differentiation 3; ROR1, Receptor Tyrosine Kinase-like Orphan Receptor 1; ESR1, Estrogen Receptor Alpha; Folate Receptor Alpha; c-Met, Mesenchymal-Epithelial Transition Factor",oncology; hematology; breast cancer; ovarian cancer; lung cancer,kinases; immune checkpoint; other; nuclear receptors; other; other; kinases,Phase 3; Phase 3; Phase 2; Approved; Phase 2; Phase 2; Phase 2; Phase 1; Approved; Phase 1; Phase 3; Phase 2; Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,new animal-free models,https://www.animalfreeinnovationtpi.nl/partners-tpi/zonmw
oregon health & science university,2025-10-01 15:55:12,Yes,aducanumab; donanemab; lecanemab; gantenerumab; solanezumab,"Amyloid, Amyloid Beta Plaques and Oligomers; Tau, Tau Protein; Inflammation",CNS; neurodegenerative diseases,other,Approved; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,transforming human skin cells into eggs that can be fertilized in the lab,https://www.oregonlive.com/health/2025/10/ohsu-researchers-create-human-eggs-from-skin-cells-pointing-to-new-frontier-in-fertility-treatment.html,No,,,No,,,No,,
university hospitals cleveland medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Fenofibrate; AMT-260,"CD40–TRAF2 pathway; p53, Tumor Suppressor Gene; AAV9, Adeno-Associated Virus 9",gastroenterology; oncology; CNS,cytokine; other; other,Phase 1; Phase 1/Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
children''s hospital of philadelphia,2025-10-17 20:00:01,Yes,CDX0239-PBD; DFMO,"ALK, Anaplastic Lymphoma Kinase; MYCN",oncology; pediatric cancers,kinases; other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"personalized gene editing therapy developed in collaboration with Penn Medicine, University of Pennsylvania Health System",https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,Yes,The hepatitis B vaccine is safe and highly effective,https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,No,,,No,,
children's hospital of philadelphia,2025-10-17 20:00:01,Yes,RP-A501,"LAMP-2, Lysosome-Associated Membrane Protein-2",rare diseases; cardiovascular,enzyme,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,personalized gene editing therapy developed in collaboration with Penn Medicine,https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,Yes,The hepatitis B vaccine is safe and highly effective,https://www.linkedin.com/company/the-childrens-hospital-of-philadelphia,No,,,No,,
novartis ag,"Error: Connection failed - HTTPSConnectionPool(host='seekingalpha.com', port=",No,Ianalumab,Not specified,immunology,Not specified,Phase 3,Yes,"Fabhalta (iptacopan) is an oral, Factor B inhibitor",https://www.novartis.com/news/media-releases/novartis-fabhalta-iptacopan-meets-phase-iii-primary-endpoint-slows-kidney-function-decline-patients-iga-nephropathy-igan,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
st. jude children’s research hospital inc,2025-10-16 18:00:24,Yes,Not specified,Not specified,oncology,Not specified,Not specified,Yes,investigating mutations in influenza proteins and their impact on pathogenicity,https://www.linkedin.com/company/st-jude-childrens-research-hospital,No,,,Yes,examining aberrant signaling through cell-surface receptors in cancer progression,https://www.linkedin.com/company/st-jude-childrens-research-hospital,Yes,development of one of the nation’s largest immunotherapy research programs for children with cancer,https://www.cancer.gov/research/infrastructure/cancer-centers/find/stjude,No,,,No,,,No,,,Yes,"application of CAR T-cell therapy in treating childhood acute leukemia, lymphoma and solid tumors",https://www.linkedin.com/company/st-jude-childrens-research-hospital,No,,,No,,,No,,
medical college of wisconsin,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Abemaciclib; Durvalumab; Asciminib; Atezolizumab,"CDK, Cyclin-Dependent Kinase; HER2, Human Epidermal Growth Factor Receptor 2; Not specified; CD19, Cluster of Differentiation 19",oncology; sarcoma; breast cancer; leukemia; hematologic/blood related cancers; thoracic cancers,kinases; immune checkpoint; kinases; immune checkpoint,Phase 2; Phase 3; Phase 2; Phase 2/Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
allovir inc,2025-03-18 20:21:39,Yes,Posoleucel; ALVR106; ALVR109,BK virus; Epstein-Barr virus; Human herpesvirus 6; Adenovirus; Cytomegalovirus; Virus-associated hemorrhagic cystitis; Respiratory syncytial virus; Influenza; Human metapneumovirus; Parainfluenza virus; COVID-19,infectious diseases,other,Phase 2; Failed,No,,,No,,,Yes,"TH103 is a fully humanized, recombinant fusion protein",https://www.globenewswire.com/news-release/2025/03/18/3044996/0/en/Kalaris-Announces-Closing-of-Merger-with-AlloVir.html,No,,,No,,,Yes,"TH103 is a fully humanized, recombinant fusion protein",https://www.globenewswire.com/news-release/2025/03/18/3044996/0/en/Kalaris-Announces-Closing-of-Merger-with-AlloVir.html,No,,,No,,,No,,,No,,,No,,
kalaris therapeutics inc,2025-10-18 14:46:03,Yes,TH103,"VEGF, Vascular Endothelial Growth Factor",retinal diseases; neovascular age-related macular degeneration; diabetic macular edema; retinal vein occlusion,cytokine,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina,https://www.ophthalmologytimes.com/view/kalaris-and-allovir-inc-complete-merger
massachusetts general hospital,2025-10-01 22:05:49,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
beijing you''an hospital,Error: can't compare offset-naive and offset-aware dateti,No,JS207,"PD-1, Programmed Cell Death Protein 1; VEGF, Vascular Endothelial Growth Factor",oncology,immune checkpoint; other,Phase 2/3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
sidney kimmel comprehensive cancer center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
bristol-myers squibb co,2025-10-18 13:00:01,Yes,iza-bren; BL-B01D1,"EGFR, Epidermal Growth Factor Receptor; HER3, Human Epidermal Growth Factor Receptor 3",oncology,other,Phase 1,Yes,targeted therapies,https://www.linkedin.com/company/bristol-myers-squibb,No,,,No,,,Yes,bispecific antibodies,https://www.linkedin.com/company/bristol-myers-squibb,Yes,ADCs,https://www.linkedin.com/company/bristol-myers-squibb,No,,,No,,,Yes,Unlocking the Promise of Cell Therapy,https://www.linkedin.com/company/bristol-myers-squibb,No,,,Yes,targeted protein degradation,https://www.linkedin.com/company/bristol-myers-squibb,No,,
huaian first people''s hospital,"Error: Connection failed - HTTPSConnectionPool(host='www.sinophi.com', port=4",No,Cadonilimab,"PD-1, Programmed Cell Death Protein-1; CTLA-4, Cytotoxic T Lymphocyte Antigen-4",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
organogenesis holdings inc,2025-10-17 19:36:58,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"regenerative medicine, bio-active wound healing, soft tissue regeneration",https://www.linkedin.com/company/organogenesis
hong kong children''s hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of michigan comprehensive cancer center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Reqorsa,"ALK, Anaplastic Lymphoma Kinase; TUSC2, Tumor Suppressor Candidate 2",oncology,kinases; other,Preclinical,Yes,nearly 50 cancer drug development projects currently underway,https://www.cancer.gov/research/infrastructure/cancer-centers/find/umichiganccc,No,,,No,,,Yes,inotuzumab ozogamicin is a monoclonal antibody,https://www.rogelcancercenter.org/clinical-trials/find-clinical-trials,Yes,"inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a toxic agent called ozogamicin",https://www.rogelcancercenter.org/clinical-trials/find-clinical-trials,No,,,No,,,Yes,Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 directed CART Cell Therapy,https://www.rogelcancercenter.org/clinical-trials/find-clinical-trials,No,,,No,,,Yes,Researchers at Rogel Cancer: were the first to identify cancer stem cells in solid tumors,https://www.cancer.gov/research/infrastructure/cancer-centers/find/umichiganccc
roger williams medical center,"Error: Connection failed - HTTPSConnectionPool(host='www.wpri.com', port=443)",No,CARVYKTI; YESCARTA; TECARTUS; KYMRIAH; MM-001; CEA-001; RWMC-IPC 001,"CD38; CEA, Carcinoembryonic Antigen; PSMA, Prostate-Specific Membrane Antigen",oncology; immunology,immune checkpoint; other,Approved; Phase 1; Phase Ib/II,No,,,No,,,No,,,Yes,development of new cancer treatments such as T-Cell immunotherapy,https://www.chartercare.org/locations/rwmc/,No,,,No,,,No,,,Yes,CAR T-cell therapy for the treatment of adult patients with relapsed or refractory multiple myeloma,https://www.chartercare.org/,No,,,No,,,No,,
shenzhen second people''s hospital,"Error: Connection failed - HTTPSConnectionPool(host='med.szu.edu.cn', port=44",No,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
uclas jonsson comprehensive cancer center,2025-09-30 20:19:03,Yes,Pembrolizumab; LUT014; JD006,"PD-1, Programmed Cell Death Protein 1; BRAF, B-Raf Proto-Oncogene Serine/Threonine Kinase; CDK4/6, Cyclin-Dependent Kinase 4/6",oncology,immune checkpoint; kinases; kinases,Phase 3; Phase 2; Preclinical,Yes,"Successful targeted cancer therapies such as trastuzumab, imatinib, enzalutamide, and others were developed from basic studies performed in Center laboratories",https://www.cancer.gov/research/infrastructure/cancer-centers/find/uclajonsson,No,,,No,,,Yes,Successful targeted cancer therapies such as trastuzumab,https://www.cancer.gov/research/infrastructure/cancer-centers/find/uclajonsson,Yes,PSMA-targeted radioligand therapy,https://www.linkedin.com/company/jonsson-cancer-center,No,,,No,,,No,,,No,,,No,,,No,,
jinan central hospital,2019-06-10 00:00:00,No,Spesolimab; Sodium Phenylbutyrate; Nitisinone; Emapalumab; Selumetinib; Sirolimus; Octreotide; Dimethyl Fumarate; Lanreotide; Miglustat; Narlumosbat; Sapropterin; Pirfenidone; Naxitamab; Pembrolizumab; Vemurafenib; Trametinib; Riociguat; Luspatercept; Eculizumab; Mepolizumab; Vigabatrin; Risdiplam; Tafamidis; Clobazam,Not specified,rare diseases; oncology; CNS; cardiovascular; metabolic diseases,Not specified,Marketed,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
la paz university hospital,"Error: Connection failed - HTTPSConnectionPool(host='www.comunidad.madrid', p",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
wake forest university health sciences,"Error: Connection failed - HTTPSConnectionPool(host='taggs.hhs.gov', port=443",No,GTB-3650; GTB-5550,CD33; B7H3,oncology,immune checkpoint; other,Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nkgen biotech inc,2025-10-09 13:39:50,Yes,Troculeucel; SNK01,"Disease Name, Alzheimer’s disease; Disease Name, Neurodegenerative disorders; Disease Name, Cancers",neurology; oncology,other,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapeutics",https://www.globenewswire.com/news-release/2025/09/09/3146867/0/en/NKGen-Biotech-Inc-Announces-Completion-of-NKMax-Co-Ltd-Acquisition-Gains-Full-Control-of-Global-Manufacturing-and-Intellectual-Property-Assets.html,No,,,No,,,No,,
recibio inc,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
arcellx inc,2025-10-14 18:10:55,No,CART-ddBCMA; anito-cel; ACLX-001; ACLX-002,"BCMA, B-cell Maturation Antigen",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"cell therapy, CAR-T, anitocabtagene autoleucel (anito-cel)",https://www.linkedin.com/company/arcellx,No,,,No,,,No,,
san gerardo hospital,2020-04-20 00:00:00,No,Remdesivir,"ACE2, Angiotensin-Converting Enzyme 2",infectious diseases,enzyme,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
beth israel deaconess medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
shanghai cell therapy group co,"Error: Connection failed - HTTPSConnectionPool(host='www.cbinsights.com', por",No,Satri-cel; Zevor-cel; CT071; CT011; CT0590; CT0596; KJ-C2219; KJ-C2320; KJ-C2114; KJ-C2526,"Claudin18.2; BCMA, B-cell Maturation Antigen; GPRC5D; GPC3, Glypican-3; CD19/CD20; CD38; NKG2DL",oncology; hematologic malignancies; solid tumors; autoimmune diseases,other; other; other; other; other; other; other,Marketed; Phase 2; Phase 1; Phase 1; Phase 1; Phase 1; Phase 2; Phase 2; Phase 2; Phase 2,No,,,No,,,No,,,Yes,antibody research,https://www.cmocro.com/company/Shanghai+Cell+Therapy+Group+Co.%2CLtd./index.html,No,,,No,,,No,,,Yes,cellular pharmaceuticals,https://www.cmocro.com/company/Shanghai+Cell+Therapy+Group+Co.%2CLtd./index.html,No,,,No,,,No,,
the cleveland clinic foundation,2025-10-18 15:01:05,No,Lorundrostat; PALA,Aldosterone Synthase; Aspartate Transcarbamoylase,cardiovascular; oncology,enzyme,Phase 3; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
neximmune inc,2025-10-15 00:00:00,Yes,NEXI-001; NEXI-002,"Disease Name, Acute Myeloid Leukemia; Disease Name, Multiple Myeloma",oncology,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"NEXI-001, an allogeneic cell therapy",https://stockanalysis.com/quote/otc/NEXI/,No,,,No,,,Yes,"Artificial Immune Modulation, a vivo directly injectable modality platform",https://stockanalysis.com/quote/otc/NEXI/
ann & robert h lurie children’s hospital of chicago,2025-10-17 17:00:34,No,Echo 550,Osteosarcoma,oncology,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Vaccination during pregnancy is critical to protecting #newborns from this dangerous disease.,https://www.linkedin.com/company/ann-and-robert-h-lurie-children's-hospital-of-chicago,No,,,No,,
tscan therapeutics inc,2025-10-17 16:05:49,Yes,TSC-100; TSC-101; TSC-102; TSC-200; TSC-201; TSC-202; TSC-203; TSC-204,"HA-1, Not specified; HA-2, Not specified; CD45, Not specified; HPV16, Human Papillomavirus Type 16; MAGE-C2, Melanoma Antigen Gene C2; MAGE-A4, Melanoma Antigen Gene A4; PRAME, Preferentially Expressed Antigen in Melanoma; MAGE-A1, Melanoma Antigen Gene A1",oncology; hematologic malignancies; solid tumors; autoimmune disorders,other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"TCR-T cell therapy, T cell receptor (TCR)-engineered T cell (TCR-T) therapies",https://www.linkedin.com/company/tscan-therapeutics,No,,,No,,,No,,
shanghai jiading central hospital,2025-08-08 00:00:00,No,Pimicotinib; Irpagratinib,"CSF-1R, Colony Stimulating Factor 1 Receptor; FGFR4, Fibroblast Growth Factor Receptor 4",oncology,enzyme; kinases,Approved; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of minnesota medical school,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,"CISH, Cytokine-Inducible SH2-Containing Protein",oncology,immune checkpoint,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
legend biotech corp,2025-10-15 13:31:03,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"CAR-T, CAR-T Manufacturing, Cell Therapy",https://www.linkedin.com/company/legendbiotechco.,No,,,No,,,No,,
moorfields eye hospital nhs foundation trust,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,ophthalmology; neurodegenerative diseases; metabolic diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
the prince charles hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,NTM-001; CGT 1507; TRPA1 Antagonist,Not specified,acute pain,Not specified,Preclinical; Phase 1; Phase 2; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
baylor college of medicine,2025-10-04 00:00:00,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
jewish general hospital,2025-10-16 15:42:41,No,Alpha DaRT; ST-100,"CA19-9, Carbohydrate Antigen 19-9; Collagen",oncology; ophthalmology,enzyme; other,Phase 1; Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
seattle children''s hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,STRIvE-01; ENLIGHTen; PLAT-08,"EGFR, Epidermal Growth Factor Receptor; CD19, Cluster of Differentiation 19; Four Brain Cancer Antigens",oncology,other; immune checkpoint; other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
seattle children's hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,STRIvE-01; ENLIGHTen; PLAT-08; SCRI-CAR19,"EGFR, Epidermal Growth Factor Receptor; CD19, Cluster of Differentiation 19; DMG, Diffuse Midline Glioma; Brain Cancer Antigens",oncology; rare diseases; CNS,immune checkpoint; other,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
new york university school of medicine,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of texas health science center at houston,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Reqorsa; GPX-002,"TUSC2, Tumor Suppressor Candidate 2; MMP-9, Matrix Metalloproteinase-9",oncology; diabetes; CNS,other; enzyme,Preclinical; Phase 1,Yes,Researchers to study the effects of semaglutide on cocaine use disorder,https://www.uth.edu/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
icahn school of medicine at mount sinai,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
national cancer institute us,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,BBO-10203; BBO-8520,"RAS-PI3Kα, RAS-PI3K Alpha Interaction; KRASG12C, Kirsten rat sarcoma viral oncogene homolog G12C; NAMPT, Nicotinamide Phosphoribosyltransferase",oncology,other,Phase 1,Yes,anticancer drug extracted from the bark of the Pacific yew,https://www.nih.gov/about-nih/nih-almanac/national-cancer-institute-nci,No,,,No,,,Yes,monoclonal antibody Herceptin (Trastuzumab),https://www.nih.gov/about-nih/nih-almanac/national-cancer-institute-nci,No,,,No,,,No,,,Yes,first human gene therapy trial used to treat cancer,https://www.nih.gov/about-nih/nih-almanac/national-cancer-institute-nci,No,,,No,,,No,,
city of hope,2025-10-16 21:00:19,Yes,BRC-001,Breast Cancer,oncology,Not specified,Phase 1,No,,,No,,,Yes,human synthetic insulin,https://www.linkedin.com/company/city-of-hope,Yes,monoclonal antibodies,https://www.linkedin.com/company/city-of-hope,Yes,antibody-drug conjugates,https://www.linkedin.com/company/city-of-hope,No,,,No,,,Yes,Cancer Immunotherapeutics,https://www.cancer.gov/research/infrastructure/cancer-centers/find/beckmancityofhope,No,,,No,,,No,,
suzhou science and technology town hospital,"Error: Connection failed - HTTPConnectionPool(host='www.snd.gov.cn', port=80)",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mesoblast ltd,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Ryoncil; Revascor; Rexlemestrocel-L,Steroid-Refractory Acute Graft-Versus-Host Disease; Heart Failure with Reduced Ejection Fraction; Chronic Low Back Pain,immunology; cardiovascular; CNS,cytokine; other; other,Marketed; Preclinical; Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of rochester medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,HyBryte; SGX301; SGX302; SGX942; SGX945; RiVax; CiVax,Malignant T-cells,oncology; dermatology; infectious diseases; rare diseases,other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
alaunos therapeutics inc,2025-09-21 00:00:00,No,Not specified,"CD19, Cluster of Differentiation 19",oncology,immune checkpoint,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,TCR-T cell therapy,https://alaunos.com/,No,,,No,,,No,,
unc lineberger comprehensive cancer center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Not specified,Not specified,oncology,enzyme,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR-T immunotherapy,https://www.cancer.gov/research/infrastructure/cancer-centers/find/unclineberger,No,,,No,,,No,,
indiana university school of medicine,No timestamp found,No,ILT3 × CD3,"ILT3, Immunoglobulin-like transcript 3",oncology; immunology,immune checkpoint,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
hadassah medical organization,Error: Connection failed - HTTPSConnectionPool(host='hadassahinternational.or,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
ohsu knight cancer institute,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Indomethacin,"Macrophages, White Blood Cells",oncology,immune checkpoint,Preclinical,Yes,"imatinib (Gleevec), the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed",https://www.cancer.gov/research/infrastructure/cancer-centers/find/ohsuknight,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
immunic inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",Yes,IMU-838; vidofludimus calcium,"Nurr1, Nuclear Receptor Related 1",neurology,nuclear receptors,Phase 3,Yes,"developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases",https://www.linkedin.com/company/immunic-therapeutics,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
the university of texas md anderson cancer center (bay area),"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
the university of texas md anderson cancer center.,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,OBX-115,Not specified,oncology,Not specified,Phase 1,Yes,small molecule,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,Yes,biologic,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,Yes,immunotherapy,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,No,,,No,,,Yes,cell-based therapies,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,No,,,No,,
university of texas md anderson cancer center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,NX-5948; NX-2127; NX-1607; OBX-115,"Disease Name, Advanced B-cell Malignancies; Disease Name, Solid Tumors; Disease Name, Metastatic Melanoma",oncology,immune checkpoint,Phase 1,Yes,small molecule,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,Yes,biologic,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,Yes,immunotherapy,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,No,,,No,,,Yes,cell-based therapies,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson,No,,,No,,,Yes,Cancer Prevention and Population Sciences division,https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson
herbert irving comprehensive cancer center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Guselkumab; Risankizumab; Mirikizumab; V565; SAR441566; Etrasimod; Zasocitinib; Brepocitinib; Ritlecitinib; VTX958; Tulisokibart; RVT-3101; Duvakitug; ABX464; MBF-118; E6011; AGMB-129; MORF-057; AZD7798,"IL23/p19 subunit; TNFα, Tumor Necrosis Factor Alpha; S1P1, Sphingosine-1-Phosphate Receptor 1; S1P4, Sphingosine-1-Phosphate Receptor 4; S1P5, Sphingosine-1-Phosphate Receptor 5; TYK2, Tyrosine Kinase 2; JAK1, Janus Kinase 1; TL1A, TNF-like Ligand 1A; MiR-124, MicroRNA-124; PPARγ, Peroxisome Proliferator-Activated Receptor Gamma; CX3CL1, Fractalkine; TGFβRI/ALK5, Transforming Growth Factor Beta Receptor I/Activin Receptor-Like Kinase 5; α4β7, Alpha4 Beta7 Integrin Receptor; CCR9, C-C Motif Chemokine Receptor 9",gastroenterology; inflammatory bowel disease; Crohn's disease,cytokine; cytokine; gpcr; gpcr; gpcr; kinases; kinases; cytokine; cytokine; nuclear receptors; cytokine; kinases; other; other; cytokine; kinases; other; gpcr,Phase III; Phase III; Phase III; Phase II; Phase II; Phase II/III; Phase II; Phase II; Phase II; Phase II; Phase IIa; Phase II; Phase IIb; Phase IIb; Phase IIa; Phase II; Phase IIa; Phase II,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
h. lee moffitt cancer center & research institute inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Not specified,Not specified,oncology,Not specified,Not specified,Yes,"Chemical Biology and Molecular Medicine, which integrates chemical biology and systems biology technologies to develop new therapeutic approaches for the treatment of cancer.",https://www.cancer.gov/research/infrastructure/cancer-centers/find/moffitt,No,,,No,,,Yes,"Bispecific antibodies offer a promising new option for relapsed/refractory B-cell NHL, with response rates of 50–80%.",https://www.linkedin.com/company/moffittcancercenter,No,,,No,,,No,,,Yes,"Moffitt conducted nationwide clinical trials that led to the initial FDA approvals of CAR T-cell therapy, a personalized therapy using a patient’s own immune cells to fight certain types of cancers.",https://www.cancer.gov/research/infrastructure/cancer-centers/find/moffitt,No,,,No,,,Yes,Bispecific antibodies (BiTEs) therapy for patients with relapsed/refractory multiple myeloma.,https://www.linkedin.com/company/moffittcancercenter
h. lee moffitt cancer center and research institute hospital inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,oncology,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
first affiliated hospital of guangdong pharmaceutical university,2019-05-08 00:00:00,Yes,Compound 27,"FABP1, Fatty Acid Binding Protein 1; FABP4, Fatty Acid Binding Protein 4; PPARα, Peroxisome Proliferator-Activated Receptor Alpha; PPARγ, Peroxisome Proliferator-Activated Receptor Gamma; PPARδ, Peroxisome Proliferator-Activated Receptor Delta",metabolic diseases,enzyme; nuclear receptors,Preclinical,Yes,Molecular targeted therapy,https://pubmed.ncbi.nlm.nih.gov/40795794/,No,,,No,,,Yes,Immunotherapy,https://pubmed.ncbi.nlm.nih.gov/40795794/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
national cancer center hospital,2025-10-14 18:01:14,Yes,BBO-10203; BBO-8520,"RAS, Rat Sarcoma; PI3Kα, Phosphoinositide 3-Kinase Alpha; KRASG12C",oncology,kinases,Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
amgen inc,"Error: Connection failed - HTTPSConnectionPool(host='finance.yahoo.com', port",No,Tezspire,"TSLP, Thymic Stromal Lymphopoietin",immunology; respiratory diseases,cytokine,Approved,No,,,No,,,Yes,Amgen harnesses the best of biology and technology to fight the world’s toughest diseases,https://www.linkedin.com/company/amgen,Yes,BLINCYTO for the treatment of patients with acute lymphoblastic leukemia,https://www.marketbeat.com/instant-alerts/filing-koshinski-asset-management-inc-boosts-stock-holdings-in-amgen-inc-amgn-2025-10-18/,No,,,No,,,No,,,No,,,No,,,No,,,No,,
metrohealth medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,CAR-T; TIL,Not specified,oncology,immune checkpoint,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
wannan medical college first affiliated hospital,Error: Connection failed - HTTPSConnectionPool(host='www.intimestudyadvisors.,No,AP40,"TSPAN33, Tetraspanin-33",autoimmune diseases,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tongji university school of medicine,"Error: Connection failed - HTTPSConnectionPool(host='www.digiedupro.com', por",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
renji hospital,"Error: Connection failed - HTTPSConnectionPool(host='www.shsmu.edu.cn', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
zhujiang hospital of southern medical university,Error: Connection failed - HTTPSConnectionPool(host='www.chinaorganharvest.or,No,Not specified,"FOXP1, Forkhead Box Protein P1; SP8, Specificity Protein 8",oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
peking university shenzhen hospital,"Error: Connection failed - HTTPSConnectionPool(host='www.eyeshenzhen.com', po",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university hospital la paz,"Error: Connection failed - HTTPSConnectionPool(host='www.comunidad.madrid', p",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university hospital of lyon,Error: Connection failed - HTTPSConnectionPool(host='h2020qualitop.liris.cnrs,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
fundacio sant joan de deu,"Error: Connection failed - HTTPSConnectionPool(host='www.irsjd.org', port=443",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
nino jesus university children''s hospital,"Error: Connection failed - HTTPSConnectionPool(host='beamerproject.eu', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"exoskeletons, such as ATLAS 2030",https://www.btsbioengineering.com/customer-success/hospital-infantil-universitario-nino-jesus/
nino jesus university children's hospital,"Error: Connection failed - HTTPSConnectionPool(host='beamerproject.eu', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
leiden university medical center,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,aclarubicin; abiraterone; enzalutamide,Not specified,oncology,Not specified,Preclinical,No,,,No,,,Yes,blood proteins in people with Duchenne muscular dystrophy,https://www.lumc.nl/en/,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
g. papanikolaou hospital,"Error: Connection failed - HTTPSConnectionPool(host='commission.europa.eu', p",No,AMS-2140; C-Phycocyanin,Not specified,oncology; gene therapy,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,transplants of blood-producing cells of all types,https://www.ithanet.eu/community/organisations?orgID=884,No,,,No,,,No,,
matilde tettamanti foundation,"Error: Connection failed - HTTPSConnectionPool(host='it.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
tettamanti foundation m.de marchi onlus,"Error: Connection failed - HTTPSConnectionPool(host='it.wikipedia.org', port=",Yes,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,T cells genetically engineered to recognize and eliminate tumor cells through synthetic chimeric antigen receptors (CARs),https://pmc.ncbi.nlm.nih.gov/articles/PMC9077369/,No,,,No,,,Yes,CAR-based cellular immunotherapy using immune cell types aside from conventional T cells,https://pmc.ncbi.nlm.nih.gov/articles/PMC9077369/
casa sollievo della sofferenza hospital,"Error: Connection failed - HTTPSConnectionPool(host='operapadrepio.it', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
vardhman mahavir medical college & safdarjung hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
azellon ltd (inactive),"Error: Connection failed - HTTPSConnectionPool(host='gtr.ukri.org', port=443)",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
hyogo prefectural kobe children''s hospital,Error: Connection failed - HTTPSConnectionPool(host='www.hyogo-kodomo-hosp.co,No,Anti-CD19 CAR T-cell therapy,"CD19, Cluster of Differentiation 19",immunology; rare diseases,immune checkpoint,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
shanghai yuesai biotechnology co ltd,"Error: Connection failed - HTTPSConnectionPool(host='equalocean.com', port=44",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
steno diabetes center copenhagen,"Error: Connection failed - HTTPSConnectionPool(host='steno.dk', port=443): Ma",Yes,semaglutide; sotagliflozin; finerenone; tirzepatide,"GLP-1, Glucagon-Like Peptide-1 Receptor; SGLT2, Sodium-Glucose Cotransporter 2; Mineralocorticoid Receptor; GIP, Glucose-Dependent Insulinotropic Polypeptide Receptor",metabolic diseases; cardiovascular; nephrology,gpcr; enzyme; other,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university hospital of amiens,"Error: Connection failed - HTTPSConnectionPool(host='www.eib.org', port=443):",No,STRO-003; rinatabart sesutecan; ARV-766; EP262; EP547; ORKA-001; ORKA-002; clemizole hydrochloride; ripretinib; vimseltinib,"ROR1, Receptor Tyrosine Kinase-like Orphan Receptor 1; FRα, Folate Receptor Alpha; AR, Androgen Receptor; MRGPRX2, Mas-related Protein-coupled Receptor X2; MRGPRX4, Mas-related Protein-coupled Receptor X4; IL-23p19, Interleukin-23p19; IL-17A/F, Interleukin-17A/F; SCN1A, Sodium Channel Na v 1.1; Not specified",oncology; dermatology; CNS; rare diseases; immune disorders,kinases; other; nuclear receptors; gpcr; cytokine; ion channels; Not specified,Preclinical; Phase 1; Phase 2; Phase 3; Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
rigshospitalet,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
mink therapeutics inc,2025-09-29 13:30:08,No,AgenT-797; MiNK-215,"CD1d, Cluster of Differentiation 1d; FAP, Fibroblast Activation Protein",oncology; immunology,other; cytokine,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,allogeneic invariant natural killer T (iNKT) cell therapies,https://oncodaily.com/oncolibrary/mink-stock-cancer-nkt-cell-therapy,No,,,No,,,No,,
"mink therapeutics, inc.",2025-09-29 13:30:08,No,AgenT-797; MiNK-215,"CD1d, Cluster of Differentiation 1d; FAP, Fibroblast Activation Protein",oncology; immuno-oncology,other; cytokine,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,allogeneic invariant natural killer T (iNKT) cell therapies,https://oncodaily.com/oncolibrary/mink-stock-cancer-nkt-cell-therapy,No,,,No,,,No,,
anika therapeutics inc,2025-10-17 15:30:14,No,CINGAL; MONOVISC; ORTHOVISC,"Disease Name, Osteoarthritis of the Knee",orthopedics,other,Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,"hyaluronic acid (HA), a non-toxic and non-inflammatory biopolymer found in tissues throughout the body",https://www.massbio.org/members/anika-therapeutics-inc/
karolinska university hospital,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Not specified,Not specified,oncology; rare diseases; neuromuscular diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
gansu provincial cancer hospital,2024-11-05 02:03:02,No,Cadonilimab,"PD-1, Programmed Cell Death Protein-1; CTLA-4, Cytotoxic T Lymphocyte Antigen-4",oncology,immune checkpoint,Phase 3,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,heavy ion beams are regarded as the most optimal radiation for tumor treatment,https://www.stdaily.com/web/English/2024-09/02/content_222682.html
tata memorial hospital,2025-10-05 18:27:40,No,Not specified,Not specified,oncology,other,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
regina margherita children''s hospital,Error: can't compare offset-naive and offset-aware dateti,No,Not specified,Not specified,rare diseases; pediatric-onset rare diseases; nononcology,Not specified,Phase 1; Phase 2; Phase 3; Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Stem-cell transplants,https://lionmagazine.org/articles/enhancing-care-upgrading-the-pediatric-oncology-ward-at-regina-margherita-childrens-hospital/,No,,,No,,,No,,
indiana university,2025-10-04 06:21:00,No,SHIP1 inhibitor; MBX 2109,"SHIP1, INPP5D; Hypoparathyroidism",neurology; rare diseases,enzyme; other,Preclinical; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
university of oslo,"Error: Connection failed - HTTPSConnectionPool(host='www.uio.no', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
life sciences institute,"Error: Connection failed - HTTPSConnectionPool(host='lsi.ubc.ca', port=443): ",No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
statens serum institut,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,ProC6C,Not specified,infectious diseases,Not specified,Phase 2,No,,,No,,,Yes,recombinant antigens for vaccine formulations,https://www.transvac.org/Partners/statens-serum-institut-(ssi),Yes,"SSI Antibodies develops, produces and sells monoclonal and polyclonal antibodies",https://en.ssi.dk/,No,,,No,,,No,,,No,,,Yes,Center of Vaccine Research is internationally recognised for its vaccine research and clinical pipeline,https://www.transvac.org/Partners/statens-serum-institut-(ssi),No,,,No,,
innsbruck medical university,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",Yes,Amiodarone,"mTOR, Mechanistic Target of Rapamycin",oncology,kinases,Preclinical,Yes,Pharmaceutical Sciences – Drug Development and Regulatory Affairs – Master's Programme,https://studyinaustria.at/en/study/institutions/universities/medical-university-of-innsbruck,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
institute of post graduate medical education and research,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Clofazimine; Haloperidol; Bacampicillin; Benzocaine; Ciclopirox; Ciclosporin; Co-dergocrine mesilate; Dicycloverine; Fludrocortisone; Fluticasone; Isoxicam; Lansoprazole; Levopropoxyphene; Lomustine; Metixene; Myricetin; Niclosamide; Nocodazole; Pentoxifylline; Sirolimus; Thiamazole; Tocainide; Tretinoin; Valproic acid; Zuclopenthixol,Not specified,infectious diseases,Not specified,Preclinical,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
microbot medical inc,2025-10-03 20:59:50,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,LIBERTY® Endovascular Robotic System,https://www.globenewswire.com/news-release/2025/10/16/3167906/0/en/Microbot-Medical-to-Commercially-Debut-the-LIBERTY-System-at-The-Symposium-on-Clinical-Interventional-Oncology-Annual-Meeting.html
cook group inc,"Error: Connection failed - HTTPSConnectionPool(host='en.wikipedia.org', port=",No,Chronobead; Cook Magnetic Anastomosis Device; Cook Venous Valve System; Drug-Eluting Stent - Below The Knee; Duralift; Spectrus; Stratusflo; Thermoflo; TRAIPTA; Urology Unplugged; Zenith Connection Endovascular Covered Stent; Zenith Eterna; Zenith Fenestrated+ Endovascular Graft; Zenith P-Branch,Chronic Venous Insufficiency; Below The Knee; Tricuspid Annuloplasty; Aortic Aneurysm,vascular; urology; reproductive health; critical care; endoscopy; cardiovascular,Not specified,Preclinical; Phase 1; Phase 2; Phase 3; Approved,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
cancer research uk,2025-10-16 18:19:08,Yes,HTL0039732; NXE0039732,"EP4, Prostaglandin E2-type prostanoid receptor 4",oncology,gpcr,Phase 2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,CAR T-cell therapy,https://uk.linkedin.com/company/cancer-research-uk,No,,,No,,,No,,
the major extremity trauma research consortium,No timestamp found,No,ONP-002; MR-301; ACD 856; AP-188,"Steroid Receptors; Dopaminergic Receptors; Trk Receptors; Sigma Receptors; 5-HT2A, Serotonin 2A Receptor",neurology; traumatic brain injury; stroke recovery,nuclear receptors; gpcr; kinases; other,Phase 2; Phase 2; Phase 1; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
children''s research institute,No timestamp found,Yes,Not specified,Not specified,Not specified,Not specified,Not specified,Yes,developing an ecosystem on-site for innovations such as new drugs,https://research.childrensnational.org/,No,,,No,,,Yes,Antigen Assimilating Multispecific T Cell Engagers,https://www.seattlechildrens.org/research/research-institute/,No,,,No,,,No,,,Yes,cell processing facility that places us among the few pediatric facilities that meet strict FDA requirements for manufacturing therapies,https://www.seattlechildrens.org/research/research-institute/,No,,,No,,,No,,
children''s national research institute,No timestamp found,Yes,CLN-301,"CLN3, Ceroid Lipofuscinosis Neuronal 3",neurology; rare diseases,other,Phase 1/2,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,cell-based therapies,https://www.childrensnational.org/about-us/health-equity/investing-in-the-future-of-healthcare/research-opportunities,No,,,No,,,No,,
servier institute of international research,2025-10-09 07:43:20,No,Not specified,Not specified,Not specified,Not specified,Not specified,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,,No,,
astellas pharma inc,"Error: Connection failed - HTTPSConnectionPool(host='www.linkedin.com', port=",Yes,Enfortumab vedotin; Gilteritinib; Zolbetuximab; ASP1570; ASP2138; ASP2074; ASP1002; ASP3082,"Nectin-4; FLT3, Fms-like Tyrosine Kinase 3; Claudin 18.2; DGKζ, Diacylglycerol Kinase Zeta; Claudin 18.2; CD3, Cluster of Differentiation 3; TSPAN8, Tetraspanin 8; KRAS G12D, Kirsten Rat Sarcoma Viral Oncogene Homolog",oncology,immune checkpoint; kinases; other; other; immune checkpoint; immune checkpoint; immune checkpoint; other,Phase 3; Phase 3; Filed; Phase 1; Phase 1; Phase 1; Phase 1; Phase 1,No,,,No,,,No,,,No,,,No,,,No,,,No,,,Yes,Cell therapies are opening new pathways for restoring sight and transforming care for those affected by progressive and irreversible vision loss associated with retinal diseases.,https://www.linkedin.com/company/astellaspharmainc,No,,,No,,,No,,
